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In health the fungus Candida albicans resides as a harmless member of the normal human microbiota 
on mucosal surfaces and is tolerated by the immune system. However, when surrounding conditions 
change the host is unable to control fungal colonization. This enables C. albicans to switch from 
commensal to pathogenic state. Consequently the majority of infections arise from the colonizing 
fungi, but also nosocomial transmissions are possible. 
Candida species are the most frequent fungal commensals on the buccal mucosa and skin. After all, 
prevalence of Candida colonization depends on the investigated population and geographical region. 
Colonization rates appeared to be overestimated for the investigated region of southern Switzerland, 
but C. albicans remained the most prevalent species. C. albicans isolates from healthy and diseased 
individuals displayed an extensive genetic diversity, but neither distinct alleles nor clonal complexes 
could be correlated with the origin of the isolates. 
Furthermore we focused on the interaction of randomly selected natural isolates with the host, 
especially at mucosal sites, in the well-established model of oropharyngeal candidiasis. The isolates 
displayed no gross differences in growth or cell wall composition in vitro, but they triggered highly 
variable degrees of inflammation in vivo. High-pathogenic isolates induced a rapid and acute immune 
response leading to fungal clearance. Whereas, weak and delayed induction of Interleukin 17 (IL-17) 
and antimicrobial effector molecules by certain isolates correlated with their persistence in the 
mucosal epithelium. IL-17-mediated immunity has emerged as a critical mechanism of the host to 
regulate the antimicrobial response, thereby limiting fungal overgrowth at the epithelial barriers. This 
is conserved among C. albicans isolates, irrespective of the underlying pathogenicity. 
Complementarily, neutrophils contribute to host defense by preventing dissemination of highly 
pathogenic fungi. Albeit low-pathogenic persistent isolates do not induce neutrophil recruitment. The 
underlying mechanism of immune evasion of low-pathogenic isolates remains to be elucidated. In a 
co-infection with a low- and high-pathogenic isolate we demonstrated the persistence of the low-
pathogenic isolate despite the induction of a strong inflammatory response by the high-pathogenic 
isolate. The induced immune response led to the selective clearing of the high-pathogenic isolate 
irrespective of the close co-localization of both isolates at the same areas of the tongue. 
1 Summary           
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It is generally believed that the host immune status alone determines the outcome of the interaction 
between the commensal fungus and its host, resulting in either health or disease. This study 
demonstrates that the natural diversity of C. albicans comes into the limelight for the fine balance 
between commensalism and disease in vivo.  
 
 
 
 
Bei gesunden Individuen weilt der Pilz Candida albicans als harmloses Mitglied des normalen 
menschlichen Mikrobioms auf mukösen Oberflächen und wird vom Immunsystem toleriert. Ändern 
sich allerdings die Bedingungen, ist der Wirt nicht mehr in der Lage die Pilz-Kolonisierung zu 
kontrollieren. Dieser Umstand ermöglicht es C. albicans vom kommensalen in den pathogenen Zustand 
zu wechseln. Folglich werden die meisten Infektionen vom kolonisierenden Pilz hervorgerufen, 
obgleich auch nosokomiale Übertragungen möglich sind. 
Candida Spezies sind die häufigsten kommensalen Pilze in der Mundschleimhaut und auf der Haut. 
Nichtsdestotrotz ist die Häufigkeit der Kolonisierung mit Candida abhängig von der untersuchten 
Population und dem geographischen Gebiet. Die Kolonisierungsrate scheint für die untersuchte Region 
der Südschweiz überbewertet zu sein, allerdings bleibt C. albicans die vorherrschende Spezies. 
C.  albicans Isolate von gesunden und erkrankten Individuen zeigten eine sehr hohe genetische 
Diversität. Jedoch konnte keine Korrelation zwischen bestimmten Allelen oder klonalen Gruppen und 
der Herkunft der Isolate festgestellt werden. 
Des Weiteren haben wir die Interaktion zwischen zufällig ausgewählten klinischen Isolaten und dem 
Wirt untersucht, im Speziellen mit der Mukosa im bewährten oropharyngealen Candidiasis Model. Die 
Isolate zeigten keine massiven Unterschiede im Wachstum oder der Zusammensetzung der Zellwand 
in vitro, aber sie lösten in vivo stark unterschiedliche Grade der Inflammation aus. Hoch-pathogene 
Isolate induzierten eine schnelle und starke Immunantwort, welche zur kompletten Beseitigung des 
Pilzes führte. Wohingegen eine schwache und verspätete Induktion von Interleukin 17 (IL-17) und 
antimikrobiellen Effektor-Molekülen durch bestimmte Isolate mit der Persistenz im mukosalen 
Epithelium korrelierte. 
IL-17-vermittelte Immunität hat sich als entscheidender Wirtsmechanismus herausgestellt, welcher 
die antimikrobielle Antwort reguliert und dabei das Überwachsen des Pilzes an der Epithel-Barriere 
2 Zusammenfassung         
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limitiert. Dieser Mechanismus besteht konserviert bei allen Isolaten, unabhängig von ihrer 
Pathogenität. Komplementär tragen Neutrophile zur Wirtsantwort bei, indem sie die Ausbreitung von 
hoch-pathogenen Pilzen verhindern. Obgleich schwach pathogene Isolate keine Rekrutierung der 
Neutrophilen hervorrufen. Der zugrundeliegende Mechanismus der Immunevasion von schwach-
pathogenen Isolaten muss noch genauer erforscht werden. In einer Ko-Infektion mit einem schwach-
und einem hoch-pathogenen Isolat, konnten wir die Persistent des schwach-pathogenen Isolates 
zeigen, trotz der starken Immunantwort durch das hoch-pathogene Isolat. Die induzierte 
Immunantwort führte zu einer selektiven Beseitigung des hoch-pathogenen Isolates ungeachtet der 
nahen Ko-Lokalisation von beiden Isolaten an der gleichen Stelle der Zunge. 
Es wird allgemein angenommen, dass nur das Immunsystem des Wirtes den Ausgang der Interaktion 
zwischen dem kommensalen Pilz und dem Wirt bestimmt, was folglich zu Gesundheit oder Krankheit 
führt. Diese Studie zeigt deutlich, dass die natürliche Diversität von C. albicans an Bedeutung für das 
empfindliche Gleichgewicht zwischen Kommensalismus und Krankheit in vivo gewinnt. 
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 Candida albicans: from harmless commensal to pathogen 
In a world full of microbes, 1.5 million different fungal species are known (Butler 2010). Fungi appear 
in a broad range of shape, size and structure. They occur in the soil, on plants, animals, humans and in 
extreme environments such as hyperosmotic areas or the desert (Vaupotic et al. 2008). Fungi are also 
used in our daily life: to brew beer, make wine or raise bread dough. In addition to the use in food 
industry, fungi are also indispensable in the pharmaceutical industry. (Demain, Sanchez 2009). A 
majority of fungi positively contribute to people´s life and well' being and only a few hundred fungi are 
actually pathogenic for humans (Butler 2010).  
Those pathogenic species include Apergillus fumigatus, Histoplasma capsulatum and Cryptococcus 
neoformans, which live as environmental fungi, but can cause exogenous infections in humans 
(Casadevall 2008). However, most human fungal pathogens cause endogenous infections. They live as 
part of the normal microbiota on the epithelial surface of healthy individuals and only cause disease 
symptoms if natural barriers are breached. Malassezia and Candida are part of this group with an 
adaptation to an endogenous life (Hube 2009). 
The species of Candida belong to the phylus of ascomycetes and can be found both in human and other 
mammalian sources and also, to a lesser extent, in the environment (McManus, Coleman 2014). Only 
a few members are of clinical importance. Among those are Candida dubliniesnis, Candida tropicalis, 
Candida parapsilosis, Candida glabrata and Candida albicans ( Pfaller 1996; Pfaller et al. 2007). The 
most pathogenic and prevalent one is C. albicans, the 2nd most common nosocomial infection agent in 
the US (Mendes Giannini, M. J. S. et al. 2013; Delaloye, Calandra 2014). 
3.1.1 Polymorphism 
C. albicans is a polymorphic fungus, meaning it can switch between several morphological states (Odds 
1988). Only C. albicans and its closest relative C. dubliniensis can form true hyphae, and they can grow 
in the yeast and filamentous form (Jackson et al. 2009). 
The three main phenotypes of C. albicans are the yeast form (formerly called blastospores), 
pseudohyphae and true hyphae (Berman, Sudbery 2002) (Figure 1). Hyphae and pseudohyphae are 
classified as filamentous morphologies because of their growth in an elongated form. Pseudohyphae 
look similar to hyphae but are physiologically closer to yeast cells (Odds 1988; Sudbery et al. 2004). 
3  General Introduction         
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Pseudohyphal cells are usually ellipsoid and show a constriction at the septin ring (Sudbery 2001). In 
contrast, hyphal cells have parallel sides and true septa with pores for a cell-cell communication, which 
is non−existent in pseudohyphae (Odds 1988). In nature, a mix and/or intermediates of all 
morphological forms are found, such as parallel-sided pseudohyphae or elongated single yeast cells 
(Thompson et al. 2011).  
 
Figure 1. Morphological forms of C. albicans. (Top) Differential interference contrast microscopy 
(black bar 10 μm). (Bottom) schematic picture of each morphology (Thompson et al. 2011) 
 
It is generally believed that the yeast form appears during non-invasive commensalism and that, on 
the contrary, the hyphal form of the fungus is more invasive (Berman, Sudbery 2002). However in vivo 
studies revealed the expression of hyphae-associated genes, such as HWP1, during both 
commensalism and disease (Naglik, JR et al. 2006). In fact, both forms are found in infected organs 
(Odds 1988). It is proposed that during dissemination in the bloodstream, yeast cells are the 
predominant form due to their shape and size (Jacobsen et al. 2012). Serum components and blood 
are stimuli for hyphae formation, a hyphae to yeast switch after breaking the first epithelial barrier 
therefore seems rather unlikely. It is proposed that hyphae cells provide access for yeast cells to the 
underlying tissue and bloodstream (Jacobsen et al. 2012). A mechanism of contact sensing, or 
thigmotropism, allows hyphal cells to recognize and penetrate weak point of the host tissue (Gow et 
al. 2002). 
Recently novel morphological phenotypes have been discovered. The white and opaque morphologies 
are part of a tristable phenotype switching system including the gray phenotype (Tao et al. 2014). The 
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phenotypic switch between the white and opaque form correlate with mating and biofilm formation 
(Miller, Johnson 2002; Daniels et al. 2006). They show differences in terms of: activity of the secreted 
aspartyl protease (SAP), colony morphology, mating competency and virulence (Tao et al. 2014). 
3.1.2 Virulence factors 
C. albicans evolved several factors which contribute to the pathogenic potential (Mayer et al. 2013). 
Among them are various mechanisms of interaction with epithelial cells including adherence, invasion 
and induction of damage (Zhu, Filler 2010). Additionally, yeast-to-hyphae transition, secretion of 
hydrolytic enzymes and fast adaptation to environmental changes, helps C.  albicans to colonize 
diverse host niches (Mayer et al. 2013). A fast adaptation is also facilitated by the stress response to 
heat, oxidative, nitrosative or osmotic stress (Haynes et al. 2012). 
3.1.2.1 Adherence and Biofilm 
A basic requirement of the interaction between C. albicans and the host surfaces is adherence to 
epithelial cells. Therefore adherence to abiotic surfaces (e.g. catheters) or biotic surfaces (e.g. 
epithelial cells) are the first steps of colonization, growth and development of disease (Zakikhany et al. 
2007; Wachtler et al. 2011b). Hyphae formation and adhesion are closely related. After contact with 
host cells or abiotic surfaces, hyphae-associated adhesion genes are highly expressed (Jacobsen et al. 
2012). Adherence, and subsequent colonization, is also a known risk factor for disseminated 
candidiasis (Marr et al. 2000). C. albicans has different mechanisms of adherence and expresses 
different surface structures (Zhu, Filler 2010). The family of agglutinin-like surface structures (Als) 
consist of eight glycosylphosphatidylinositol (GPI)-anchored surface proteins that mediate adherence 
and invasion to host substrates (Zhao et al. 2005; Sheppard et al. 2004). The hyphal wall protein (Hwp1) 
is only expressed on hyphal cells and binds to proteins on the host surface by functionally mimicking 
host proteins (Ponniah et al. 2007). 
Hwp1 also binds to Als1 and Als3 and mediates cell-cell contact, which is especially important for 
biofilm formation (Nobile et al. 2008). Biofilm on medical devices counts as risk factor for systemic 
candidiasis as dispersed yeast cells from the biofilm can disseminate into the bloodstream (Uppuluri 
et al. 2010). 
3.1.2.2 Invasion 
A further key event of the C. albicans pathogenesis is cell invasion. In a murine model of mucosal 
candidiasis it was shown that C. albicans with a reduced ability to invade causes a less severe infection 
(Naglik, JR et al. 2008). Invasion into epithelial cells can occur through two distinct mechanisms: host 
induced endocytosis or fungal driven active penetration (Dalle et al. 2010; Wachtler et al. 2011b). The 
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interaction between Als3, a fungal invasin and E-cadherin or Human epidermal growth factor receptor 
2 (Her2) drives induced endocytosis. Her2 also forms a heterodimer with the epidermal growth factor 
receptor (EGFR) and leads to clathrin-dependent uptake of the fungus (Phan et al. 2007; Moreno-Ruiz 
et al. 2009; Zhu, Filler 2010). This usually occurs within the first hours after initial contact (Tang et al. 
2016). Als3 is expressed by hyphal cells, consequently endocytosis has only been observed for C. 
albicans hyphae (Phan et al. 2007; Zakikhany et al. 2007). Induced endocytosis is exclusively host 
driven, because inactivated hyphae are taken up in a similar manner than viable hyphae (Tang et al. 
2016). In contrast, active penetration is fungi−dependent; hyphal extension and consequential 
expression of SAPs are thus important factors (Naglik, JR et al. 2003a; Wachtler et al. 2011b). 
3.1.2.3 Damage 
During superficial candidiasis, damage is defined as the loss and permeabilization of the superficial 
epithelium (Farah et al. 2000). The mechanism of damage induction is not completely understood, but 
SAPs are known to play an important role. A large number of genes associated with damage is also 
involved in thigmotropism (Wachtler et al. 2011b). The capacity to induce damage is a feature of 
mucosal pathogens which distinguishes them from harmless commensals (Koropatnick et al. 2004). 
Recently, the first fungal cytolytic peptide toxin has been discovered. The secreted peptide, 
Candidalysin (Ece1), damages epithelial membranes probably by membrane permeabilization and 
calcium influx. Next to tissue damage, Ece1 induces epithelial immunity (Moyes et al. 2016). 
It has been shown that interepithelial penetration following the initial invasion might play a major role 
in damage induction by the fungus (Zakikhany et al. 2007). Beside the fungus, the inflammatory cells 
infiltrating in the infected tissue may lead to a substantial tissue damage (Wallach et al. 2014).  
3.1.3 Diversity of C. albicans isolates 
Natural isolates of C. albicans exhibit a high molecular diversity, at the level of chromosome 
rearrangements as well as single nucleotides (Afsarian et al. 2015; Selmecki et al. 2010).The variability 
in the karyotype of clinical isolates is still poorly understood (Rustchenko 2007; Merz et al. 1988; 
Rustchenko-Bulgac 1991). Genomic changes can be: loss of heterozygosity (LOH), aneuploidy and 
general chromosomal rearrangements or chromosome truncations (Rustchenko 2007; Selmecki et al. 
2010). Multiple repeat sequences are the favorable sites of translocation and are found on all 
chromosomes, except chromosome 3 (Chindamporn et al. 1998). It is suggested that extreme genomic 
changes reveal a fast adaptation mechanism to different stressors (Selmecki et al. 2010). It is most 
likely that this genomic rearrangements contribute to high variation in the phenotype. A single passage 
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through the mouse host increase the variability in phenotype and leads to genomic rearrangements ( 
Forche et al. 2005;Forche et al. 2009) . 
Based on variations on the genome level, a large spectrum of phenotypic attributes across isolates 
have been observed. Clinical isolates show quantitative variation in their ability to form biofilm (Li et 
al. 2003) as well as stress and antifungal resistance, growth rates and filamentation (Hirakawa et al. 
2015). Furthermore, striking intraspecies differences in virulence were found in a murine model of 
systemic infection (MacCallum et al. 2009).  
3.1.4 Types of Candida infections 
Vertical and ,to a lesser extent, horizontal transmission contribute to Candida colonization (Bliss et al. 
2008). Colonization is defined by a harmless co-existence with the host in equilibrium with the 
microbiome (Jacobsen et al. 2012). Most cases of candidiasis are caused by an endogenous source, 
such as C. albicans , which is a commensal in the oral cavity ( Pfaller 1996; Hattori et al. 2006; Shimizu 
et al. 2011). The appearance of C. albicans in the host can be differentiated in colonization, superficial 
infection and systemic infection (Odds 1994).  
3.1.4.1 Superficial infections 
3.1.4.1.1 Vulvovaginal candidiasis 
Half of all woman experience vulvovaginal candidiasis (VVC) at least once during the course of their 
life. Approximately 5 % of these woman develop recurrent episodes of vulvovaginal candidiasis (RVVC) 
(Mardh et al. 2002). Pregnancy and estrogen replacement in postmenopausal woman increase the risk 
of RVVC (Geiger A. M., Foxman 1996). Superficial infections are usually caused by a disturbance of the 
normal microbial flora or a compromised immune system. Vaginal candidiasis and symptomless 
colonization are equally common in healthy and HIV−positive woman (Schuman et al. 1998). This 
indicates that, in contrast to other Candida infections, vaginitis is not related to immunosupression, 
but rather to external predisposing factors like dysbiosis and antibiotic treatment (Mardh et al. 2002) 
3.1.4.1.2 Oral candidiasis 
Oral candidiasis is the most common oral infection in humans (Muzyka 2005). Among the local risk 
factors are denture wearing, poor mouth hygiene, intake of broad spectrum antibiotic and a high sugar 
diet. Several local but more likely systemic factors are known to increase the risk of developing the 
disease. A reduced immune status, like HIV infection, endocrine disease, chemotherapy and 
immunosuppressive drugs are part of systemic factors, with possibility of one patient presenting 
several of those factors simultaneously (Darwazeh, Darwazeh 2014). As opposed to vaginal candidiasis, 
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oropharyngeal candidiasis occurs in 80-90 % of HIV−positive patients (Samaranayake 1992). 
Consequently it is also referred as ¨the disease of the diseased¨ (Darwazeh, Darwazeh 2014).  
3.1.4.1.3 Chronic mucocutaneous candidiasis 
Chronic mucocutaneous candidiasis (CMC) is described as a heterologous group of disorders with a 
persistent, non-invasive Candida infection of the skin, nails and mucosa (Heimall et al. 2010; Puel et al. 
2011). In contrast to other superficial Candida infections, the underlying cause of disease is often 
genetic and not environmental. CMC is caused by acquired T-cell immunodeficiencies or inborn errors 
of immunity (Figure 2) (Milner, Holland 2013b). We will further concentrate on primary 
immundeficiencies underlying CMC. 
During an infection C. albicans invades and is recognized via Dectin 1, Dectin-2 by dendritic cells (DCs). 
This triggers, through the spleen tyrosine kinase (Syk), the expression of proinflammatory cytokines IL-
6, IL-23 and tumor necrosis factor ( TNF-α) mediated by caspase recruitment domain family member 
(CARD9) (Plato et al. 2013). 
IL-17A and IL-17F induction by T-cells and innate lymphoid cells requires IL-23 production by DCs. 
(Hirota et al. 2011; Kashem et al. 2015a). Signal transducer and activator of transcription 3 (STAT3) and 
STAT1 are required for the induction of Th17 cells. 
Patients with mutations in the activator of transcription 3 (STAT3), STAT1 and CARD9 display an 
impaired development of T-cells, which produce IL-17 and IL-22 ( Milner et al. 2008; Minegishi et al. 
2009; Glocker et al. 2009). Patients affected by autosomal recessive autoimmune polyendocrinopathy 
syndrome (APECED) have mutations in AIRE, which leads to high titers of antibodies against IL-17A, IL-
17F and IL-22 (Husebye et al. 2009). The central role of IL-17 in fungal immunity is promoted by the 
identification of mutations in IL-17F and IL-17RA in CMC patients (Puel et al. 2011). 
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Figure 2 Defects in IL-17-IL17 receptor pathway cause CMC. C. albicans invade and are recognized 
via Dectin1 and 2 by dendritic cells. Mutation in CARD9 leads to an impaired detection of the fungus. 
A gain-of-function mutation in STAT1 and dominant-negative mutation in STAT3 blocks the induction 
of Th17 cells and in case of STAT3 to an impaired production of AMP. Mutations in IL17A/F or IL17R 
and antibodies against IL-17A, IL-17F and IL-22 results in a defective antifungal immunity. Dashed 
arrows indicate T-cell differentiation (Milner, Holland 2013b). 
 
3.1.4.2 Systemic infections 
Systemic infections with C. albicans are characterized by dissemination of the fungus in the 
bloodstream. C. albicans has two different routes to enter the bloodstream, either by gastrointestinal 
or skin-derived candidiasis (Lionakis 2014). Entry through the gastrointestinal mucosal barrier is 
exclusively seen in immunosuppressed patients, usually in combination with other risk factors. Skin-
derived candidiasis arises in patients at the intensive care unit by breached integrity of the skin e.g. via 
intravenous catheters or open wounds (Kullberg, Am Oude 2002; Lionakis 2014). Leading risk factors 
are thus central venous catheter, immunosupression, neutropenia and gastrointestinal surgery and 
burns (Perlroth et al. 2007; Lionakis 2014). Candidemia can be a manifestation of invasive candidiasis 
originating from various organs (Fridkin 2005). 
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 Host response to C. albicans infections 
The immune system consists of three main components: the physical barrier, the innate and adaptive 
immune system.  
3.2.1 Epithelial recognition and innate immune response 
The first line of defense is the epithelium, in some tissues in combination with a mucus layer and/or 
the commensal flora, as a physical barrier and through the regulation of a cytokine and antimicrobial 
peptide (AMP) network. Epithelial cells can discriminate between commensal and pathogenic forms of 
Candida, due to the fungal load and the morphology. This enables them to orchestrate the innate 
immunity (Moyes et al. 2010). The nuclear factor NF-кB and the initial mitogen-activated protein kinase 
(MAPK) response are independent of fungal morphology (Moyes et al. 2010). In contrast, the activation 
of the c-Fos transcription factor and the MAPK phosphatase MKP1 through a secondary MAPK 
response in epithelial cells is hyphae−dependent (Moyes et al. 2010). The cytolytic peptide toxin Ece1, 
called Candidalysin, was shown to be necessary and sufficient to induce epithelial immune activation 
(Moyes et al. 2016). OPC infection with ece1Δ/Δ lacking the cytolytic peptide fragment 3 is unable to 
induce damage, phosphorylation of MKP1 and activation of c-Fos (Moyes et al. 2016). Fungal 
recognition by epithelial cells is less well understood than the mechanism of fungal recognition by 
myeloid cells, such as macrophages and monocytes. 
The initial step in innate immune activation is the recognition of fungal pathogen-associated molecular 
patterns (PAMP) by pathogen recognition receptors (PRR). PAMP on the surface of C. albicans include 
mannans, beta-glucans and chitin, which can be recognized by the mannose receptor, dectin-1, dectin-
2, Toll-like receptor 2 (TLR2), TLR4 and the complement receptor 3 (CR3) (Jouault et al. 2009; Netea et 
al. 2008). Fungal recognition by epithelial cells is likely not via the classical PAMPS and PRRs, rather 
through interaction with E-cadherin and Her2 (Moyes et al. 2010; Zhu et al. 2012; Naglik et al. 2014) 
Human oral epithelial cells release IL-1α, IL-1β, Granulocyte-macrophage colony-stimulating factor 
(GM-CSF), Granulocyte colony-stimulating factor (G-CSF), IL-6 and “regulated on activation normal T 
cell expressed and secreted” (RANTES) (Weindl et al. 2010). 
The resulting signal transduction leads to the release of pro-inflammatory cytokines/chemokines, 
which further promotes the activation of the adaptive immune system, if PRR signaling takes place in 
DCs/APCs ( LeibundGut-Landmann et al. 2007; Tang et al. 2016). These cytokines/chemokines in turn 
trigger an inflammatory response and recruit inflammatory immune cells including neutrophils and 
monocytes to the site of infection. Neutrophils were reported to enhance the production of 
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antimicrobial peptides and alarmins, like Calprotectin (S100A8/9) and beta-defensins (Weindl et al. 
2010; Moyes, Naglik 2011). 
3.2.1.1 Neutrophil and macrophage mediated antifungal defense 
After invasion, C. albicans face phagocytic cells. Mobilization of neutrophils from the bone-marrow 
occurs in a G-CSF dependent manner (Roberts 2005). Neutrophils are recruited into the infected tissue 
by locally produced chemokines. Following the invasion of Candida, keratinocytes release IL-1α which 
elevates the production of G-CSF (Altmeier et al. 2016). Macrophages and recruited neutrophils can 
both phagocytose yeast and short hyphae cells. Neutrophils can inhibit the growth, the yeast-to 
hyphae transition and efficiently kill the fungus (Fradin et al. 2005). After oral infection, neutrophils 
prevent dissemination into deeper tissue layer (Brown 2011). 
Phagocytosed yeast cells may escape by transforming into hyphae and killing the macrophage (Lorenz 
et al. 2004). Phagocytic cells kill C. albicans by the production of reactive oxygen species, a mechanism 
also called oxidative burst. The fungus produces superoxide dismutase to escape this attack (Fradin et 
al. 2005; Frohner et al. 2009). Hyphae cells which can not be engulfed are killed or inhibited by the 
release of neutrophil extracellular traps (NETs), also mast cells and eosinophils can cope with microbes 
by extracellular traps (Urban et al. 2009). NETs contain fibers of released DNA and histones with 
antimicrobial effector molecules, like Calprotectin (Urban et al. 2009). 
3.2.1.2 Antimicrobial peptides 
Epithelial cells, neutrophils and other immune cells can produce and secrete diverse antimicrobial 
peptides (Kiyoura, Tamai 2015). Cathelicidin (LL-37) acts against bacterial and viral skin infection 
(Lopez-Garcia et al. 2005). In C. albicans it causes an efflux of proteins and nucleotides by a massive 
disruption of the cell membrane (den Hertog et al. 2005). It was also demonstrated to be chemotactic 
for monocytes and neutrophils (Kiyoura, Tamai 2015).  
In humans, six β-defensins have been identified and all of them can be found in oral epithelial cells and 
the saliva (Diamond et al. 2001). In an oral Candida model, murine β-defensins (mBD1) plays a role in 
early fungal control and the induction of innate inflammatory modulators (Tomalka et al. 2015). mBD3 
shows strong similarity with the hBD2 and serves as an innate defense against oral Candida infections 
(Burd et al. 2002). 
Histatin 5 (Hst-5) is the most potent antimicrobial peptide in the saliva (Puri et al. 2015). Compared to 
LL-37, it causes smaller leaks in the cell membrane (den Hertog et al. 2005).  
  
13 
 
In several infection models, Calprotectin is critically for protection from C. albicans (Urban et al. 2009; 
Trautwein-Weidner et al. 2015b). We focused on S100A9, a subunit of the Calprotectin protein 
complex, which chelates calcium and zinc. It was also found to be attached to NETs and to be essential 
for antifungal activity in vitro (Urban et al. 2009). 
3.2.2 Adaptive immune response: 
PRRs on antigen presenting cells (APCs) bind PAMPs, like beta-glucan and mannan, and phagocytose 
the fungus. Three distinct signals are essential for the priming of T-cells. Antigenic peptides are 
presented by MHC class II lead in combination with APC-mediated co-stimulation to activation and 
expansion of T-cells. The cytokine milieu, depending on the induced signals by PRRs, direct the T cell 
polarization and associated effector functions. In consequence, T cells differentiate into different 
subsets (Th1, Th2, Th17, regulatory Tcells (Treg)), each with a characteristic effector function (Zhu et 
al. 2010; Richardson, Moyes 2015). Candida specific T-cells are the Interferon-γ secreting Th1 cells and 
IL-17 secreting Th17 cells (Kashem et al. 2015b). During Th17 differentiation, cells might become Tregs, 
determined by the cytokine milieu (Ghoreschi et al. 2010). The Th2 phenotype is rather associated with 
outgrowth and dissemination of the fungus (Richardson, Moyes 2015). The importance of T cells in the 
antifungal immunity is highlighted by the high prevalence of mucocutaneous candidiasis in AIDS 
patients with CD4+ T-cell depletion (Fidel, JR 2011). 
3.2.2.1 Non-redundant role of IL-17 
The family of the IL-17 cytokines consists of six members (IL-17A-IL-17F) and five receptors (IL-17RA-
IL-17RE) (Gaffen 2009). The hallmark cytokines IL-17A and IL-17F (called IL-17 from hereon, if not 
specified otherwise), can form hetero- and homodimers and signal through the same heteromeric 
receptor complex IL-17RA-IL-17RC (Wright et al. 2008). IL-17 can be secreted by a variety of cells 
including Th cells and innate lymphoid cells (ILC) (Cua, Tato 2010; Gladiator et al. 2013). Epithelial cells 
and fibroblasts are the main targets of IL-17 (Gaffen 2009). IL-17 is strictly required for fungal control 
and host protection. IL-17 mediated mechanisms are critical to eliminate the fungus from the host 
tissue, presumably by the regulation of antimicrobial peptides. In a murine model of oropharyngeal 
candidiasis (OPC), IL-17 is not required for neutrophil recruitment (Trautwein-Weidner et al. 2015b), 
even though this function of IL-17 was demonstrated in other settings. In addition to T cells, innate 
sources of IL-17 have been described in mouse models of acute candidiasis (cutaneous candidiasis, 
OPC) (Gladiator et al. 2013; Sparber, LeibundGut-Landmann 2015; Kashem et al. 2015a) 
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C. albicans is an important opportunistic pathogen in humans. Disease symptoms occur if specific 
protective immune mechanisms are breached. Antifungal immune defense mechanisms that protect 
from different forms of diseases have been characterized. It is generally believed that the host immune 
status determines the outcome of the interaction between the commensal fungus and its host. In 
addition to host factors, the intrinsically high diversity of C. albicans favors health or disease. 
This work sets out to investigate the natural diversity among C. albicans isolates and the impact on the 
decision between health and disease.  
In the first project, we assess the colonization rates by Candida spp. on the oral mucosae and skin of 
healthy children in southern part of Switzerland. Prevalence of colonization fluctuates depending on 
investigated age and geographical region. Furthermore, we compare isolates from healthy individuals 
by MLMT analysis with different disease-associated isolates and analyze the genetic diversity.  
In the second project we probe the interaction between natural C. albicans isolates and the host in 
vivo using the well-established model of oropharyngeal candidiasis (OPC). We investigate the broad 
spectrum of responses that are raised through natural variations in the pathogen. We highlight the 
requirement of the IL-17 pathway for preventing fungal outgrowth, irrespective of the natural diversity 
of C. albicans. 
Finally, in the third project of this thesis, we aim to further investigate the correlation of a rapid and 
acute inflammatory response and infiltrating neutrophils and fungal clearance. We address this by co-
infection experiments with a high-pathogenic isolate, which induces a rapid neutrophil response, and 
a low-pathogenic strain, for which we did not observe a significant neutrophil response. 
Project II is accepted in Mucosal Immunology . 
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 Abstract 
Knowledge on the prevalence of Candida albicans in healthy children is scarce. The aim of this work 
was to study the frequency of Candida spp. colonization in symptomless children and to investigate 
genetic diversity among isolates from healthy individuals and Candida-infected patients. The oral 
cavity, the skin or perianal region of 130 children were swabbed and the isolated Candida species were 
identified by plating on chromogenic fungal media and by MALDI-TOF analysis. Genetic diversity of 
isolates from healthy children and adults and diseased individuals was investigated by Multilocus 
Microsatellite typing. About 19.2 % of the children were colonized with Candida spp., mainly C. 
albicans (11.5%). Isolates from healthy children displayed a high genetic variation that is comparable 
5 Project I           
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to the diversity found in healthy adults or in diseased populations. This study gives further insights on 
the epidemiology and distribution of Candida species in healthy children, and helps understanding the 
genotypic composition of Candida populations in diseased and healthy individuals. 
 Introduction 
Skin and mucosal surfaces of the human body are colonized by a large variety of microorganisms, 
including several fungal species (Sanchez de Medina et al. 2013). Candida species are common 
components of the human microbiome that usually reside as harmless commensals in the mucosae of 
the oral, vaginal and gastrointestinal tract (Ghannoum et al. 2010). They pose a potential threat only 
if barrier integrity and host defenses are breached. 
As an opportunistic pathogen Candida spp. may cause primary superficial infections of mucosal 
surfaces of the oral cavity or the vagina, but under specific circumstances it may also lead to invasive 
infections that are associated with a high mortality rate (Brown et al. 2012). In fact, Candida spp. are 
among the leading causes of nosocomial bloodstream infections (Wisplinghoff et al. 2014) and 
infection rates are rising also because of the increase in use of immunosuppressive medications or of 
invasive medical interventions and transplantations (Brown et al. 2012). Currently, 90% of all invasive 
fungal infections are caused by Candida albicans, Candida glabrata, Candida parapsilosis, Candida 
tropicalis and Candida krusei (Mendes Giannini, M. J. S. et al. 2013; Delaloye, Calandra 2014).  
C. albicans is  the most prevalent fungus in the oral cavity (Ghannoum et al. 2010). In healthy adult 
individuals Candida colonization of the oral cavity is estimated to range between 17% to 75% (Cannon, 
Chaffin 1999; Javed et al. 2014), although numbers may vary according to age or geographical 
differences. Colonization occurs mainly by vertical transmission from the mother after birth but 
horizontal transmission is also frequent (Bliss et al. 2008). Infections usually arise from an endogenous 
source and are therefore associated with a prior colonization of other body sites (Pfaller 1996). In 
healthy children, numbers for Candida colonization range from 27% in the tonsillopharynx to 52% 
positive fecal samples (Gammelsrud et al. 2011).  
Chronic mucocutaneous candidiasis (CMC), on the other hand, is a rare disease in which skin, nails and 
mucosal membranes are affected by Candida species (mainly C. albicans) (Puel et al. 2011). Primary 
immunodeficiencies have been found to be associated with CMC, leading to a defect in the Interleukin 
17 and T-helper cells 17 mediated antifungal response or an impaired innate detection of fungal 
infections (Cypowyi et al. 2012; Milner, Holland 2013a).  
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Epidemiological studies concentrated so far mainly on the prevalence of Candida spp. in bloodstream 
infections (Wisplinghoff et al. 2014) or in individuals with different predisposition for oral candidiasis, 
such as HIV-infected or diabetes patients (Samaranayake 1992; Samaranayake et al. 2002; Martinez et 
al. 2013). Findings about the prevalence of commensal colonization in healthy children are rare and 
controversial (Martin, Wilkinson 1983; Akdeniz et al. 2002; Kadir et al. 2005; Smiline et al. 2012). 
C. albicans is a diploid organism that shows a high genetic plasticity, even if the reproduction is largely 
clonal (Selmecki et al. 2010). Genetic changes such as mutations, loss of heterozygosity (LOH) and 
ploidy changes have been described (McManus, Coleman 2014; Bennett et al. 2014). Microevolution 
during infection (Bougnoux et al. 2006) and azole resistance (Coste et al. 2006) have been shown to be 
caused by LOH events. C. albicans was the first human fungal pathogen for which the full genomic 
sequence has been made available (Jones et al. 2004). The whole genome consists of 8 chromosome 
homologues and has a total length of 16 Mbp (Chibana 2000). 
Due to the availability of the full sequence information, two PCR-based methods Multilocus sequence 
typing (MLST) and Multilocus microsatellite typing (MLMT) have been developed to examine the 
population structure and epidemiology of C. albicans and are considered the gold standard. 
MLST is based on the sequence analysis of DNA fragments of up to 10 housekeeping genes and the 
detection of single nucleotide polymorphisms (Bougnoux et al. 2002). MLMT targets tandemly 
repeated sequences and assigns isolates to sequence types depending on the length of the fragment 
(Taylor, Fisher 2003).  
Microsatellites are 1-6 bp long tandem nucleotide repeats, also called short tandem repeats (STR) and 
are distributed in the whole genome (Botterel et al. 2001). These short sequences are highly 
mutagenic. Repeated units undergo deletions or additions, resulting in variations in the number of 
copies. This occurs due to DNA polymerase slippage between repeated sequences (Jarne, Lagoda 1996; 
Lai, Sun 2003). MLMT targets tandemly repeated sequences by PCR amplification with primers flanking 
this regions (Taylor, Fisher 2003). The length of fragments at each locus can be related to an allelic 
profile and each profile corresponds to a Sequence Type (ST). Differences in length are caused by 
different numbers of repeats of the microsatellite (Botterel et al. 2001). Strains belonging to a specific 
ST are considered clonal and isolates can be assigned to clonal complexes based on allelic differences 
(Feil et al. 2004). 
Population studies of C. albicans have shown that sub-groups can be differentiated by MLMT/MLST 
and isolates assigned to clades (Chavez-Galarza et al. 2010). Currently 18 major and minor 
clades/clonal complexes can be distinguished by MLST and some show phenotypic and geographical 
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accumulation (Odds et al. 2007). Several phenotypic attributes such as acid-phosphatase activity 
(MacCallum et al. 2009) and resistance to flucytosine and terbinafine (Odds 2009) have been 
correlated with specific clades by MLST, but no clear correlation between genotype lineage and 
virulence has so far been identified (MacCallum et al. 2009). A study on isolates originating from 
healthy volunteers, bloodstream and non-bloodstream infections using the microsatellite locus CEF3 
showed no association between clonal complexes and virulence (Dalle et al. 2000). A subsequent study 
with the same isolates using eleven microsatellite loci indicated a distribution of the isolates within 
eight phylogenetic groups (L'ollivier et al. 2012).  
So far, not much is known on the genotypic composition of the C. albicans populations colonizing the 
oral mucosae of healthy volunteers or patients suffering from mucocutaneous candidiasis or 
vulvovaginal candidiasis and candidemia patients. It is also unknown whether or not C. albicans strains 
colonizing patients with persistent or recurrent candidiasis are genotypically substantially different 
from those isolated from healthy controls. We were therefore aiming to assess the colonization rates 
by Candida spp. on the oral mucosae and skin of healthy children in southern part of Switzerland and 
to compare them by MLMT analysis with different disease-associated isolates. 
 
 Results 
5.3.1 Candida spp. colonization frequency in healthy children is low 
We investigated the colonization rates and distribution of Candida spp. in the oral cavity and skin of 
healthy children aged between 1 month and 16 years in Southern Switzerland (Table 1). Twenty-five 
out of 130 symptomless children (19.2%) were colonized by five Candida spp.. C. albicans was the most 
prevalent colonizer with 11.5 %. The second most frequent species was Candida guilliermondii, found 
in 3.8 % of all tested children. Candida pelliculosa and C. parapsilosis were recovered in 2 cases (1.5%) 
and C. krusei in one (0.8%). No individuals were colonized concurrently by two different species of 
Candida.  
 
Table 1 Prevalence of Candida spp. in healthy children. Frequency of colonization by individual 
Candida spp. in 130 healthy children. Absolute numbers (n) and percentages (%) of Candida spp. 
distribution are indicated. 
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5.3.2 Healthy children are colonized by a clonal population 
To investigate the diversity of the C. albicans populations in healthy children, we tested 12 isolates 
from healthy children by MLMT. To ensure a high discriminatory power, we analyzed three well 
described microsatellite markers CDC3, EF3 and HIS3 that are located on different chromosomes. CDC3 
is located downstream of the cell division cycle protein, EF3 in the promoter region of the elongation 
factor 3, and HIS3 downstream of the coding sequence of the imidazole glycerol phosphate 
dehydratase gene (Botterel et al. 2001). Fragment sizes of the reference strain SC5314 were consistent 
across independent measurements (data not shown) confirming the reproducibility of the method.  
We examined 16 randomly selected individual colonies for each of 12 C. albicans isolates out of the 
population described above (Table 2) by MLMT. All three loci analyzed were identical in all colonies, 
indicating clonality of the C. albicans populations in the healthy children. On the other hand, the alleles 
varied greatly between the different C. albicans isolates (Table 2).  
 
Table 2 Healthy children are colonized by a clonal population of C. albicans. 16 randomly picked 
colonies of the indicated isolates from the oral cavity (O) or skin (S) were examined by MLMT analysis 
to assess the clonality of the population. The fragment length of both alleles for the three loci CDC3, 
EF3 and HIS3 (in base pairs) and the corresponding STs are shown. 
 
We further examined whether or not the same clonal C. albicans would be present in all different 
anatomical sites of the same individual. We performed MLMT on C. albicans isolates that were 
collected from different body sites including oral cavity, skin, and perianal region of a child affected 
with oral candidiasis (002) and a symptomless child (101). Clonality was also observed across different 
collection sites within an individual (Table 3). Moreover, C. albicans populations were stable at these 
different body sites over the investigated time of three weeks (Table 3). .Because these results 
confirmed clonality of C. albicans at the level of an individual, we used only one colony of each 
individual in the consecutive experiments/analysis. Among the 14 isolates from healthy children (Table 
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2+3), we identified 12 different STs. Only one isolate (101, ST 54) from the population of healthy 
children had a homologous allelic profile at all three loci. 
 
Table 3 Clonality of C. albicans isolates across different body sites. The isolates 101 (from a healthy 
children) and 002 (from oral candidiasis patient) were collected from the skin (S), the oral cavity (O), 
perianally (P), and 15 randomly selected individual colonies of each isolate were examined by MLMT. 
The fragment length of both alleles for the three loci CDC3, EF3 and HIS3 (in base pairs) and the 
corresponding STs are shown. 
 
5.3.3 C. albicans isolates show genetic variation 
After assessing clonality of the C. albicans population within individuals, we were interested in the 
diversity among individuals. When examining the fragment lengths of the CDC3, EF3 and HIS3 
microsatellites in the collection of isolates from healthy children (Table 2), it became obvious that the 
isolates displayed greatly variable alleles.  
We then compared the isolates from the healthy children cohort to those from healthy adults (Table 
4). One colony of each individual was tested, since we showed colonization with a clonal population 
before (Table 2Table 3). Similar to isolates from healthy children, we detected a high diversity in 
fragment length of the alleles from the three tested loci.  
The alleles were mostly heterologous at the analyzed loci, with three isolates (V196, V67, VolG, ST 47) 
being homologous at all loci, compatible with our findings in isolates from healthy children. No 
increased frequency of any particular allele or resulting ST was found. Allele size at each of the locus 
defined the ST. Isolates showing the same allele size at all loci were assigned to one ST. Therefore, the 
high genetic variation and the high number of corresponding STs was independent of the age of the 
population. 
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Table 4 Genetic diversity of C. albicans isolates from healthy adults. MLMT analysis of 34 isolates 
from healthy individuals. The fragment length of both alleles for the three loci CDC3, EF3 and HIS3 (in 
base pairs) and the corresponding STs are shown. 
 
We expanded our analysis to isolates from candidiasis patients, including oral candidiasis and chronic 
mucocutaneous candidiasis (grouped together as mucocutaneous candidiasis), vulvovaginal 
candidiasis and candidemia (Table 5). Similarly to isolates from healthy individuals, C. albicans isolates 
from different patient groups displayed a broad diversity in fragment sizes of the alleles at the three 
loci analyzed. In agreement with results from healthy adults and children there was no increased 
frequency of a specific allelic combination or the resulting ST. Heterologous loci were detected in the 
majority of the isolates and in some isolates both alleles gave rise to PCR products of the same length. 
Three STs (ST 47, ST 54, ST 14) in total, consisted of homologous allelic combinations in all three loci. 
In conclusion, genetic variation in the tested loci CDC3, EF3 and HIS3 is independent of the origin and 
the age of the tested population. 
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Table 5 Genetic diversity of C. albicans isolates from diseased individuals. MLMT analysis of isolates 
from oral candidiasis and CMC patients (MC), vaginal isolates form vulvovaginal patients (VVC) and 
blood isolates from candidemia patients (INV). The fragment length of both alleles for the three loci 
CDC3, EF3 and HIS3 (in base pairs) and the corresponding STs are shown. 
 
Given the large diversity in length of microsatellites alleles identified, we aimed at analyzing the 
distribution of the different alleles and therefore monitored the frequency of each of the allelic 
combinations for the three loci analyzed. Various combinations of these alleles resulted in 14, 25, and 
32 different allele combinations for CDC3, EF3 and HIS3 locus, respectively (Figure 3). Amplification of 
EF3 and HIS3 led to the highest variability in fragment size lengths, resulting in a discriminatory power 
of 0.89 and 0.88, respectively. CDC3 alone just led to a discriminatory power of 0.82, in other words a 
82% probability to separate two unrelated strains (Hunter, Gaston 1988). Most of the allelic 
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combinations were heterologous, but some frequently found allelic pairs appeared also to be 
homologous. At the CDC3 locus we detected 6 homologous allelic combinations, 8 combinations 
appeared homologous at EF3 and 10 were homologous at the HIS3 locus. The frequency of different 
allele pairs varied greatly at each locus, with some shared among many isolates and others occurring 
only rarely (Figure 3).For the CDC3 locus, the 116:124 allele pair was by far the most frequent one 
found in 33 isolates. The most frequent allele pairs for EF3 and HIS3 were the allelic combinations 
119:128 with 24 isolates and 158:158 with 25 isolates, respectively.  
 
Figure 3 Variation of allelic relations in all three loci. Isolates from healthy individuals and candida-
affected patients with symptoms tested by MLMT analysis with CDC3, EF3, HIS3 locus.  
 
 
Based on these allelic profiles, we assigned distinct STs (Table 2-Table 5, column ‘ST’). Isolates sharing 
a ST were defined as clonal. When assessing all 88 isolates, including those from healthy children (Table 
2Table 3) and adults (Table 4) and from diseased individuals (Table 5), 59 STs could be defined in total 
(Figure 4). Each allelic combination from all three tested loci were assigned to one ST. This led to a 
discriminatory power of 0.979, which describes an approx. 98% probability to distinguish two 
unrelated STs (Hunter, Gaston 1988). The STs showed very different abundances, with ST 24 being the 
most frequent one. The majority (47 out of 59 STs) are less abundant and contain only one isolate. 
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All isolates from oral candidiasis patients, except 529L, were from individuals living in the southern 
part of Switzerland. They all belong to different STs, supporting the hypothesis that there is no clonal 
regional population. This is also shown in Table 2 and 4 for isolates from healthy individuals, all isolated 
from the same geographical area (southern Switzerland). Isolates from the adult healthy population 
showed an accumulation with at least three isolates in STs 22, 24, 41, 43 and 47. The 18 isolates from 
vulvovaginal candidiasis patients formed 15 STs. Two isolates clustered in ST 22 and 24 but also isolates 
from other origins belong to these STs. ST 24 was the most common one involving 10 isolates from 
several distinct origins. The three mucocutaneous candidiasis isolates (Table S1) sharing ST 3 belong to 
one family, indicating that all tested family members carry the same C. albicans isolate.  
 
Figure 4 Distribution of C. albicans isolates in STs. Frequency of isolates from healthy children, 
healthy adults or diseased individuals separated in vulvovaginal candidiasis (VVC), invasive 
candidiasis (INV) and mucocutaneous candidiasis (MC) patients in the different sequence types. 
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5.3.4 Comparable distribution of commensal and disease-associated isolates in 
clonal complexes 
After dividing the 88 isolates in 59 STs clonal complexes were assigned of STs with only one divergent 
allele from all three loci. The allelic profiles obtained through the MLMT analysis could be clustered 
into clonal complexes by an algorithm that is based upon related STs (BURST (Aanensen, Spratt 2005).  
Applying this algorithm to our 59 STs led to the formation of four clonal complexes (Figure 5). 
Combination of STs within a clonal complex indicates their hypothetical phylogenetic relationship (Feil 
et al. 2004; Spratt et al. 2004). The most abundant ST 24 was part of the largest clonal cluster 1 
comprising 32 isolates grouped in 15 different ST. ST 24 acted as the primary founder of the complex, 
which also comprised a subcomplex of six ST with ST 37 acting as a subgroup founder. Clonal 
complexes 2 and 3 consisted of five and four STs, respectively. Clonal complexes 4 comprised only two 
STs. 33 STs could not be assigned to any clonal complex (singletons). The large number of singletons 
underlined the high degree of diversity among the isolates tested. 
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Figure 5 Clustering of the STs in four clonal complexes by BURST analysis. Four clonal complexes of 
variable size and complexity are shown. The size of the circle denotes the number of isolates within 
each ST. 
 
The distribution of isolates within clonal complexes according to their origin was mixed. In clonal 
complex 1, 17 of all isolates were from healthy and 15 from diseased individuals, respectively (Figure 
6). In addition, the smaller clonal complexes 2, 3 and 4 comprised isolates from healthy and diseased 
individuals in almost equal proportions. Also the singletons were isolates from both groups (23 from 
healthy individuals and 16 from diseased individuals resulting in 33 ST. The isolates from healthy 
children were restricted to clonal complex 1 or they were singletons. This result, however, might have 
been a consequence of the limited number of isolates in the group of healthy children.  
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We could not detect an accumulation of any isolates from a specific population in STs or clonal 
complexes but rather a high variation within isolates. 
 
Figure 6. Isolates from healthy and symptomatic individuals segregated to similar proportions into 
clonal complexes. Distribution of isolates from healthy individuals (children and adults) and 
diseased-individuals in clonal complexes (CC) and singletons. 
 
 Discussion 
We observed a low frequency of Candida colonization in healthy children but we detected a high 
genotypic variation among isolates from different individuals. MLMT analysis confirmed that the 
findings in the healthy children population apply also to adults and diseased individuals affected with 
mucocutaneous, vulvovaginal or invasive candidiasis and indicated a high genetic variation among 
isolates. 
Candida colonization is common in healthy individuals. In the present study, we re-evaluated the 
prevalence of Candida spp. colonization in healthy children from a restricted and defined geographical 
area. Surprisingly, we found that only every fifth child was colonized. C. albicans, the most prevalent 
species, was detected in one out of nine children. In the literature, the reported overall prevalence of 
Candida spp. in children with a similar age ranges between 26 % in 0-12 year old children in Turkey 
and 71% in 10-year-old children in the United Kingdom (Martin, Wilkinson 1983; Kadir et al. 2005). 
Based on our data, these numbers appear to be overestimates, although colonization rates may also 
be influenced by age, population and dietary intake (Kadir et al. 2005). Differences may also exist due 
to the geographic location and investigated body site.  
C. guilliermondii, C. pelliculosa, C. parapsilosis and C. krusei were also isolated, albeit at rather low 
frequencies. This correlates well with previous reports on the distribution of Candida spp. and their 
clinical importance (Gammelsrud et al. 2011; Kadir et al. 2005). C. pelliculosa (teleomorph Pichia 
anomala) has only been occasionally reported in cases of nosocomial candidemia (Paula et al. 2006). 
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This yeast is usually isolated from the environment, including vegetables and soils (Kalkanci et al. 2010). 
We could not detect C. glabrata or C. tropicalis in the tested population, even though C. glabrata is 
the second or third most common Candida species in superficial and invasive infections due to the 
natural resistance to antimycotic therapy (Fidel, JR et al. 1999). In agreement with previous studies, 
we showed that prevalence of Candida spp. colonization is dependent on the geographical area(Singhi 
et al. 2008). This study strengthened the need for local epidemiology studies. 
Nowadays two methods established to be the gold standard for genetic population studies, MLMT and 
MLST. Analysis of an organism’s genetic diversity requires a method that gives reliable and 
reproducible results. We used MLMT analysis with the CDC3, EF3 and HIS3 loci. 
A disadvantage of MLMT is the lack of a public database such as the one available for MLST (Bougnoux 
et al. 2004). Fragment sizes obtained by MLMT can differ among laboratories depending on the 
electrophoresis method, instrument and fluorescent labels used, by the distance of the fragment from 
the used standard and the analysis software. Both methods have a similar discriminatory power and 
results of assigned groups obtained by the two methods correlate well (Garcia-Hermoso et al. 2007; 
L'ollivier et al. 2012). Microsatellites are robust markers, faster and cost-effective due to a higher 
throughput compared to MLST (Virk et al. 1999).We used MLMT analysis in a multiplex option with 
three loci, therefore the method is faster and cost-effective due to a higher throughput compared to 
MLST (Virk et al. 1999). 
We observed clonal populations within, but no clonality among healthy individuals. This is in 
agreement with results from other studies in which one individual was shown to be stably colonized 
by a single strain of C. albicans in several body sites over time (Mendes Giannini, M. J. S. et al. 2013; 
Hattori et al. 2006; Shimizu et al. 2011). Other studies applying DNA fingerprinting and randomly 
amplified polymorphic DNA analysis on samples from the oral cavity, vaginal mucosa and rectum from 
woman with candidiasis (Xu et al. 1999) or MLST analyses with isolates from CMC patients (Moorhouse 
et al. 2016) showed similar results. 
This study is limited to isolates collected at a single time point and over a short time period of three 
weeks and lacks the inclusion of long-term follow-up samples. This would allow the detection of 
microvariations, defined by small genetic rearrangements (Dalle et al. 2008). Isolate 101 appeared to 
be stable at all microsatellite loci over three weeks. We showed clonality in all colonized bodysites and 
over time, supporting the argument of a clonal mode of propagation (Gräser et al. 1996; L'ollivier et 
al. 2012). We therefore assumed that the use of one colony per individual is representative for the 
colonizing Candida population (Dalle et al. 2008). The Patient colonized with isolate 002 could only be 
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investigated for one week, due to antimycotic treatment of the patient and the potential clearance of 
the fungus. 
The 88 isolates tested in this study clustered in 59 STs based on differences in fragment size. 
Differences in length of the microsatellites arise through differences in the number of tandem repeats. 
Mutation rates for Microsatellites vary between 10-4  and 5x10-6 (Bretagne et al. 1997). Several isolates 
were homologous at one locus and three STs consisted of homologous allelic combinations in all three 
tested loci. This could be the result of same length of the amplified fragments by convergent 
evolutionary events or the isolates were haploid at this locus through loss of heterozygosity (Dalle et 
al. 2008). 
Mutational changes of microsatellites mostly increase or decrease the repeat number by one; this 
occurs through a mechanism called replication slippage, however motif composition can also undergo 
mutation (Jarne, Lagoda 1996). The latter can only be detected by sequencing, which was not carried 
out in this study. 
Almost each individual harbored one isolate of a specific ST. Isolates belonging to the same ST may be 
identical due to relatedness of the colonized individuals. Isolates from ST 3 were all isolated from one 
family affected by CMC. This confirms the results from a study that showed intrafamilial transmission 
of Candida in families affected with Crohn`s disease (Bougnoux et al. 2006). Other STs might be further 
separated by the use of more discriminate markers than used in this study. 
In the present study we could separate two unrelated isolates with a probability of 98%. The 
comparison of isolates from healthy children versus those from healthy adults did not reveal a distinct 
pattern, neither did the comparison of healthy- versus disease-associated isolates. This indicated that 
genotypically characterized ST or clonal complexes do not correlate with the health status and the 
demographics of the individuals from whom they are isolated.  
STs were grouped in clonal complexes by their similarity to an allelic profile from a founder ST. Four 
clonal complexes were determined. Clonal complex 1, with the founder ST 24, was the largest of all 
complexes deduced from 32 isolates in 15 distinct STs and comprised a subgroup with the ST 37 as a 
founder. In all clonal complexes, isolates from healthy and diseased individuals were almost equally 
frequent. The group of singletons (33 isolates) consisted of a larger proportion of isolates from healthy 
individuals, but no clonal complex consisted exclusively of isolates from a specific group.  
The STs formed independently from the anatomical site. We could not distinguish the isolates by their 
anatomical site of isolation, but a previous study has shown that the site of isolation is not associated 
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with a specific clade/clonal complex (Odds et al. 2007). But MLST analysis showed an association 
between geographical origin and organ distribution of oral, vaginal and blood isolates amongst the 
major clades within western European isolates (Odds et al. 2007). Overrepresented allelic 
combinations for all three loci proved, in agreement with a previous study, the equal distribution of all 
tested isolates (L'ollivier et al. 2012). It was proposed that some allelic combinations of the HIS3 locus 
are associated with a pathogenic profile (L'ollivier et al. 2012). We could not detect distinct alleles and 
a correlation with the origin of the isolates. 
The number of patients who develop fungal infections, as candidiasis and candidemia, has increased 
dramatically in the last decades, particularly in immunosuppressed patients. A more detailed 
knowledge of the epidemiology of Candida species in children will be helpful to predict infection 
patterns, through the knowledge of possible vertical and horizontal transmissions, and eventually to 
develop effective prevention or/and treatment schedules. In the present study we showed a low 
prevalence of C. albicans in healthy children, probably by the dependence on the geographical area. 
Furthermore, we could proof extensive genetic diversity among isolates from healthy individuals and 
patients. 
 
 Material and Methods 
5.5.1 Study design for the collection of Candida spp. isolates from healthy 
children and oral candidiasis patients 
Samples from 130 healthy children and 6 patients with oral candidiasis were collected in the frame of 
a clinical trial in Ticino, Switzerland. The cantonal ethics committee of the Canton of Ticino, Switzerland 
approved the study (approval number CE 2669).  
The study population consisted of children between 1 month and 16 years. During a routine check visit 
of their child, parents were asked to participate in the study and to give their consent to the 
participation of their child in the study. This control visit coincided with the Screening visit. 
Demographics, medical history and concomitant therapies were recorded. Immunosuppression, 
immune disease and antibiotic treatment were used as exclusion criteria. A complete physical 
examination was carried out and swabs from mouth region/throat, skin and perianal region were taken 
by the treating physician or a study nurse. Follow up swabs were taken at home by the parents at 
weekly intervals (1 swab/week) for three weeks, after careful instruction of the parents on how to take 
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the swabs, which were then sent by mail to the laboratory. Paediatric patients with a diagnosis of oral 
candidiasis were immediately treated after the first swab. 
5.5.2 Candida albicans isolates used for MLMT analysis 
All 88 C. albicans isolates used in this study are listed in Supplementary Table 1. They comprise 14 
isolates from healthy children, 34 from healthy adults and 40 from patients with oral candidiasis or 
chronic mucocutaneous candidiasis, vulvovaginal candidiasis or candidemia. All isolates were grown 
on Sabouraud agar (Biomérieux, Switzerland) at 37°C for one day. For long term storage, they were 
kept in YPD medium supplemented with 20% glycerol at -80°C. 
5.5.3 Species identification 
For Candida species identification the isolates were grown on chromogenic Candida agar plates (Can2; 
Biomérieux, Switzerland) for a preliminary morphological identification. They were subsequently 
inoculated on Sabouraud Agar and identified by Matrix-Assisted Laser Desorption/Ionization Time-of-
Flight Mass Spectrometry (MALDI-TOF) as described by (Benagli et al. 2012). Small amounts of Candida 
cells were transferred from the Sabouraud agar plate directly on a 48-position stainless steel 
FlexiMass™ target plate (Shimadzu Biotech, Kyoto, Japan) and overlaid with 1 µl of α-cyano-4-
hydroxycinnamic acid (CHCA)-Matrix solution containing 40 mg/ml CHCA in acetonitrile/ethanol/water 
(1∶1:1) supplemented with 3% trifluoroacetic acid. All mass spectra were acquired using an AXIMA 
Confidence™ (Shimadzu Biotech, Kyoto, Japan) mass spectrometer. The peak list with m/z values were 
compared to reference SuperSpectra™ of Candida spp. present in the SARAMIS™ (Spectral Archive And 
Microbial Identification System) database to produce identifications at the species level. 
5.5.4 Multilocus Microsatellite typing (MLMT) 
DNA was extracted from C. albicans colonies grown on Sabouraud agar using InstaGene matrix 
(BioRad) following the manufacturer’s instructions. The Microsatellites used were CDC3, EF3; HIS3 
(Table 1) ( Bretagne et al. 1997; Botterel et al. 2001; Sampaio et al. 2005). One primer of each set was 
5' labelled with hexachloro-fluorescein (for CDC3, HIS3) or fluorescein amidite (for EF3). PCR reactions 
were carried out according to standard protocols using HotStarTaq Polymerase (Qiagen) and a 2720 
Thermal Cycler (Applied Biosystems). Gene products were analyzed on a 3500 Genetic Analyzer 
(Applied Biosystems) using a GeneScan 600 Liz dye size standard (Applied Biosystems) and the 
GeneMapper v4.1 software (Applied Biosystems). To assess reproducibility, the bloodstream isolate 
SC5314 (Gillum et al. 1984b) was used as a reference strain in all fragment analyses to prove 
consistency of electrophoresis and DNA extraction. Molecular data were analyzed by eBurst ver. 3 
(http://eburst.mlst.net/) (Aanensen, Spratt 2005). The use of the combination of 3 markers leads to a 
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discriminatory power of 0.98, as calculated by the Simpson index of diversity (Hunter, Gaston 1988). A 
high discriminatory power ((close to 1) indicates that unrelated isolates can be well distinguished from 
the rest of the population (Hunter 1990). 
 
Table 6. Microsatellites used in this study. The repeat motif, primer sequences, the obtained 
fragment sizes, locus and Gene ID from NCBI GenBank are indicated. 
 
  
33 
 
 Supplementary files
 
  
34 
 
 
Supplementary Table 1. All isolates used in this study. Isolates clustered by origin in volunteers (V), 
oral candidiasis (MC-OC), chronic mucocutaneous candidiasis (MC-CMC), vulvovaginal candidiasis 
(VVC) and candidemia (INV). The bodysite of isolation or kind of sample is indicated with oral cavity 
(O), skin (S), perianal region (P), vaginal swab (VS) and blood culture (BC). The source and ST (ST) are 
shown. 
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Running Head: Diversity of C. albicans pathogenicity in vivo 
 
 Abstract 
The host immune status is critical for preventing opportunistic infections with C. albicans. Whether the 
natural fungal diversity that exists between C. albicans isolates also influences disease development 
remains unclear. Here, we used an experimental model of oral infection to probe the host response to 
diverse C. albicans isolates in vivo and found dramatic differences in their ability to persist in the oral 
mucosa, which inversely correlated with the degree and kinetics of immune activation in the host. 
Strikingly, the requirement of IL-17 signaling for fungal control was conserved between isolates, 
including isolates with delayed induction of IL-17. This underscores the relevance of IL-17 immunity in 
mucosal defense against C. albicans. In contrast, the accumulation of neutrophils and induction of 
inflammation in the infected tissue was strictly strain-dependent. The dichotomy of the inflammatory 
neutrophil response was linked to the capacity of fungal strains to cause cellular damage and release 
of alarmins from the epithelium. The epithelium thus translates differences in the fungus into 
qualitatively distinct host responses. Together, this study provides a comprehensive understanding of 
the antifungal response in the oral mucosa and demonstrates the relevance of evaluating intraspecies 
differences for the outcome of fungal-host interactions in vivo. 
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 Introduction 
Candida albicans is an important pathobiont in humans that can cause diseases ranging from mild 
superficial symptoms affecting the skin and the mucosa to severe systemic infections associated with 
high mortality rates. The development of disease is generally attributed to defects in host resistance. 
Individuals with impaired cellular immunity such as AIDS patients with low CD4+ T cell counts or 
glucocorticoid-treated patients display an increased susceptibility to fungal infection and frequently 
display symptoms of oral thrush (Kirkpatrick 2001). More recently, primary immunodeficiencies 
affecting the T cell compartment and in particular the Th17 subset of T cells, which are associated with 
chronic forms of mucocutaneous candidiasis (CMC), revealed a critical role of the IL-17 pathway, in 
particular the two IL-17 family members IL-17A and IL-17F, in host protection from C. albicans (Puel et 
al. 2012).  
The discovery of genetic defects associated with fungal infections and experimental work with mouse 
infection models helped to decipher the mechanisms of antifungal defense in the mucosal epithelium. 
IL-17A and IL-17F are rapidly induced in response to C. albicans by different tissue-specific innate 
cellular sources (Gladiator et al. 2013; Conti et al. 2014; Kashem et al. 2015a). They act in a synergistic 
manner (Gladiator et al. 2013; Whibley et al. 2016) and target the epithelium for induction of 
antimicrobial peptides (Conti et al. 2016; Trautwein-Weidner et al. 2015b). The IL-17-dependent 
epithelial response is complemented by neutrophils, which rapidly infiltrate the infected tissue in an 
IL-17-independent manner (Trautwein-Weidner et al. 2015b) and prevent fungal growth and 
dissemination to underlying tissue (Trautwein-Weidner et al. 2015b; Huppler et al. 2014). Together, 
the tight interplay between immune cells and the epithelium guarantees for efficient fungal control in 
the mucosa. In addition, IL-17 may exert direct effects on C. albicans and thereby affect its virulence 
(Zelante et al. 2012).   
Infections with C. albicans are usually not contagious. Rather, the fungus is acquired through childbirth 
from the mother as part of the normal microbiota. The C. albicans population within a given individual 
is largely clonal (Moorhouse et al. 2016; Bougnoux et al. 2008b; Pujol et al. 1993). The colonizing fungus 
  
38 
 
itself may turn pathogenic and cause disease when host defenses are breached. Therefore, variations 
in fungal isolates that exist between individuals, in addition to host factors, may contribute to disease 
susceptibility, although this notion is often undervalued and not well understood. C. albicans displays 
a significant intra-species diversity both at a phylogenomic and phenotypic level (Odds et al. 2007; 
MacCallum et al. 2009; Hirakawa et al. 2015). Phenotypic variations include differences in adherence, 
stress responses, gene expression, morphological plasticity and the capacity to form biofilm. The basis 
for this variation and its impact on the host response remain largely unclear. Strain-specific differences 
recently drew attention in the murine intravenous challenge model (Marakalala et al. 2013; Hirakawa 
et al. 2015; MacCallum et al. 2009). No study so far analyzed differences in pathogenicity of natural 
fungal isolates at mucosal surfaces, which is the site where C. albicans usually resides, and how they 
determine the decision between commensalism and disease. 
Here, we probed the interaction between diverse and randomly selected natural C. albicans isolates 
and the host in vivo using the well-established model of oropharyngeal candidiasis (OPC). This allowed 
us to assess in a uniform and Candida-naïve host background the spectrum of responses that are raised 
through natural variations in the pathogen and how they define the outcome of the interaction with 
the fungus. Irrespective of their mucosal or blood origin, we observed striking differences between 
isolates in their ability to persist in the host, which inversely correlated with their capacity to induce a 
rapid inflammatory response in the host. While the accumulation of neutrophils in the infected tissue 
was strictly strain-dependent, the IL-17 pathway was essential across different strains to restrict fungal 
growth in the mucosal tissue. Strain-specific differences in the induction of an inflammatory response 
did not correlate with expression of known C. albicans virulence genes including ECE1, but rather 
associated with the capacity to cause epithelial damage and release IL-1α from keratinocytes. 
Together, this study emphasizes the key role of IL-17 in host defense against C. albicans, which is 
uncoupled from the neutrophil response, and it sets the stage for evaluating fungal determinants 
associated with commensalism versus pathogenicity of the fungus in vivo. 
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 Results 
6.3.1 Fungal persistence in the host varies between isolates and inversely 
correlates with transient weight loss of infected animals at the onset of 
infection. 
The acute host response to OPC infection with C. albicans SC5314 in mice is characterized by an acute 
inflammatory response that comprises neutrophil infiltration and induction of IL-17 and antimicrobial 
effector molecules (Trautwein-Weidner et al. 2015b; Conti et al. 2009). The infection is accompanied 
with a transient loss in body weight. Weight recovery within 4 to 7 days generally correlates with fungal 
clearance in wildtype (WT) mice. In contrast, immunodeficient animals lacking these protective 
immune mechanisms are unable to control the fungus and suffer from prolonged cachexia (Trautwein-
Weidner et al. 2015b; Conti et al. 2009).  
To assess whether this response was general or affected by variation in the fungal strain, we selected 
a small number of C. albicans isolates from different origins that were genetically unrelated (Fig S1AB) 
and showed comparable growth in rich and minimal media in vitro (Fig S2A). The cell wall composition 
and degree of β-glucan exposure of these isolates was also comparable (Fig S2CD). We performed OPC 
infection of WT mice with four isolates, namely SC5314, Cag, 529L and 101. They were all equally 
capable of infecting the oral mucosa as evaluated by quantification of the fungal load in the tongue on 
day 1 post-infection (Figure 7A). Histology analysis revealed that all isolates formed hyphae in the 
tissue and invaded the oral keratinized epithelium (Figure 7BC). Transmission electron microscopy 
showed that they penetrated keratinocyte cell membranes in the stratum corneum comparably 
(Figure 7C). However, striking differences between the isolates were observed when analyzing the 
course of infection over time. The degree of weight loss induced in the mice by the different isolates 
varied greatly on day 1 to day 3 p.i. (Figure 7D). To determine how these differences were associated 
with fungal control in the host, we assessed the fungal burden in the tongue of infected mice on day 3 
and day 7 p.i.. In contrast to strain SC5314, which was rapidly cleared to undetectable levels, all other 
isolates persisted in the host and high fungal counts could still be recovered one week p.i. (Figure 7EF). 
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The high fungal load remained detectable for up to 4 weeks p.i., at least in case of strain 101 (Fig S3) 
These data indicated that transient weight loss during the first days of OPC was not a consequence of 
high fungal burden in the mice, but rather that strong changes in weight during the initial phase of 
infection were associated with enhanced fungal control. Importantly, for the persistent fungal isolates 
no tissue pathology was observed despite the prolonged presence of high fungal loads (Figure 7G).  
 
Figure 7. Fungal persistence in the host inversely correlates with transient weight loss of infected 
animals at the onset of infection. WT mice were infected with C. albicans SC5314, Cag, 529L or 101. 
(A) Tongue fungal burden on day 1. (B) Representative images of sagittal tongue sections (day 1) 
stained with PAS. Arrows: inflammatory infiltrates. Scale bars: 50 μm. Inset: 2-fold magnification. (C) 
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Representative transmission electron microscopy images of infected tongues (day 1). Red circles: 
fungal penetration of cell membranes in the stratum corneum. Scale bars: 5 μm. (D) Body weight of 
infected mice. Data are the mean +- SD (n = 6, pooled from two independent experiments). (E-F) 
Tongue fungal burden on day 3 and day 7. (G) Representative images of sagittal tongue sections (day 
7) stained with PAS. Scale bars: 100 μm. In A, E, F, each symbol represents one mouse. Data are the 
pool of two independent experiments. The geometric mean and significant differences between each 
group and the SC5314-infected group are indicated. In A, E, F, each symbol represents one mouse. 
Data are the pool of two independent experiments. The geometric mean and significant differences 
between each group and the SC5314-infected group are indicated 
6.3.2 Persistent fungal isolates fail to induce an acute inflammatory response in 
the host. 
To investigate the cause of these differences in colonization versus clearance with different C. albicans 
isolates we assessed the response of the host in the four infected groups. Histology of the infected 
tissue revealed striking differences in the degree of inflammation induced on day 1 p.i. (Figure 7B). 
While large infiltrates of inflammatory cells, which consist mainly of neutrophils (Fig S4A) (Trautwein-
Weidner et al. 2015b) were observed in the tongue of strain SC5314-infected mice, barely any cellular 
infiltrates were observed in strain 101-infected animals and only few and small infiltrates were found 
in the other groups on day 1 p.i.. Quantification of neutrophils by flow cytometry of single cell 
suspensions prepared from the infected tongues confirmed these results (Figure 8A, Fig S4A). 
Importantly, the neutrophil response to strain SC5314 was strongest, even if the infection dose was 
lowered 25-fold (Fig S4B). The blunted neutrophil response to infection with the persistent C. albicans 
isolates correlated with their limited capacity to induce neutrophil-recruiting chemokines such as 
CXCL2 and the granulopoietic factor G-CSF (Figure 8BC). G-CSF was measured in the serum accounting 
for the endothelial source of this factor (Altmeier et al. 2016b). Of note, we did not observe 
dissemination of the persistent isolates away from the mucosal epithelium despite the fact that 
neutrophils are critical for preventing fungal dissemination in case of strain SC5314 (Trautwein-
Weidner et al. 2015b). These results demonstrate that the role of neutrophils during OPC is strain 
specific. Induction of IL-6 and TNF was also differentially induced in response to the different isolates, 
albeit difference for TNF did not reach statistical significance (Figure 8DE). Next, we assessed the 
activation of the IL-17 pathway and downstream targets on day 1 p.i.. IL-17 expression was strongly 
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reduced in the tongue of mice infected with the persistent C. albicans isolates compared to strain 
SC5314 (Figure 8FG). Similarly, S100a9 transcripts were very weakly if at all induced (Figure 8H). 
Together, this indicated that natural C. albicans isolates stimulated a highly variable response in the 
host, whereby the extent of inflammation induction correlated with fungal clearance (see below). 
 
 
Figure 8 Persistent C. albicans isolates induce a limited inflammatory response in the host.  
WT mice were infected with C. albicans SC5314, Cag, 529L or 101 and analyzed after 1 day. (A) 
Quantification of tongue CD11b+ Ly6C+ Ly6G+ neutrophils by flow cytometry. (B) Cxcl2 expression in 
tongue was assessed by qRT-PCR. (C) Serum G-CSF was quantified by ELISA. (D – H) Il6, Tnf, Il17a, 
Il17f and S100a9 expression in the tongue was assessed by qRT-PCR. Each symbol represents one 
mouse. Data are the pool of two independent experiments. The mean (C) or the geometric mean (A, 
B, D - H) of each group and significant differences between each group and the SC5314-infected 
group are indicated. Solid line: (geometric) mean of a naïve control group. 
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6.3.3 The variation in the pathogenicity of C. albicans isolates does not correlate 
with their clinical origin 
All isolates tested so far, which displayed low-pathogenicity and thus persisted in the host, were 
collected from the oral mucosa of patients and healthy individuals, while SC5314 was originally 
obtained from a blood culture. To test whether the origin of the isolates correlated with their 
pathogenicity, we examined the behavior of two additional independent blood isolates (UC820 and 
ATCC14053) in the OPC mouse model. These isolates displayed similar growth kinetics, cell wall 
composition and β-glucan exposure in vitro as strain SC5314 (Fig S2). Irrespective of their origin, they 
readily colonized the oral mucosa and persisted for over a week without inducing significant weight 
loss in the host (Figure 9A-C). Similar to the oral isolates analyzed before (Figure 7,Figure 8), they 
induced an attenuated inflammatory response (Figure 9D-F).  
Within a larger collection of natural isolates (see below), we identified additional strains of high-
pathogenicity similar to strain SC5314. One of them, strain CEC3605, which was collected from the 
vaginal mucosa and displayed a normal phenotype in vitro (Fig S2), was then tested for its behavior in 
vivo. Similar to SC5314, mice infected with CEC3605 displayed a strong transient weight loss (Figure 
9A) and rapid fungal control (Figure 9BC). As expected from the similar behavior of CEC3605 to SC5314, 
CEC3605 triggered a very strong and rapid inflammatory response in the oral mucosa on day 1 p.i. with 
large neutrophilic infiltrates (Figure 9DG) and high levels of neutrophil-recruiting chemokines, Il6 and 
Tnf transcripts in the epithelial tissue (Figure 9H-J) as well as high G-CSF levels in the serum (Figure 
9K). Moreover, Il17a, Il17f and IL-17 target genes were strongly induced by strain CEC3605 on day 1 
p.i. (Figure 9EF, L). 
Together, these results suggested that the host compartment, from which C. albicans isolates were 
collected, was not decisive for their behavior in the host. Rather the intrinsic capacity of individual 
isolates to promote a response in a previously C. albicans-naïve host determined whether they 
persisted in the host or were rapidly cleared. Moreover, the degree of early inflammation induced by 
a strain seemed to determine the outcome of infection, with an inverse correlation between the 
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inflammatory response triggered in the host and fungal persistence (Figure 9M). This is consistent with 
what was observed before in different experimental systems (Rahman et al. 2007; Misme-Aucouturier 
et al. 2016). 
 
Figure 9 The variation in the pathogenicity of C. albicans isolates did not correlate with their origin. 
WT mice were infected with C. albicans SC5314, ATCC14053, UC820 or CEC3605. (A) Body weight of 
infected mice. Data are the mean + SD (n = 6, pooled from two independent experiments). (B – C) 
Tongue fungal burden on day 3 and day 7. (D) Quantification of tongue CD11b+ Ly6C+ Ly6G+ 
neutrophils (day 1) by flow cytometry. (E – F) Il17a and S100a9 expression in the tongue was 
assessed (day 1) by qRT-PCR. (G) Representative images of sagittal tongue sections (day 1) stained 
with PAS. Arrows: inflammatory infiltrates. Scale bars: 50 μm. Inset: 2-fold magnification. (H – J) 
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Cxcl2, Il6 and Tnf expression in the tongue on day 1 was assessed by qRT-PCR. (K) Serum G-CSF on 
day was quantified by ELISA. (L) Il17f expression in the tongue was assessed (day 1) by qRT-PCR. (M) 
Scatter plot with data from figures 1F, 2A and 3D. Color code: mucosal isolates (green), blood isolates 
(red). In B – F and H – L, each symbol represents one mouse. Data are the pool of two independent 
experiments (except for the CEC3605 group in (B), which was from one experiment). The mean (A, K) 
or geometric mean (B – F, H – J, L) of each group and significant differences between each group and 
the SC5314-infected group are indicated. Solid line in D – F, H – L: (geo)mean of a naïve control 
group. 
6.3.4 Filamentation in vitro is not a good predictor of the pathogenicity of C. 
albicans isolates in the oral mucosa in vivo.  
To explore the underlying cause of the variability in the outcome of the interaction of the C. albicans 
isolates with the host, we compared the fungal morphology under different conditions. C. albicans is 
able to undergo morphological switching between budding yeast, pseudohyphal and hyphal forms. 
The ability to filament is generally thought to be a critical feature of pathogenicity (Hebecker et al. 
2014). All strains formed hyphae in FCS-containing liquid medium in a comparable manner with small 
differences in hyphal length after 3 hours (Fig S5A). Differences in filamentation between the C. 
albicans isolates were much more pronounced when grown on Spider medium for 10 days. While 
filamentation was observed reproducibly with strains SC5314, CEC3605 and UC820, while strains Cag, 
529L and ATCC14053 had a more variable phenotype and no filamentation was observed for strain 101 
in this assay (Fig S5BC). When growing the fungal strains on TR146 keratinocytes, all isolates were 
found to filament, albeit the proportion of cells forming pseudohyphae or hyphae, the hyphal length 
and the degree of branching varied (Fig S5D). Importantly, no correlation was found between hyphal 
growth on TR146 and the behavior of the fungal isolates in vivo: ATCC14053, which induced a similar 
degree of inflammation as Cag, formed mostly short pseudohyphae, while long hyphae were observed 
in case of Cag (Fig S5D). Likewise, 101, but not UC820 formed typical hyphal structures on TR146 cells, 
although none of the two induced significant inflammation in vivo (Fig S5D).  
Finally, we assessed fungal morphology in vivo using two pathogenic and two persistent isolates as 
examples. They all formed hyphal filaments in the infected tongue, which were hardly distinguishable 
in shape and length (Figure 7B, Figure 9G). This observation was confirmed when analyzing histology 
in top view of horizontally-cut tongues at 24 hours p.i. (Error! Reference source not found.A). 
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etermining the localization of C. albicans in the third dimension of the oral epithelium was not possible 
1 day p.i. when large neutrophil infiltrates were present in the mucosa of mice infected with SC5314 
and CEC3605 (Figure 7B,Figure 9G). We therefore shifted our analysis to an earlier time point during 
infection. This revealed important differences in the invasion depth of C. albicans isolates in the oral 
epithelium, which reflected the differential inflammatory response that they elicited (Error! Reference 
source not found.B). While the pathogenic isolates SC5314 and CEC3605 penetrated into the stratum 
spinosum and granulosum, the persistent isolates 529L and 101 were found exclusively in the 
amorphous stratum corneum at this early (Error! Reference source not found.B) as well as at later time 
points (Figure 7G). Together, these results indicated that the variation in pathogenicity between C. 
albicans isolates were not easily explained by differences in fungal morphology, but rather by their 
differential localization within the squamous mucosal epithelium. 
 
Figure 10 Filamentation in vitro is not a good predictor of the pathogenicity of C. albicans isolates 
in the oral mucosa in vivo. Representative images of tongue sections from WT mice infected with 
SC5314, 529L, 101 or CEC3605 stained with PAS. Top view of dorso-ventral sections on day 1 (A) and 
sagittal sections after 12 hours (B). Inset in A: 4-fold magnification. Filled arrows: boundary between 
stratum corneum and stratum granulosum; open arrows: stratum basale. 
6.3.5 Induction of damage and IL-1α in keratinocytes reflects the pathogenicity 
of C. albicans in vivo. 
 As a first contact point, epithelial cells play a key role in the initial interaction between C. albicans and 
the host during superficial infections. C. albicans can adhere, invade and damage the epithelium, all  
parameters associated with enhanced virulence (Hebecker et al. 2014). All isolates adhered to the 
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keratinocytes cell line TR146, albeit to variable degrees (Fig S6A). Likewise, the capacity of the isolates 
to form biofilm varied and did not show a pattern that could be associated with the observed 
phenotypes in vivo (Fig S6B). In contrast, the extent to which the different isolates caused epithelial 
cell damage, as assessed by LDH release, reflected their differential induction of inflammation in vivo 
(Figure 11AB). Importantly, the differences in damage induced by the isolates were conserved at 
different infection doses (Fig S6C). The release of LDH by cultured keratinocytes in response to C. 
albicans in vitro was thus a good correlate for fungal pathogenicity in vivo (Figure 11CD).  
In the following, we used the LDH release assay as a surrogate to examine the variation in pathogenicity 
of C. albicans within a larger collection of 74 natural isolates. Although largely diverse, they all ranked 
between the two extremes identified as high damage inducers (>10% LDH release after 8 hours of 
stimulation, exemplified by SC5314 and CEC3605) and low damage inducers (<10% LDH release after 
24 hours of stimulation, exemplified by 101, 529L and UC820). A small proportion of isolates fell into 
the group of intermediate damage inducers (<10% LDH release after 8 hours, >10% after 24 hours of 
stimulation) (Figure 11E). Confirming our previous results (Figure 9M), the degree of damage induced 
by different isolates did not correlate with their source, namely mucosal tissues or blood cultures 
(Figure 11F).  
The induction of cellular damage by C. albicans was recently associated with the virulence factor ECE1, 
which gives rise to a pore forming toxin Candidalysin (Moyes et al. 2016). We therefore assessed ECE1 
expression by C. albicans isolates in contact with TR146 cells. Although we detected significant 
differences in ECE1 expression between the different isolates (Figure 11G), they did not correlate with 
the degree of LDH release (Figure 11H) or the in vivo pathogenicity induced. Moreover, we did not 
detect significant differences in expression of KEX1 and KEX2, two proteinases involved in the 
processing of ECE1 (Moyes et al. 2016) between the isolates tested (Fig S6D). Therefore, mechanisms 
beyond those involving ECE1 seem to determine the capacity of C. albicans to cause host damage when 
moving away from strain SC5314. Expression of other well-known virulence factors, such as ALS3, 
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SAP4, SAP5, SAP6, SAP9 and HWP1 and the virulence-associated transcriptional regulators EFG1 and 
CPH1 were also not significantly altered between the isolates (Fig S6EF).  
Induction of cellular damage is linked to the release of cytoplasmic molecules, some of which can act 
as alarmins and promote inflammation if freed into the extracellular space where they do not usually 
reside. Indeed, IL-1α release by keratinocytes in response to C. albicans isolates mirrored the levels of 
LDH release (Figure 11IJ). In contrast, keratinocyte secretion of other cytokines such as IL-6 and IL-8 
did not follow the same pattern (Fig S6G). The differential IL-1α response by pathogenic and non-
pathogenic isolates was also observed in the infected tongue, as shown for a prototypic isolate of each 
type, SC5314 and 101 (Figure 11K).  
Together, these data indicate that the induction of damage and release of danger-associated 
molecules from cultured keratinocytes in vitro is a good predictor of C. albicans pathogenicity in vivo. 
Moreover, they suggest that the epithelium translates differences in the fungus into differential host 
responses.  
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Figure 11 Induction of damage and IL-1α in keratinocytes reflects the pathogenicity of C. albicans in 
vivo. (A – B) LDH release from TR146 cells stimulated with C. albicans SC5314, Cag, 529L, 101, 
ATCC14053, UC820, CEC3605 or the mutant strain efg1Δ/Δ, which was included as a negative control, 
for 8  hours (A) or 24 hours (B). (C – D) Scatter plot of data from figures 5A, 2A and 3D (C) or figures 
5B, 2A and 3D (D). Color code as in figure 3M. (E – F) Damage induction by C. albicans 76 isolates 
(including the seven isolates used in this study) classified as low (<10% LDH release at 24 hours), mid 
(<10% at 8 hours / >10% after 24 hours) and high (>10% after 8 hours).  In F, the number of isolates 
in each category is shown separately for isolates from mucosal surfaces (superficial) and blood 
cultures (invasive). (G) ECE1 mRNA expression by C. albicans isolates upon contact with TR146 
keratinocytes for 24 hours. (H) Scatter plot of data from figure 5B and G. (I) IL-1α levels in the 
samples from (B). Solid line: basal IL-1α levels in the supernatant of unstimulated TR146 cells. (J) 
Scatter plot of data from figure 5B and I. (K) Representative images of sagittal tongues sections from 
WT mice infected with SC5314 or 101 for 1 day and stained with anti-IL1-α (red) and DAPI (blue) (top) 
or PAS (bottom). Scale bars: 100 μm. In A, B and I, each symbol represents a separate well, the mean 
of each group is indicated. Data are a pool of two independent experiments. In G, data are the pool 
of 3 independent experiments, the geomean of each group is indicated. 
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6.3.6 Persistent C. albicans isolates induce a delayed and qualitatively altered 
response in the oral mucosa  
Our data suggested that non-pathogenic C. albicans isolates persisting in the stratum corneum of the 
oral mucosa induce a very limited host response. However, the observation that they did not overgrow 
the host or disseminate, indicated that they were not completely uncontrolled by the host. We 
therefore examined the antifungal response to the persistent strains 101 and 529L at later time points. 
In contrast to the strong and transient neutrophil response induced by pathogenic isolates (Figure 
12A), 529L and 101 induced small and isolated neutrophil infiltrates in the infected tongue on day 3 
and 5 p.i. (Figure 12A). This attenuated response was paralleled by a strongly impaired induction of G-
CSF and Cxcl2 expression (Figure 12BC).  
 
Figure 12 The neutrophil response to persistent isolates is strongly attenuated. (A) Representative 
images of sagittal tongue sections from WT mice infected with SC5314, 529L, 101 or CEC3605 for 1, 3 
or 5 days and stained with anti-Ly6G. Scale bars: 1 mm. (B – C) Serum G-CSF (B) and tongue Cxcl2 
mRNA (C) of WT mice infected with SC5314, 529L or 101 for 1, 3 or 5 days. Each symbol represents 
one mouse. The mean (B) or geometric mean (C) of each group is indicated. Data in B and C are 
pooled from two independent experiments. Solid line: (geo) mean of a naïve control group. 
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Significant differences between each group and the SC5314-infected group (day 1) or between naïve 
and infected groups for each strain are indicated by asterisks or by hashes, respectively.  
 
In contrast, expression of IL-17 and IL-17 target genes was strongly induced in the tongue of 529L- and 
101-infected mice on day 3 and 5 that reached comparable levels to those found in SC5314-infected 
tongues on day 1 p.i. (Figure 13A-C). These data were further confirmed by measuring IL-17A and IL-
17F protein induction in response to persistent isolates at later time points (Figure 13DE). Likewise, C. 
albicans-specific Th17 cells were induced comparably by all isolates tested in the draining lymph nodes 
on day 7 p.i. (Fig S7).  
Together, these results indicated that C. albicans isolates, which initially induced a restrained response, 
did not remain undetected by the immune system and an IL-17 signature response was readily 
triggered after a few days of fungal presence in the host. In contrast, the recruitment of neutrophils 
remained very limited, even at later time points when the fungal load was still high. 
6.3.7 IL-17 signaling is essential for preventing fungal overgrowth irrespective 
of the degree of fungal pathogenicity 
To evaluate whether the IL-17 response to OPC infection with persistent strains was relevant for host 
defense and fungal control in the oral mucosa despite the delayed induction, we infected mice with a 
genetic defect in IL-17 signaling. Both IL-17RA- and IL-17RC-deficient mice showed increased fungal 
loads after infection with strains 101 and 529L if compared to WT control hosts (Figure 13FG). Groups 
of mice infected with strain SC5314 were also included in this experiment for comparison (Figure 
13FG). The relevance of the IL-17 pathway for limiting the growth of all fungal isolates was also obvious 
when analyzing infected tongues by histology (Figure 13H). Infection of IL-17 receptor deficient mice 
with strains 101 or 529L did not results in major changes in body weight (Fig S8), re-emphasizing that 
the weight loss during the early phase of OPC, as seen with pathogenic strains of C. albicans, was not 
directly associated with the fungal burden.  
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Figure 13 IL-17 signaling is essential for preventing fungal overgrowth irrespective of the degree of 
fungal pathogenicity (A – C)  Il17a, S100a9, Defb3 expression in the tongue of WT mice infected with 
SC5314, 529L or 101 for 1, 3 or 5 days. Each symbol represents one mouse. The geometric mean of 
each group is indicated. Solid line: geometric mean of a naïve control group. Data are pooled from 
two independent experiments. (D – E) IL-17A and IL-17F protein levels in the tongue of WT mice 
infected with 529L or 101 for 1 or 3 days compared to the respective levels induced by SC5314 on 
day 1 post-infection. In A-E, significant differences between each group and the SC5314-infected 
group (day 1) or between naïve and infected groups for each strain are indicated by asterisks or by 
hashes, respectively. (F – G) Tongue fungal burden on day 7 in WT and Il17ra-/- (F) or Il17rc-/- mice 
(G) infected with SC5314, 529L or 101. Each symbol represents one mouse. The geometric mean of 
each group is indicated. Significant differences of the knockout to the corresponding WT control 
group for each fungal strain are indicated. (H) Representative images of sagittal tongue sections of 
101-infected WT and Il17ra-/- mice stained with PAS. Scale bars: 250 μm. Inset: 4 fold magnification, 
scale bars: 50 μm. 
 
In conclusion, these results showed that IL-17 signaling plays a non-redundant role for mucosal 
immunity against C. albicans, irrespective of the nature of the infecting strain, whereas epithelial cell 
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damage, mucosal inflammation and neutrophil infiltration display a strain-specific dichotomy and are 
associated with fungal pathogenicity.  
 
 Discussion 
C. albicans is a common pathobiont and one of the most important disease-causing fungi in humans. 
Disease symptoms occur if host defenses are breached. Specific immune mechanisms that protect 
from different forms of diseases have been characterized. However, little attention has been paid so 
far to the contribution of the natural diversity of C. albicans to the decision between health and 
disease. In this study, we took advantage of a mouse model of OPC to probe the differential interaction 
of the host with diverse fungal isolates in a complex but uniform and C. albicans-naïve environment in 
vivo. We identified major qualitative and temporal differences in immune activation by distinct fungal 
isolates. The capacity of C. albicans to trigger a response by the epithelium such as the release of 
alarmins/IL-1α correlates with the induction of an inflammatory response and the rapid control of the 
fungus by the host. Thereby, the functional variability of C. albicans natural isolates determines a fine 
balance between commensalism and pathogenicity and thus the long-term outcome of the interaction 
with the host. In contrast, the requirement of the IL-17 pathway for preventing fungal outgrowth was 
conserved among all isolates tested, highlighting the key role of this cytokine in host protection from 
C. albicans, irrespective of the fungal pathogenicity.  
Significant diversity exists between natural isolates of C. albicans, both from a phylogenomic as well 
as a phenotypic perspective. Population studies of C. albicans support a predominantly clonal mode of 
reproduction of this diploid and largely heterozygous organism (Pujol et al., 1993; Bougnoux et al., 
2008b; Moorhouse et al., 2016). Examples of phenotypic variation across C. albicans isolates have been 
studied most extensively in the context of antifungal drug resistance (Cowen et al., 2015; Loll et al., 
2015). Differences between natural C. albicans isolates that affect their interaction with the host have 
also been reported (MacCallum et al., 2009). A striking example of phenotypic intraspecies variation is 
provided by the differential behavior of two unrelated natural isolates in mice lacking the β-1,3-glucan 
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receptor Dectin-1, which was based on differences in the composition and nature of their cell walls 
and recognition by innate immune cells in vivo (Marakalala et al., 2013). Variation may also exist in the 
extent to which TLR4 recognizes different C. albicans isolates (Netea et al., 2010). In all these examples, 
the genetic basis for the phenotypic differences remains unexplored. This also applies to the isolates 
analyzed in this report. Future research will be needed to decipher the genetics underlying natural 
differences in the virulence traits of C. albicans, although the high degree of sequence variation 
between individual isolates makes this endeavor a challenge (Ford et al., 2015; Hirakawa et al., 2015).  
Existing intraspecies variation however is likely contributing to the probability of disease development 
and/or the severity of symptoms when comparing individuals with a comparable immune status. C. 
albicans infections are generally not transmissible, but rather caused by the fungal strain that was 
already present as a component of the microbial flora prior to the outbreak of symptoms. This is 
consistent with the observation that the origin of the isolates from mucosal surfaces or blood cultures 
did not segregate by differences in pathogenicity.  
In the current study, we focused on how the fungal diversity affects the host response in vivo. Infection 
of mice via the sublingual route revealed a spectrum of temporally and qualitatively different immune 
responses to different isolates with the two extremes exemplified by strains SC5314 and 101, and 
various intermediate cases. While some isolates triggered a massive infiltration of neutrophils and a 
strong expression of IL-17 in the infected tissue within one day p.i., as it was observed previously for 
strain SC5314 (Gladiator et al., 2013; Trautwein-Weidner et al., 2015b), the response to other isolates 
was delayed with induction of IL-17 from day 3 p.i., but only very limited neutrophil recruitment. The 
former scenario was associated with rapid fungal elimination from the host, whereas the latter allowed 
persistent colonization of the host mucosal epithelium by the isolate. Rapid induction of an 
inflammatory response appeared thus to be critical for the decision between fungal colonization 
versus elimination and the contribution of infiltrating neutrophils to the response is strain-dependent. 
The segregated host response was paralleled by very distinct patterns of weight loss and recovery 
during infection with different isolates. Our data suggest that not the fungal load, as previously thought 
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(Conti et al., 2009; Trautwein-Weidner et al., 2015b), but rather the rapid inflammatory response, and 
possibly the associated damage caused to the host, elicits the drop in weight on day 1 – 2 p.i.. It remains 
unclear whether and which specific host factor(s) account for it, and if so, which one. IL-1 or TNF, which 
can cause cachexia in other contexts, do not seem to be involved in the experimental setting used 
here. According to our preliminary data, IL-1 receptor deficiency did not relieve the drop in weight, 
and no significant increase in systemic TNF levels were measured upon infection with strain SC5314. 
The qualitative differences in the host response between different C. albicans isolates, and in particular 
the observation that the delayed induction of IL-17 by persistent isolates was not accompanied by 
significant neutrophil infiltration, underlines the notion that the two pathways are uncoupled during 
OPC (Trautwein-Weidner et al., 2015b). Although genes associated with neutrophil trafficking and 
function can be affected by IL-17 in some cases (Schwarzenberger et al., 1998; Laan et al., 1999; 
Miyamoto et al., 2003), defective IL-17 signaling does not impair neutrophil recruitment to the site of 
infection during OPC (Trautwein-Weidner et al., 2015b), and the induction of IL-17 does not entail an 
enhanced neutrophil response as shown here.  
The IL-17 pathway has emerged as a key player in protection from superficial candidiasis, as evidenced 
by the strong association of CMC with defects in genes linked to IL-17 production or signaling (Puel et 
al., 2012). Likewise, the critical role of the IL-17 pathway in preventing uncontrolled fungal overgrowth 
in the epithelium was conserved in mice irrespective of the pathogenicity of the infecting strain, albeit 
the delayed induction of IL-17 and IL-17 target genes appeared insufficient from eliminating colonizing 
fungus from the murine host. 
C. albicans-specific Th17 cells can be found in the circulation of most individuals irrespective of the 
fungal diversity within the human population (Sparber and LeibundGut-Landmann, 2015). C. albicans-
specific Th17 cells are also induced in mouse models of superficial candidiasis (Bär et al., 2012; 
Hernandez-Santos et al., 2012; Trautwein-Weidner et al., 2015a). In this study we compared the Th17 
response to different C. albicans isolates and found that it was induced to comparable degrees in all 
cases. Thus, the drastic differences in inflammation during the initial acute host response do not 
  
56 
 
translate in differences of adaptive immunity. This suggests that the initial inflammatory response to 
some isolates is redundant for the initiation of adaptive antifungal immunity. Alternatively, the 
increased antigen load in case of infection with persistent isolates may also compensate for the initially 
limited induction of T cell activating/polarizing cytokines.  
During OPC infection with highly virulent C. albicans strains, such as SC5314, IL-17 is induced rapidly 
and prior to the initiation of cytokine production by conventional Th17 cells (Gladiator et al., 2013; 
Conti et al., 2014; Kashem et al., 2015). Lymphocytes of the innate immune system including innate 
TCRαβ+ T cells, TCRγδ+ T cells and innate lymphoid cells (ILCs) have been identified as the source of the 
immediate production of IL-17 in the skin and oral mucosa within one day p.i. (Gladiator et al., 2013; 
Conti et al., 2014; Kashem et al., 2015). The cell type(s) responsible for tongue IL-17 production 3 – 5 
days after infection of mice with colonizing isolates of C. albicans and the signals responsible for the 
delayed IL-17 production in this situation remain to be identified. 
Our data demonstrated that the differential induction of an inflammatory response by diverse C. 
albicans isolates in the oral mucosa correlated closely with the degree of damage that these isolates 
caused in keratinocyte cultures. Consistent with previous reports (Dongari-bagtzoglou et al., 2004; 
Moyes et al., 2016), LDH release as a readout for damage induction also correlated closely with the 
release IL-1α by keratinocytes. We show that this applies also in vivo, where induction of IL-1α in the 
oral epithelium was greatly increased in response to strain SC5314 compared to strain 101. IL-1 
signaling is linked to the regulation of neutrophil recruitment in response to C. albicans (Tomalka et 
al., 2015; Altmeier et al., 2016). Therefore, the epithelium is capable of sensing differences between 
fungal isolates that it translates into an inflammatory response, and thereby determines the overall 
degree of the (innate) host response. The measure of LDH and IL-1α release by keratinocytes in 
response to C. albicans isolates thus serves as a surrogate for determining the degree of inflammation 
induced in the host tissue in vivo and the efficiency of fungal control, which in turn are linked to 
differences between commensalism and pathogenicity. The keratinocyte assay may thus be used to 
predict the outcome of the interaction between C. albicans isolates and the host epithelial/superficial 
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tissues in vivo. It may serve for screening collections of fungal isolates from cohorts of patients with 
specific immune defects to assess a possible correlation between the pathogenicity of the isolates and 
the severity of symptoms.  
Epithelial damage caused by C. albicans appears to result from a combination of different mechanisms. 
Filamentation is generally thought to be a prerequisite for damage induction, and expression of many 
virulence genes is associated with fungal morphology (Thompson et al., 2011). More recent results 
however have challenged the dogma that there is a precise correlation between morphology and 
virulence/damage, and filamentation per se appears not sufficient for damage induction or virulence 
(Noble et al., 2010; Moyes et al., 2016). Similarly, the degree of filamentation of different C. albicans 
isolates analyzed in this study did not correlate well with the degree of damage they induced in 
keratinocytes. Moreover, the expression of well-known virulence genes such as ALS3, SAP4, SAP5, 
SAP6, SAP9, HWP1 and EFG1 upon fungal contact with the epithelium did also not match the functional 
response of the epithelium to the different isolates. Among all examined virulence genes, the largest 
variations in expression between the isolates were observed for ECE1. Proteolytic cleavage of the Ece1 
protein leads to the release of a peptide toxin called Candidalysin, which was recently described to be 
sufficient and required for induction of epithelial cell damage by C. albicans strain SC5314 (Moyes et 
al., 2016). While we could confirm strong expression of ECE1 by strain SC5314 in contact with 
keratinocytes, ECE1 expression did not correlate with keratinocyte damage induction in all cases. A 
limitation of our study may be that ECE1 expression was measured at the transcript level, and 
polymorphisms in the ECE1 gene were not analyzed, which may add to the complexity in the system. 
The molecular and genetic basis for the diversity among C. albicans isolates triggering epithelial cell 
damage and inflammation, and thus for the variation between pathogenicity and commensalism in the 
host remains to be determined in the future. Importantly, of all the different parameters analyzed in 
vitro in this study, only very few could be linked closely to the behavior of C. albicans isolates in vivo in 
the living host organism. Results from in vitro studies, such as the assessment of fungal growth on 
Spider medium, should thus be interpreted with care and not extrapolated to fungal pathogenicity in 
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vivo. This is reminiscent of strain-specific differences in virulence that manifest in Dectin-1-deficient 
hosts, which could only be revealed in vivo (Marakalala et al., 2013).  
Together, our extensive study with different unrelated C. albicans isolates in contact with the host 
offered detailed insights into the intricate interplay between the fungus and host in vivo, and 
emphasized the limitations of results obtained from studies with a single (random) strain. This study 
taught us how not only different immune pathways differ in their contribution to antifungal immunity, 
but also how variations in the fungus result in selective activation of distinct defense mechanisms and 
thereby influence the outcome of the microbe-host interaction. While the requirement of IL-17 for 
fungal control in the mucosa is highly conserved, inflammation and neutrophil infiltrates are only 
triggered by highly pathogenic strains, which thereby induce their rapid clearance. Accordingly, the 
natural diversity of C. albicans is an important determinant of the fine balance between commensalism 
and pathogenicity in vivo. 
 
 Material and Methods 
6.5.1 Fungal strains and media 
The C. albicans blood isolates SC5314 (Gillum et al. 1984a), UC820 (ATCC MYA-3573 (Lehrer, Cline 
1969)), ATCC14053 (Skowronski, Feldman 1989), the oral isolate 529L (isolated from an oral candidiasis 
patient (Rahman et al. 2007), a kind gift from J. Naglik), the oral isolates 101 (isolated from a healthy 
volunteer during an epidemiological clinical trial (approved by the cantonal ethics committee of the 
Canton of Ticino, Switzerland, approval number CE 2669)), Cag (isolated from a CMC patient with 
unknown etiology, kindly obtained from D. Firinu) and the vaginal isolate CEC3605 ((Sdoudi et al. 2014), 
isolated from a healthy carrier) were included in this study. Additional 67 isolates of different origin 
(mainly Europe and North Africa) were from the collection of the d’Enfert laboratory (Sdoudi et al. 
2014; Bougnoux et al. 2006; Odds et al. 2007; Bougnoux et al. 2008a; Shin et al. 2011; Angebault et al. 
2013). C. albicans isolates were obtained after written informed consent by adult subjects or by their 
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parent/guardian in case of children and were analyzed anonymously. The isogenic mutant strain 
efg1Δ/Δ ((Lo et al. 1997a), a kind gift from A. Mitchell) was used as a control in some experiment.  
All isolates were maintained on Sabouraud or Yeast Peptone Dextrose (YPD) agar plates for short term 
and in glycerol at -80°C for long term storage. For determining fungal growth in vitro, Yeast Nitrogen 
Base (YNB) with 2% Glucose or Hams`s Nutrient Mixture F12 medium (SIGMA) supplemented with L-
Glutamine, Penicillin, Streptomycin and 1% FCS was used. For other in vitro experiments and for in vivo 
and cell culture infection experiments, C. albicans was inoculated at an OD595 = 0.1 and grown in YPD 
medium at 30°C and 180 rpm for 15-18 hours.  For induction of hyphae in liquid medium, Hams`s 
Nutrient Mixture F12 medium (SIGMA) supplemented with L-Glutamine, Penicillin, Streptomycin and 
10% FCS (filamentation assay) or 1% FCS (RNA-Isolation, damage induction) was used. For 
determination of the fungal cell wall composition and β-glucan exposure, C. albicans was grown in YPD 
medium at 37°C overnight and subcultured into fresh YPD at OD600 = 2 for 3.5 hours at 37° C to obtain 
logarithmic-growing cells.  
6.5.2 Microsatellite analysis 
For microsatellite analysis, C. albicans was grown overnight on Sabouraud agar plates at 37°C and DNA 
was extracted using InstaGene matrix following the manufacturer’s instructions. Primers were Cdc3 
fwd, 5'-CAGATGATTTTTTGTATGAGAAGAA-3', Cdc3 rev 5'-CAGTCACAAGATTAAAATGTTCAAG-3', Ef3 
fwd 5'-TTTCCTCTTCCTTTCATATAGAA-3’, Ef3 rev 5'-GGATTCACTAGCAGCAGACA-3' , His3 fwd 5'-
TGGCAAAAATGATATTCCAA-3', His3 rev 5'-TACACTATGCCCCAAACACA-3', CaV fwd 5’-
TGCCAAATCTTGAGATACAAGTG-3’, CaV rev 5’-CTTGCTTCTCTTGCTTTAAATTG-3’, CaVII fwd 5’-
GGGGATAGAAATGGCATCAA-3’, CaVII rev 5’-TGTGAAACAATTCTCTCCTTGC-3’ (Botterel et al. 2001; 
Sampaio et al. 2005). One primer of each set was 5' labelled with Hexachloro-fluorescein (for CDC3, 
HIS3 and CAVII) fluorescein amidite (for EF3, CAV), respectively. PCR reactions were done according to 
standard protocols using HotStarTaq Polymerase (Qiagen) and a 2720 Thermal Cycler (Applied 
Biosystems). Gene products were analyzed on a 3500 Genetic Analyzer (Applied Biosystems) using a 
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GeneScan 600 Liz dye size standard (Applied Biosystems) and GeneMapper v4.1 software (Applied 
Biosystems). 
6.5.3 Multilocus sequence typing (MLST) 
MLST was performed as published previously (Bougnoux et al., 2003). Allele and diploid sequence type 
(DST) assignments were determined using the C. albicans MLST database 
(http://pubmlst.org/calbicans). A UPGMA dendrogram was constructed using the Molecular 
Evolutionary Genetics Analysis (MEGA) v7 software.  
6.5.4 C. albicans biofilm formation 
Biofilm formation was assessed as described (Nobile et al. 2006) with the following modifications. After 
overnight culture in YPD, C. albicans yeast cells were washed twice in PBS and resuspended at 106 
cells/ml in RPMI medium (Sigma) supplemented with 10% fetal calf serum (FCS). The cell solution was 
added to 1 cm2-sized FCS-treated adhesive silicone gel sheets (Smith & Nephew) placed into a 24-well 
cell culture plate and incubated for 90 minutes at 37° C, 60 rpm for initial cell adhesion. Silicone gel 
sheets were then washed with PBS to remove non-adherent cells and moved to a new 24-well plate 
containing 1ml fresh medium. After 48 hours at 37° C in a humidified incubator without shaking, the 
squares were washed with PBS and biofilm was assessed at OD490 after addition of 0.5g/l filtered XTT 
(Sigma) in PBS. 
6.5.5 C. albicans filamentation assays 
After overnight culture in YPD, C. albicans yeast cells were washed twice in PBS and adjusted to 107 
cells/ml in Hams`s Nutrient Mixture F12 medium (SIGMA) supplemented with L-Glutamine, Penicillin, 
Streptomycin and 10% FCS. One ml of this cell suspension was incubated for 3 hours at 37°C on a glass 
coverslips placed in a 24-well plate. After three time washing with PBS, cells were stained with 
Calcofluor white. Hyphae length was determined with an Axiolab Microscope (Carl Zeiss) and 
AxioVisionRel4.6 software. 
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For testing the colony morphology on Spider medium C. albicans cells were grown in YPD and washed 
in PBS as described above, and adjusted to 107 cells/ ml in PBS. 5μl of this cell suspension and of a 
1:100 dilution was spotted on Spider medium plates and incubated for 10 days at 37°C. Pictures were 
taken with a Dinolite Digital Microscope and the Dinocaptire 2.0 software. 
6.5.6 Analysis of the fungal cell wall composition  
Logarithmically-growing C. albicans was washed three times in 50ml of 1mM cold 
phenylmethanesulfonyl fluoride (PMSF). 3 volumes of glass beads were then added to one volume of 
pellet and vortexed for 10-15 times at 1-minute intervals to break the cells. The cell lysate was again 
washed three times with 50 ml cold PMSF, before addition of 3 volumes of 2% SDS to the pellet and 
incubation for 10 min at 100° C for two rounds. SDS was removed by washing the pellet in 1mM PMSF 
and the pellet was dried overnight at 55°C before re-suspension in 1mM PMSF to a solution of 0.01 g 
dry weight / ml and storage at -20°C. Total chitin was extracted and measured as described (Kapteyn 
et al. 1997). Total mannan were extracted from isolated cell walls by alkali treatment and further 
precipitated with Fehling’s solution as a copper complex as described (Chaffin et al. 1998). Total glucan 
was extracted as described (Dijkgraaf et al. 1996) and the extracted glucan and mannan components 
were then measured by the Dubois method (DuBois et al. 1956) using glucose as a standard. 
6.5.7 Determination of β-glucan exposure of C. albicans 
Quantification of -1,3-glucan exposure on the surface of C. albicans was done as previously published 
(Wartenberg et al. 2014), with some modifications. 200 µl of logarithmically-growing C. albicans 
suspension was pelleted in a 96-well plate by centrifugation at 3500 rpm for 5 minutes. Cells were 
fixed with 1% formaldehyde, washed twice with PBS and blocked with 1% BSA for 1 hour at room 
temperature with gentle shaking, before incubation with an anti--1,3-glucan monoclonal antibody 
(mouse IgG, Biosupplies; 1:600 dilution in 1% BSA) overnight at 4 C with gentle shaking, followed by 
three washing steps in PBS, incubation with an Alexa Fluor 488-coupled anti-mouse IgG (Molecular 
Probes; 1:300 dilution) for 1 hour at room temperature with gentle shaking and three final washing 
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steps in PBS. Relative fluorescent intensities were then calculated by taking the ratio of the tested 
sample stained with/without secondary Alexa Fluor 488-coupled anti-mouse IgG antibody. 
6.5.8 Cell lines  
The oral keratinocyte cell line TR146 ((Rupniak et al. 1985), Sigma) was grown in Hams`s F12 nutrient 
mixture supplemented with L-Glutamine, Penicillin, Streptomycin and 10% FCS if not indicated 
otherwise. For experiments, cells were seeded at 2x105 cells/well in 6-well plates or at 2x104 cells/well 
in 96-well plates, respectively, and grown to confluent monolayers for 2-3 days prior to infection as 
described below for the individual assays.  
6.5.9 Filamentation of C. albicans on TR146 cells 
For assessing C. albicans filamentation, TR146 cells were grown to confluency on cover slips placed in 
a cell culture dish. C. albicans was grown in YPD overnight, washed twice in PBS and added onto the 
keratinocytes in cell culture medium at 103 cells/ml. After 24 hours, the medium was removed and the 
cells fixed with acetone followed by Calcofluor white staining. Microscopic pictures were taken with 
an Axiolab Microscope (Carl Zeiss) and AxioVisionRel4.6 software. 
6.5.10 Adherence of C. albicans to TR146 cells 
Adherence assay was performed as described (Murciano et al. 2012) with the following modifications. 
Monolayers of TR146 cells in 6-well plates were incubated with 102 Candida yeast cells for 2 hours at 
37°C. The supernatant was then removed and distributed on YPD agar plates to determine the number 
of non-adherent fungal cells. After rinsing the 6-well plates with PBS the wells were overlaid with 
melted Wort agar at 40°C and incubated for 1 day at 37°C to count fungal colonies. Adherence was 
determined as (# of colonies grown on Wort agar) / (# of colonies grown on Wort agar) + (# of colonies 
grown from culture supernatant).  
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6.5.11 Cytokine secretion by TR146 cells 
TR146 cells were grown to confluency in 96-well plates in Hams`s F12 nutrient mixture with 1% FCS 
and stimulated with 2x104 C. albicans yeast cells per well for 24 hours. Human IL-6, IL-8 and IL-1α 
secretion by TR146 cells was quantified with the ELISA MAX Deluxe Set kits (Biolegend) according to 
manufacturer’s instructions. 
6.5.12 LDH release assay 
The damage assay was performed as described (Wachtler et al. 2011a). Briefly, TR146 cells were grown 
to confluency in a 96-well plate in grown in Hams`s F12 nutrient mixture with 1% FCS and stimulated 
with 2x104 C. albicans yeast cells per well for the indicated time period. Control wells were incubated 
with medium only or lyzed with 1% Triton-X-100 at the end of the incubation time to determine 100% 
damage. LDH release into the supernatant was quantified with the LDH cytotoxicity kit (Roche) 
according to the manufacturer’s instructions. 
6.5.13 RNA isolation and quantitative RT-PCR from C. albicans 
 Fungal cells were disrupted in Trizol reagent (Sigma) with glass beads (0.5 mm) in a FastPrep24 (MP 
Biomedicals) for 5 cycles of 1 min at 50Hz with cooling between cycles. RNA was isolated with Direct-
zol RNA Mini Prep spin columns (Zymo research) and cDNA was generated by RevertAid reverse 
transcriptase (Thermo Scientific). Quantitative PCR was performed using Fast SYBR Green Master Mix 
and a FAST 3500 Genetic Analyzer (both Applied Biosystems). The primers were Efb1 fwd 
5'-CATTGATGGTACTACTGCCAC-3', Efb1 rev 5'-TTTACCGGCTGGCAAGTCTT-3', Kex1 fwd 
5'-CTGATTCCGATTCCACCAGT-3', Kex1 rev 5'-ATGAGCGAGTGACATTGCT-3', Kex2 fwd 
5'-ATCGGCATCACAACAACAAA-3', Kex2 rev 5'-GCTGATTGTTGTCCCTCCTC-3', Hwp1 fwd 
5'-CGGAATCTAGTGCTGTCGTCTCT-3', Hwp1 rev 5'-TAGGAGCGACACTTGAGTAATTGG-3', Ece1 fwd 5'-
CGTTCCAGATGTTGGCCTTAATCT-3', Ece1 rev 5'-CTGAGCCGGCATCTCTTTTAACTG-3', Cph1 fwd 
5'-GGTGGCGGCAGTGATAGTG-3', Cph1 rev 5'-GTGTACTCCGGTGACGATTTTTC-3', Als3 fwd 5’- 
TCTCGTCCTCATTACACCAACCAT-3’, Als3 rev 5’- GGGGATTGTAAAGTGGATTCTGTG-3’, Sap4 fwd 5’-
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GCCGATGGTTCTGTTGCAC-3’, Sap4 rev 5’-GAGCCGCTATACTTGGCCTT-3’, Sap5 fwd 5’-
TGGTTTTCAAAGCGGCGAAG -3’, Sap5 rev 5’-AGCATCAACATTTCGTCCCC-3’, Sap6 fwd 5’-
CGTGGTGACAGAGGTGACTT-3’, Sap6 rev 5’-TGGTAGCTTCGTTGGCTTGG-3’, Sap9 fwd 5’-
TTTCAGCGACACTTTGCAGC-3’, Sap9rev 5’-TGTCGACTGTTCTGCTGGAG-3’, Efg1 fwd 5’-
TCCCACCACATGTATCGACAA-3’, Efg1 rev 5’-GAAGTGCTCGAGGCGTTCA-3’. 
6.5.14 Mice  
Wildtype (WT) C57BL/6J mice were purchased from Janvier Elevage. Il17ra-/- and Il17rc-/- mice were 
obtained from Amgen (Thousand Oaks, CA) and bred at the Laboratory Animal Service Center 
(University of Zürich, Switzerland). All mice were on the C57BL/6 background, kept in (Solis, Filler 
2012)specific pathogen-free conditions and used in sex- and age-matched groups at 6-12 weeks of 
age. All mouse experiments described in this study were conducted in strict accordance with the 
guidelines of the Swiss Animal Protection Law and were performed under protocols approved by the 
veterinary office of the Canton Zürich, Switzerland (license number 201/2012 and 183/2015). All 
efforts were made to minimize suffering and ensure the highest ethical and humane standards. 
6.5.15 OPC infection model  
Mice were infected sublingually with 2.5x106 cfu C. albicans yeast cells as described (Solis, Filler 2012) 
without immunosuppression. Mice were weighed daily. For determination of fungal burden, the 
tongue of euthanized animals was removed, homogenized in sterile 0.05% NP40 in H2O for 3 minutes 
at 25 Hz using a Tissue Lyzer (Qiagen) and serial dilutions were plated on YPD agar containing 100 
µg/ml Ampicillin.  
6.5.16 Isolation of tongue cells  
Mice were anaesthetized with a sublethal dose of Ketamine (100 mg/kg), Xylazin (20 mg/kg) and 
Acepromazin (2.9 mg/kg), and perfused by injection of PBS into the right heart ventricle prior to 
removing the tongue. Tongues were cut into fine pieces and digested with DNase I (200 µg/ml, Roche) 
and Collagenase IV (4.8 mg/ml, Invitrogen) in PBS at 37°C for 45-60 min. Single cell suspensions were 
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passed through a 70 µm strainer using ice-cold PBS supplemented with 1% FCS and 2 mM EDTA and 
analyzed by flow cytometry (see below).  
6.5.17 Analysis of Th17 priming  
Cervical lymph nodes were removed on day 7 post-infection and single cell suspensions were prepared 
by digested with DNase I (2.4 mg/ml, Roche) and Collagenase I (2.4 mg/ml, Invitrogen) in PBS for 15 
min at 37°C. For inducing cytokine secretion by primed T cells, 106 cervical lymph node cells were re-
stimulated for 6 hours with 105 DC1940 cells pulsed with 2.5x105/ml heat-killed C. albicans or left 
unpulsed. Brefeldin A (10 µg/ml, AppliChem) was added for the last 5 hours. IL-17 production by CD3+ 
CD4+ T cells was analyzed by intracellular cytokine staining and flow cytometry (see below).  
6.5.18 Flow cytometry  
All antibodies were from BioLegend, if not stated otherwise. Single cell suspensions of tongues were 
stained in ice-cold PBS supplemented with 1% FCS, 5 mM EDTA, and 0.02% NaN3 with LIVE/DEAD 
Fixable Near-IR Stain (Life Technologies), anti-CD45.2 (clone 104), anti-CD11b (clone M1/70), anti-Ly6C 
(clone AL-21, BD Biosciences) and anti-Ly6G (clone 1A8). For intracellular cytokine staining, T cells were 
first incubated in ice-cold PBS containing LIVE/DEAD Fixable Near-IR Stain, anti-CD4 (clone RM4-5) and 
anti-CD3ε (clone 145-2C11). After fixation and permeabilization using BD Cytofix/Cytoperm (BD 
Biosciences) the cells were then incubated in in Perm/Wash buffer (BD Biosciences) containing anti-IL-
17A (clone TC11-18H10.1) and anti-IFNγ (clone XMG1.2) antibodies.  Data were acquired on a FACS 
LSRII (BD Biosciences) or on a FACS Gallios (Becton Coulter) and analyzed with FlowJo software 
(Tristar). For all experiments, the data were pre-gated on live single cells. 
6.5.19 RNA isolation and quantitative RT-PCR from mouse tissues  
Isolation of total RNA from bulk tongues was carried out according to standard protocols using Trizol 
Reagent (Sigma). cDNA was generated by RevertAid reverse transcriptase (Thermo Scientific). 
Quantitative PCR was performed using SYBR Green (Roche) and a Rotor-Gene 3000 (Corbett Research) 
or a QuantStudio 7 Flex (LifeTechnologies). The primers were Actb fwd 5'-CCCTGAAGTACCCCATTGAAC-
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3', Actb rev 5'-CTTTTCACGGTTGGCCTTAG-3'; Cxcl2 fwd 5'-AGTGAACTGCGCTGTCAATGC-3', Cxcl2 rev 
5'-GCAAACTTTTTGACCGCCCT-3', S100a9 fwd 5’-GTCCAGGTCCTCCATGATGT-3’ and S100a9 rev 5’-
TCAGACAAATGGTGGAAGCA-3’; Il17a fwd 5’-GCTCCAGAAGGCCCTCAGA-3’ and Il17a rev 5’-
AGCTTTCCCTCCGCATTGA-3’; Defb3 fwd 5’-GTCTCCACCTGCAGCTTTTAG-3’ and Defb3 rev 5’-
ACTGCCAATCTG ACGAGTGTT-3’; Il17f fwd 5’- GAGGATAACACTGTGAGAGTTGAC-3’ and Il17f rev 5’- 
GAGTTCATGGTGCTGTCTTCC-3’; Il6 fwd 5’- GAGGATACCACTCCCAACAGACC-3’ and Il6 rev 5’- 
AAGTGCATCATCGTTGTTCATACA-3’; Tnfa fwd 5’- CATCTTCTCAAAATTCGAGTGACAA-3’ and Tnfa rev 5’- 
TGGGAGTAGACAAGGTACAACCC-3’. All qPCR assays were performed in duplicates and the relative 
gene expression (rel. expr.) of each gene was determined after normalization with β-actin transcript 
levels. 
6.5.20 Protein quantification by ELISA 
Serum G-CSF and IL-6 were determined by sandwich ELISA according to standard protocols. The 
antibodies used were anti-G-CSF (clone 67604, R&D Systems) or anti-IL-6 (clone MP5-20F3, Biolegend) 
for coating and biotinylated polyclonal rabbit anti-G-CSF (Peprotech) or biotinylated anti-IL-6 (clone 
MP5-32C11, Biolegend) for detection, respectively. IL-17A and IL-17F cytokines were quantified by 
cytometric bead array (BD Biosciences) in tissue homogenates using the mouse IL-17F and IL.17A flex 
sets according to the manufacturer’s instructions. For the preparation of tongue homogenates, the 
organ was cut in fine pieces and homogenated in 100 μl PBS supplemented with 1 x complete protease 
inhibitor cocktail (Roche) and 1% Triton-X-100 for 3 minutes at 25 Hz using a Tissue Lyzer (Qiagen). 
Data were aquired on a FACS Gallios (Becton Coulter) and analyzed with FloJo software (Tristar). 
6.5.21 Histology and immunofluorescence 
For histology, tissues were fixed in 4% PBS buffered paraformaldehyde overnight and embedded in 
paraffin, or embedded in O.C.TTM compound (Tissue-Tek), snap-frozen in liquid nitrogen and stored at 
-20°C. Sagittal sections (9 µm) were stained with periodic-acid Shiff (PAS), counterstained with 
Haematoxylin and mounted with Pertex (Biosystems Switzerland) according to standard protocols. For 
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immunofluorescence staining, tissues were embedded in O.C.TTM compound (Tissue-Tek), snap-frozen 
in liquid nitrogen and stored at -20°C. Sagittal cryosections (9 µm), were fixed with acetone for 10 
minutes at room temperature, stained with anti-IL-1α (clone ALF-161, BioXCell), anti-hamster-Cy3 
(Jackson ImmunoResearch) and 4′,6’-Diamidino-2-phenylindole dihydrochloride (DAPI, Sigma-Aldrich) 
and mounted with Mowiol (VWR International AG). All slides were scanned with a NanoZoomer 2.0 HT 
(Hamamatsu Photonics K.K.) using a 20x objective, and analyzed using NDP.scan 2.5.88 software.  
6.5.22 Transmission electron microscopy  
Transmission electron tissue samples were fixed in 2.5% glutaraldehyde (EMS) buffered in 0.1 M Na-
P-buffer overnight, washed x3 in 0.1 M buffer, post fixed in 1% osmium tetroxide (Sigma-Aldrich) and 
dehydrated in ascending concentrations of ethanol followed by propylenoxide and infiltration in 30% 
and 50% Epon (Sigma-Aldrich). At least three 0,9 m toluidine blue stained semi-thin sections per 
localisation were produced. Representative areas were trimmed and subsequently 90 nm, lead citrate 
(Merck) and uranyl acetate (Merck) contrasted ultrathin sections were produced and viewed under 
Phillips CM10, operating with Gatan Orius Sc1000 (832) digital camera, Gatan Microscopical Suite, 
Digital Micrograph, Version 230.540. 
6.5.23 Statistics 
Statistical significance was determined by one-way ANOVA with Dunnett’s or Sidak’s multiple 
comparison test, or by Pearson correlation coefficient and linear regression as appropriate using 
GraphPad Prism (GraphPad Software) with *, p < 0.05; **, p < 0.01; ***, p < 0.001; **** p < 0.0001. 
Data displayed on a logarithmic scale were log-transformed before statistical analysis.  
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Figure S. 1 C. albicans isolates are genetically unrelated (A) Analysis of the microsatellite markers 
Cdc3, Ef3, His3, CaV and CaVII by PCR amplification followed by capillary electrophoresis. The alleles 
were assigned based on the detected fragment sizes in base pairs. (B) UPGMA dendrogram showing 
the genetic relatedness for the strains of C. albicans used in this study using MLST typing. Vertical bar 
to the right of each cluster indicate the clade designation. Scale indicates P distances. Numbers at 
nodal points indicate bootstrap values (%) for 1,000 replications. NC, not classified. 
 
 
Figure S. 2. C. albicans isolates show normal growth and cell wall composition. (A – B) Growth of 
the indicated C. albicans isolates in YNB + 2% glucose medium (A) or F12 + 1% FCS medium (B) at 
37°C was monitored over 48 hours using an automated plate reader. The OD595 was determined 
every 2 hours. (C) Total chitin, mannan and glucan contents of the indicated C. albicans isolates 
displayed as dry weight content relative to strain SC5314. (D) β-Glucan exposure of the indicated C. 
albicans isolates. For determining the relative fluorescence intensity for each isolate, the 
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fluorescence intensity of cells stained with the primary and secondary antibody was divided by the 
background signal from cells stained with the secondary antibody only.   
 
 
Figure S. 3 Strain 101 persists in the host for at least 4 weeks post-infection. The fungal burden in 
the tongue of WT mice 4 weeks post-infection with strain 101 is displayed as cfu/g tissue. Data are 
the pool of two independent experiments. Each symbol represents one mouse. The dotted line 
represents the detection limit. 
 
Figure S. 4 (A) Gating strategy for the quantification of viable CD45+ Ly6C+ Ly6G+ neutrophils in the 
tongue tissue. (B) The neutrophil response to strain SC5314 is prominent irrespective of the infection 
dose. WT mice were infected with the indicated dose of strain SC5314 and CD45+ Ly6C+ Ly6G+ 
neutrophils were quantified in the tongue on day 1 post-infection by flow cytometry.  Each symbol 
represents one mouse. The mean of each group is indicated. A naïve group was included for control 
(depicted as a horizontal line). Differences between the infected groups were not significant if 
applying a one-way ANOVA and Dunnett`s multiple comparison test. 
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Figure S. 5 (A) C. albicans isolates were incubated on glass slides in FCS-containing medium and 
hyphal length was measured after 3 hours of incubation. Each symbol represents one measured 
hypha. The mean is also indicated. Data are a pool of two independent experiments. (B – C) 
Filamentation of C. albicans isolates was assessed on spider medium in top view (B) and by agar 
invasion (C). Representative images are shown for two concentrations of each isolate. (D) Fungal 
morphology after interaction with TR146 keratinocytes for 24 hours was determined after calcofluor 
white staining. Representative images at 40x (top row) and 100x magnification (bottom row) are 
shown for each isolate. Scale bars: 20 μm (40x) and 10 μm (100x).   
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Figure S. 6 Interaction of C. albicans isolates with the oral keratinocyte cell line TR146. (A) Adherence 
of the indicated C. albicans isolates to TR146 cells was quantified after 2 hours of co-incubation. The 
efg1∆/∆ strain was included as a negative control. (B) Biofilm formation of the indicated C. albicans 
isolates was quantified after 48 hours growth on medical silicon squares using the XTT assay. (C) LDH 
release by TR146 cells in response to gradual concentrations of C. albicans isolates measured after 24 
hours of stimulation. (D – F) Expression of the indicated genes by C. albicans isolates upon contact with 
TR146 keratinocytes for 24 hours. (G) IL-6 and IL-8 secretion by TR146 cells in response to stimulation 
with the indicated C. albicans isolates for 24 hours. The dotted line represents the basal levels detected 
in the supernatant of unstimulated TR146 cells. In A, B and G, each symbol represents a separate well. 
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In D-F, data are the pool of 3 independent experiments. The mean and SD are indicated. Significant 
differences between each group and the strain SC5314 group are indicated. 
 
 
 
 
Figure S. 7 Adaptive immunity is induced normally by persistent fungal isolates despite the impaired 
induction of an acute response. WT mice were infected with the indicated isolates and IL-17A 
production by CD3+ CD4+ T cells was analyzed by flow cytometry on day 7 post-infection in the cervical 
lymph nodes after re-stimulation with C. albicans. (A) Gating strategy for single, viable, CD4+ 
CD3+CD5+IL17A+ cells. (B) Quantification of IL-17A+ cells within CD3+ CD4+ T cells in response to 
infection with the indicated isolates. Each symbol represents one mouse. Data are representative of 
two independent experiments. Differences between C. albicans re-stimulated groups are not 
statistically significant if applying a one-way ANOVA and Dunnett`s multiple comparison test to 
SC5314.  
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Figure S8. IL-17 signaling is essential for preventing fungal overgrowth irrespective of the degree of 
fungal pathogenicity. 
 Body weight of C57Bl/6 and Il17ra-/- mice in response to OPC infection with SC5314, 529L, and 101 
over a period of 7 days. The mean + SD of three mice per group is shown.  
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 Abstract 
Candida albicans is an opportunistic fungal pathogen and resides usually on human mucosal surfaces 
without causing any symptoms. Under certain conditions it can also cause a variety of infections. The 
natural variability within C. albicans strains elicits a broad spectrum of host responses. In a previous 
study we reported that the highly pathogenic strain SC5314 induces a rapid and strong inflammatory 
response and is cleared rapidly. In contrast, the low-pathogenic strain 101 elicits only a diminished 
response and persists in the oral mucosa. By testing various strains, we found a strictly strain 
dependent correlation between the host inflammatory response and the subsequent clearing of the 
fungus. 
7 Project III           
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Using an experimental model of oropharyngeal candidiasis, we investigated the cause-effect 
relationship between rapid immune induction and clearance of the fungus in a setting of co-infection 
with the low-pathogenic strain 101 and the high-pathogenic strain SC5314. 
We could show that co-infection with a low- and high-pathogenic strain induces an acute inflammatory 
response. Surprisingly, we could demonstrate the persistence of the low-pathogenic strain 101 despite 
the induction of a strong inflammatory response by strain SC5314 in a co-infection setting. The 
resulting high immune response led to a selective clearing of the highly pathogenic strain SC5314. We 
show a close co-localization of both strains at the same areas of the tongue. Despite showing increased 
persistence in the oral mucosa, strain 101 did not show increased resistance to antimicrobial peptides 
or neutrophil killing. 
This study emphasizes that persistent isolates colonize the oral mucosa in a manner distinct from high-
pathogenic strains, whereby the exact mechanism remains to be elucidated. We could strengthen the 
notion that differences between C. albicans strains are relevant in infection. 
 
 Introduction 
Over the last years, research on host-pathogen interactions gained broad interest. The majority of 
studies with experimental infections focused on the interaction with a single infectious agent, while 
mixed infections involving two or more strains of different genotypes were rarely noticed. Mixed 
infections include different species but also isolates belonging to the same species but to different 
populations or genotypes (Cox 2001) . 
In mixed infections, pathogens influence each other: they can act synergistically, antagonistically or 
independently of each other (Mahuku et al. 1996). Infection with more than one genotype of the same 
pathogen occurs in many infectious diseases (Thompson 2000). In all cases, interspecies interactions 
increase the complexity of the disease (Lamichhane, Venturi 2015). Pathogen-pathogen interactions 
have been reported to increase disease severity in animals (Harms et al. 2001) in humans (Bosch et al. 
2013) and, to a lesser extent, in plants (Lamichhane, Venturi 2015). In urinary tract infections, 
Escherichia coli enhances the adhesion of Candida albicans to the mucosa of the bladder (Levison, 
Pitsakis 1987). Moreover, patients colonized with C. albicans in the respiratory tract have a higher risk 
of ventilator-associated pneumonia caused by Pseudomonas aeruginosa (Azoulay et al. 2006). 
Antagonism, on the other hand, is widely used in biological control of plant pathogens where one 
microbial antagonist is able to suppress a disease caused by another microbe (Pal, McSpadden 
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Gardener 2006). In plants, it has been shown that several fungal pathogens have the ability to induce 
resistance to high virulent pathotypes through low virulent isolates or saprophytes (Strömberg 1995; 
Martyn 1991). Infection of oilseed rape leaves with high and low virulent isolates of the fungal plant 
pathogen Leptosphaeria maculans leads to smaller lesions compared to an infection with the high 
virulent isolate alone. The isolate with low virulence can induce an acquired systemic resistance and 
coexist with the high virulent isolate in one lesion (Mahuku et al. 1996). Moreover, it has been shown 
that microorganisms inhabiting the same biological niche, thus competing for nutrients, often produce 
antimicrobial peptides (AMPs) to inhibit growth or kill competitors. In wine producing communities it 
has been found that Saccharomyces cerevisiae produces an AMP, active against other fungi including 
C. albicans (Branco et al. 2014). In human diseases, such as vaginal tract infections, it has been shown 
that lactic acid bacteria can compete with C.albicans for adhesion sites and secrete products which 
inhibit attachment (Boris, Barbés 2000). 
C. albicans does not only interact with bacteria but also with other Candida species which are emerging 
as pathogenic agents of the oral cavity such as Candida parapsilosis, Candida glabrata or 
Candida tropicalis (Sardi et al. 2013). C. albicans and C. glabrata are often co-isolated from oral 
infections, which is an interesting clinical finding as C. glabrata alone only causes a negligible invasion 
and infection (Silva et al. 2011). For successful colonization of the oral mucosa, C. glabrata relies on 
co-infection with and adherence to C. albicans hyphae (Tati et al. 2016).   
The ubiquitous yeast C. albicans is one of the most important opportunistic human fungal pathogens 
(Zipfel et al. 2011; Duhring et al. 2015). As a commensal it colonizes the urogenital tract, the vaginal 
and gastrointestinal mucosae (Moyes, Naglik 2011) and can be detected in 30 to 50 % of the healthy 
adult population (Jacobsen et al. 2012). However, changes in the host can lead to the development of 
disease symptoms (Moyes, Naglik 2011) ranging from mild forms of oral and vulvovaginal candidiasis 
(Cheng et al. 2012) to severe life-threatening systemic infections (Bassetti et al. 2006). This shows that 
C. albicans can successfully colonize different niches of the body (Kumamoto, Vinces 2005). It is 
therefore not surprising to see high intraspecies genetic variations and a broad spectrum of attributes 
within isolates, such as variability in virulence in a murine model of intravenous challenge or general 
fitness (MacCallum et al. 2009; Hirakawa et al. 2015). Differences in the genotype between isolates 
include aneuploidy, chromosome truncations, translocations and loss of heterozygosity (Rustchenko 
2007; Bennett et al. 2014). Intraspecies phenotypic differences are most likely a consequence of the 
differences in genotype. In a murine model of systemic infection, clinical isolates of C. albicans showed 
drastic variation in terms of virulence, which was also associated with differences in the growth rate 
(MacCallum et al. 2009). In addition, other Candida species, like C. glabrata, demonstrated strain-
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dependent variation regarding their capacity to induce damage and cytokine production in epithelial 
cells (Li et al. 2007). 
Our own work showed that natural C. albicans strains display a great spectrum in pathogenicity that 
results in different outcomes of the interaction with the host in vivo (Schönherr et al. 2017). Low-
pathogenic strains, as 101, persisted in the mucosa and caused only delayed IL-17 induction, while 
highly pathogenic strains, as strain SC5314, elicited a rapid and strong immune induction and were 
quickly cleared from the oral cavity. In consequence to the differences in cytokine induction, neutrophil 
infiltration into the infected tissue was strictly strain-dependent. The rapid inflammatory response led 
to body weight loss on day 1-2 post-infection and subsequent recovery (Trautwein-Weidner et al. 
2015b; Schönherr et al. 2017). Whereas strain 101 persisted in the oral mucosa for at least four weeks 
post-infection without causing body weight loss (Schönherr et al. 2017). The IL-17 pathway, although 
induced with delay by low-pathogenic strains, was shown to be essential for the growth control of all 
C. albicans strains. Key events for fungal clearance are IL-17-dependent antimicrobial mechanisms and 
IL-17 independent neutrophil infiltration and activation (Trautwein-Weidner et al. 2015b; Schönherr 
et al. 2017). The capacity of a strain to induce a rapid and strong inflammatory response in the host 
mucosa caused a fast clearance of the fungus from the host, while a diminished and delayed response 
led to persistence of strains in the host epithelium. (Schönherr et al. 2017) 
The behavior of different strains has been mapped in experiments with single infections. Our previous 
data suggest that inflammatory response and infiltrating neutrophils are responsible for the fungal 
clearance. We aimed to further investigate this hypothesis. To address this, we made use of the well-
established model of oropharyngeal candidiasis (OPC) and performed co-infection experiments with 
the highly pathogenic strain SC5314, which induces a rapid neutrophil response, and the low-
pathogenic strain 101, for which we did not observe a significant neutrophil response. We postulated 
different outcomes: (I) both strains might act together in a synergistic way and induce a higher 
inflammatory response leading to the clearance of both strains, (II) strain SC5314 would act as an 
antagonist and repeal the (unknown) mechanism of the low-pathogenic strain to persist in the host, 
(III) low-pathogenic strain 101 suppresses the inflammatory response induced by the other strain 
leading to persistence of both strains in the mucosa, (IV) the two disparate strains might act 
independent without influencing each other in the host.  
Using an experimental OPC model, this study shows that co-infection with a low and high-pathogenic 
strain induces an acute inflammatory response. Consequently, persistence of strain 101 cannot be 
explained by suppression of the immune response. Surprisingly, the overall high immune response led 
to a selective clearing of the high-pathogenic strain. The hypothesis of an independent action of the 
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strains seems to be most likely. This study emphasizes that persistent isolates colonize the oral mucosa 
in a different manner than highly pathogenic strains. The induced inflammatory response and the 
resulting clearance of the fungus is strictly strain dependent. 
 
 Results 
7.3.1 Co-infection of mice with two C. albicans strains with divergent 
pathogenicity induces an acute inflammatory response 
To investigate the interaction of two different C. albicans strains with opposite pathogenicity in the 
host, we performed co-infection experiments. To discriminate the two strains in vivo, we made use of 
fluorescently labelled variants of both C. albicans strains. 
When used for single infection, the highly pathogenic strain SC5314 induced a rapid and strong 
inflammatory response, including massive neutrophil infiltration and high induction of IL-17 and 
antimicrobial peptides on day 1 post-infection, as reported previously (Conti et al. 2009; Trautwein-
Weidner et al. 2015b; Gladiator et al. 2013; Schönherr et al. 2017). In contrast, the low-pathogenic 
strain 101 elicited a diminished IL-17 and antimicrobial response and only few neutrophils infiltrated 
to the site of infection at this time point (Schönherr et al. 2017). We examined the fungal burden and 
initial host response in co-infection with a 1:1 mixture of SC5314-GFP and 101-mCherry (Figure 14). As 
a control, we used 1:1 mixtures of either 101-GFP and 101-mCherry or SC5314-GFP and SC5314-
dTomato. Quantification of the overall fungal load showed a slightly reduced fungal burden on day one 
post-infection in mice infected with the combination of high- and low-pathogenic strains compared to 
single-strain-infections. However, the ratio of the two admixed strains was stable. Next, we 
investigated the host response elicited by the combination of the two disparate strains. Analysis of 
single cell suspensions from co- and single-strain-infected tongues by flow cytometry revealed an 
equally strong neutrophil response in co-infected mice as in mice infected with strain SC5314 alone, 
while no neutrophil response was induced by strain 101, as previously reported (Schönherr et al. 2017). 
Similarly, the coinfection of mice with the two strains did not affect the induction of IL-17 cytokines 
and IL-17 target genes, such as S100A9, which was observed in response to infection with strain SC5314 
alone.  
Together, these results indicated that the presence of strain 101 did not impair/suppress the host 
response induced by strain SC5314. Also, the co-infection did not elicit an enhanced inflammatory 
response compared to single infection, thus excluding synergism between the two strains. 
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Figure 14 Mice infected with a 1:1 mixture of C. albicans strains 101 and SC5314 show decreased 
fungal burden but no diminished immune response. Wildtype mice were sublingually infected with 
a 1:1 Mix of SC5314-GFP and 101-mCherry101-GFP and 101-mCherry or SC5314-GFP and SC5314-
dTomato or SC5314, and analyzed on day one. (A) Fungal burden in the infected tongue displayed as 
colony forming units (cfu) per g tongue. Data are the mean of two independent (mix) or one (single-
strain- infections) experiments with three mice per group. The dotted line represent the detection 
limit. (B) CD11b+ Ly6C+ Ly6G+ neutrophils in the tongue of infected and naïve control mice were 
quantified by flow cytometry. The solid line represents the mean neutrophil counts of three naïve 
mice. (C) Il17fand S100a9 mRNA expression in the tongue tissue of infected and naïve control mice 
was assessed by qRT-PCR. In B and C, each symbol represents one mouse. Statistical analysis was 
performed using one-way ANOVA and Dunnett´s multiple comparison test. Significant differences 
between each group and the strain SC5314 single-strain-infected group are indicated. 
 
7.3.2 Only the low-pathogenic strain persists in the oral mucosa during co-
infection with a high-pathogenic strain  
As expected from the strong innate immune response to a co-infection with the low- and high-
pathogenic strains SC5314 and 101, the mice displayed a strong drop in body weight (Figure 15A). The 
drop in weight loss in the co-infected group was slightly less pronounced compared to single-strain 
infection with SC5314. We wondered what the impact of this response was on the persistence of the 
strains in the host. 
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Next, we assessed the fungal burden in single-strain and co-infected animals on day 7 post-infection 
(Figure 15B). The fungus persisted in the co-infected and 101 single-strain infected animals, while 
SC5314 single-strain infected animals cleared the fungus. The use of fluorescence labelled strains 
enabled us to discriminate between the high and low-pathogenic strains. In co-infected tongues only 
the low-pathogenic 101-mCherry could be detected, whereas SC5314-GFP was completely cleared. 
SC5314 single-strain infected mice almost completely cleared the fungus, whereas strain 101 persisted 
in the host in a roughly 1:1 ration of mCherry and GFP labelled strains. 
 
Figure 15 Selective clearance of the high-pathogenic isolate by day seven post-infection. Wildtype 
mice were sublingually infected with a 1:1 mixture of 101-GFP and 101-mCherry, SC5314-GFP and 
SC5314-Tomato or SC5314-GFP and 101-mCherry. (A) Body weight of infected mice over a period of 7 
days. The mean + SD of 3 mice per group is shown. Statistical analysis was performed using one-way 
ANOVA and Dunnett´s multiple comparison test. Significant differences between each of the single-
strain-infected groups and the co-infection group are indicated by asterisks or hashes, respectively. 
(B) Fungal burden in the infected tongue on day 7 post-infection displayed as cfu per g tongue. Each 
bar is the mean + SD of 3 mice per group. The dotted line represents the detection limit. No 
statistical differences were obtained by using one-way ANOVA and Dunnett´s multiple comparison 
test. 
 
A strong expression of Il17 and high numbers of infiltrating neutrophils, as a consequence of infection 
with strain SC5314, were associated with fungal clearance from the host (Schönherr et al. 2017). 
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Surprisingly, this did not occur for strain 101 in the setting of co-infection and the low-pathogenic strain 
could persist in the oral mucosa. 
7.3.3 Altering the ratio of high-pathogenic strain in co-infection does not change 
the outcome of infection 
We wondered whether the rapid and acute response elicited by high-pathogenic strain SC5314 might 
have concealed a possible immunosuppression by strain 101 in the co-infection setting. Therefore, we 
examined if a change in the ratio of strain 101 and strain SC5314 in the co-infection setting changed 
the outcome of the infection. We performed OPC infection with a 25 times and 5 times reduced 
amount of strain SC5314 in single and co-infections with a constant number of 2.5 x106cells of strain 
101.The fungal burden in co-infected tongues was significantly higher for all ratios tested if compared 
to single infections with strain SC5314 (white bars) on day 7 post-infection (Figure 16A). The fungal 
load of single-strain infected tongues with strain 101 (black bar to the very right) was comparable to 
co-infections with 25 times, 5 times reduced or normal infection dose as tested before. In addition, 
neutrophil infiltration was not affected by the change of the ratio in co-infections. Neutrophil numbers 
of SC5314 single and co-infected mice did not reveal any differences at all ratios tested. All tested 
mixes with strain SC5314 led to a significantly stronger infiltration of neutrophils compared to single 
infection with strain 101. These results suggest that even at low infection doses, strain SC5314 was still 
highly pathogenic. Lowering the infection dose by a factor of 25 reduced the amount of infiltrating 
neutrophils only very minutely (Figure 16B white bars). 
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Figure 16 The behavior of the highly pathogenic strain SC5314 in the host was not dose-dependent. 
Wildtype mice were sublingually infected with the indicated dose of SC5314-GFP alone or in 
combination with 2.5x106 101-mCherry cells. (A) Fungal burden in the infected tongue on day 7 post-
infection displayed as cfu per g tongue. The dotted line represents the detection limit. (B) CD11b+ 
Ly6C+ Ly6G+ neutrophils in the tongue of infected and naïve mice were quantified by flow cytometry 
on day 1 post-infection. The horizontal line represents the mean neutrophil counts of three naïve 
mice. The mean + SD of 3 mice per group is shown. Statistical analysis was performed using one-way 
ANOVA and Dunnett´s multiple comparison test. Significant differences between each group are 
indicated. 
 
7.3.4 Both strains colonize the same regions of the tongue  
The persistence of strain 101 in co-infected mice suggests that this strain may selectively resist or 
evade the strong inflammatory response in the oral mucosa. We thus hypothesized that the two strains 
may segregate spatially in the infected tongue and that strain 101 may not get in close contact with 
the inflammatory mediators that are induced by the other strain. To test this hypothesis we examined 
the localization of the fluorescently-labelled strains by fluorescence microscopy analyzing co-infected 
tongues in top-view. To avoid quenching of the fluorescent reporters, we analyzed unfixed, whole 
tongues infected with SC5314-GFP and 101-mCherry (Figure 17). Fluorescence and confocal 
microscopy showed close co-localization of both strains in most of the infected regions. These findings 
therefore make the spatial segregation of the two strains as an explanation for the selective survival 
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of strain 101 in the co-infection setting rather unlikely. Lingual papillae and Candida hyphae of both 
strains were visible despite the strong auto-fluorescence of the epithelial cells. 
 
Figure 17 High and low-pathogenic isolates reside at the same sites in the tongue. Representative 
images of unstained, unfixed whole tongues co-infected with SC5314-GFP and 101-mCherry by 
fluorescence microscope (A) or fluorescent confocal microscope (B) in top view on day 1 post-
infection. White circles highlight areas with both strains. The white arrows indicated areas with only 
one strain. 
 
7.3.5 The low-pathogenic strain 101 does not display an enhanced resistance to 
host defense mechanisms 
We did not observe an obvious spatial segregation, therefore strain 101 is likely exposed closely to the 
local response induced by strain SC5314. We further investigated if strain 101 displayed an enhanced 
resistance to inflammatory and antimicrobial response (Figure 18). 
Neutrophils are the central weapon of the innate immune system. Neutrophils infiltrate directly to the 
site of infection (Lukacs et al. 1999) and prevent fungal dissemination and overgrowth (Trautwein-
Weidner et al. 2015b). We therefore tested the resistance of strain 101 to neutrophils (Figure 18A). 
For this, we isolated neutrophils from the bone-marrow of naïve mice and compared the killing rate 
after incubation with mouse-serum opsonized yeast and hyphae of strain 101 and strain SC5314. The 
low-pathogenic strain 101 was killed with a higher efficiency by neutrophils than strain SC5314. 
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Antimicrobial peptides are a second very important branch of the host response to control C. albicans 
at the mucosal barrier (Dale, Fredericks 2005). We therefore assessed resistance of C. albicans strains 
101 and SC5314 to human β-defensin-3 (hBD3), Histatin 5 (HST 5) and Cathelicidin (LL-37) in vitro 
(Figure 18B). Both strains displayed the same sensitivity to hBD3 and HST 5, with a MIC of 500 ug/ml 
and > 500 ug/ml respectively. LL-37 did not affect the viability of either strain. Together, these results 
suggested that strain 101 was not more resistant to two key antifungal host mechanisms in the oral 
mucosa and that the increased persistence of this strain in the oral mucosa can thus not be explained 
by any of the raised hypotheses. 
 
Figure 18 Low-pathogenic strain 101 is more sensitive to neutrophil killing but showed no 
enhanced susceptibility to antimicrobial peptides (A) Neutrophils from the bone marrow of naïve 
mice where co-incubated with opsonized hyphae and yeast cells and the percentage of killed 
Candida cells was assessed by alamar blue (B) The Antimicrobial peptides human Beta-Defensin-3 
(Hbd3), Histatin 5 (Hst5), Cathelicidin (LL-37) were incubated at indicated concentrations with 
Candida strain SC5314 and 101 and cell numbers were assessed. (C) TR146 cells were stimulated with 
101, SC5314 and a mix of both isolates. LDH release was determined after 24 hours. 
 
While it is known that low-pathogenic strain 101 persists in the host, we could show that the same 
outcome occurs during an acute initial immune response induced by a high-pathogenic strain in a co-
infection (Schönherr et al. 2017). 
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 Discussion 
As an opportunistic yeast, C. albicans is usually harmless on human mucosal surface but under specific 
circumstances it can also cause a variety of infections. The natural variability within C. albicans isolates 
contributes to the decision between commensalism and pathogenicity and thereby to the outcome of 
the interaction with the host. We used co-infection of a low- and high- pathogenic strain in the well-
established OPC model to investigate the cause-effect relationship between rapid immune induction 
and clearance of the fungus. We could demonstrate the persistence of the low-pathogenic strain 101 
despite the induction of a strong inflammatory response by strain SC5314 in a co-infection. The two 
strains occupied the same areas of the tongue. Strain 101 did not show an increased resistance to 
neutrophil killing or antimicrobial peptides in vitro. All these findings indicated that both strains act 
independent from each other, rather than synergistic or antagonistic, in a co-infection setting. Our 
study strengthens the notion that differences between C. albicans strains are considerable and 
relevant in infection. 
Since van Leuwenhook in the 1600s, it is known that microbes are part of complex communities (Gest 
2004). Co-infections might occur from a reinfection before the previous one is cleared (Read, Taylor 
2001). Co-infection of a host with a high- and a low-pathogenic strain of the same species, as we have 
examined in this study, may result in an enhanced response through synergism between the two 
strains, a reduced response through suppression by one strain or it may stay unaltered. In addition, 
mixed infections can impact the dynamics of the infecting pathogen populations in different ways: the 
burden of both agents may increase, one or both may be suppressed or one may have a higher burden 
while the other decreases (Cox 2001). The outcome of the infection is determined by the variability in 
pathogenicity of C.albicans strains. 
During OPC, C. albicans strains 101 and SC5314 can colonize the tongue tissue in a comparable manner 
when analyzed in single-infections, whereas co-infection with the two led to slightly reduced fungal 
load on day one post-infection. Interaction between the strains due to competition for nutrients might 
have affected the colonization efficiency or limit replication of one strain (Thomas et al. 2003). 
The massive infiltration of neutrophils and strong expression of IL-17and S100A9 triggered by strain 
SC5314 were not altered in the co-infection setting. Infections with strain 101 were accompanied with 
a diminished neutrophil infiltration .(Schönherr et al. 2017). In contrast, the high and rapid immune 
response induced by strain SC5314 also occurred in the co-infection. Indicating that strain 101 did not 
suppress the response induced by strain SC5314. 
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Of importance, the high and acute attack of the immune system did not affect the persistence of the 
low-pathogenic strain 101. The fungal burden on day seven post-infection was similar to single 
infections with strain 101. The use of fluorescence labelled strains in the co-infection revealed that 
only strain 101 remained in the host, while strain SC5314 was cleared. This suggests that a synergistic 
interaction between the two strains can be ruled out, as both strains would have been cleared or it 
would have affected the capacity of strain 101 to persist in the host. 
C. albicans has developed various efficient strategies to interfere, suppress and evade immune attacks 
from the host (Zipfel et al. 2011). The co-infection did not raise a higher immune response compared 
to the single infection with the high-pathogenic strain. It is however possible that the acute response 
caused by strain SC5314 might have concealed a possible immunosuppression by strain 101. To reduce 
the efficiency of strain SC5314, mixed infection with 4% of the initial dose was tested. Surprisingly 
lower dose of strain SC5314 did not change the infection outcome characterized by high neutrophil 
infiltrates and clearance of strain SC5314. With these findings, immunosuppressive actions from strain 
101 could be excluded as both strains would have persisted in the oral mucosa in this case. 
There are different possible explanations for how strain 101 evades the immune system (Collette, 
Lorenz 2011; Zipfel et al. 2011) but strain 101 seems neither to impair nor to suppress the immune 
response. Avoidance of killing by infiltrating neutrophils could occur due to distinct localizations of the 
two strains on the tongue tissue. Although fluorescence microscopy revealed colonization in the same 
areas of the tongue if looked in two-dimensional views, it is conceivable that strain 101 and SC5314 
reside at different depths of the squamous epithelium cells or display an enhanced intrinsic resistance 
to inflammatory cells. Even though it was shown neutrophils infiltrate in the epithelial layer where 
C. albicans resides (Trautwein-Weidner et al. 2015b). Invasion depth to an early point of infection 
revealed that strain SC5314 reaches into deeper epithelial layers, whereby strain 101 resides in the 
upper layers (Schönherr et al. 2017). Intrinsic enhanced resistance to inflammatory responses was 
tested in vitro by neutrophil and antimicrobial peptide killing, but only differences in neutrophil killing 
between strains were detected, with strain 101 being killed with a higher efficiency. Putative 
differences to inflammatory cells (e.g. macrophages), which are not neutrophils are also possible. The 
mechanism through which strain 101 avoided being attacked and cleared by neutrophils as well as 
infection dynamics elicited by strain 101 remain unclear . Further research is needed to reveal/clarify 
the mechanism behind the strain specific evasion of strain 101 from the immune system. Competitive 
interactions between the strains may occur and consequently affect the dynamics within the host. In 
addition, the host seems to be able to discriminate between the low-pathogenic strain 101 and the 
high-pathogenic strain SC5314.  
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It is established that strain 101 can coexist with the host without causing symptoms of disease, but 
additional studies are needed to investigate how strain 101 is able to persist (Schönherr et al. 2017). 
The fungus might only reside in the mucosal tissue, mainly in the stratum corneum, without 
proliferating and growing. The fungal burden between two and four weeks post-infection remains 
stable (Schönherr et al. 2017). Therefore an equilibrium of growth and killing by the host immune 
system is also possible. 
To conclude, our study using a low and a highly pathogenic strain of C. albicans in the OPC infection 
model, allowed us to gain further insights on the interplay between the host immune response and 
highly diverse C. albicans strains in single-strain and co-infection. The reason for the persistence of 
strain 101 remained unclear and requires further investigation. Yet, we could exclude some putative 
scenarios for selective persistence of strain 101, while others remain to be tested. Our study highlights 
strain specific differences in host- pathogen interaction which have to be considered in in vivo fungal 
infection. 
 
 Material and Methods 
7.5.1 Fungal strains and media 
The C. albicans blood strain SC5314 (Gillum et al. 1984b) and the oral strain 101 (Schönherr et al. 2017) 
were previously reported. SC5314-GFP was reported before (Igyarto et al. 2011). SC5314-CAF2-
yTomato was constructed analog to CAF2-mCherry (Brothers et al. 2011) but in SC5314 inserting 
dTomato ura3Δ::imm434/URA3 PADH1-dTomato_NATRand a kind gift from R.Wheeler. 101-GFP, 101-
mCherry express GFP or mCherry under the control of the ADH promoter. The construct is integrated 
at the ADHI locus with SAT1 as resistance marker. Both strains were a kind gift from D. Sanglard. All 
isolates were maintained on Sabouraud or Yeast Peptone Dextrose (YPD) agar plates for short term 
and in YPD supplemented with 20% glycerol at -80°C for long term storage. For experiments, C. albicans 
was inoculated from a preculture at an OD595 = 0.1 and grown in YPD medium at 30°C and 180 rpm for 
15-18 hours, or 12 hours if used for the damage and antimicrobial peptide assays.  For hyphae 
induction, Candida cells were adjusted to the indicated cell concentration and incubated for 3 hours 
at 37°C in PBS supplemented with 5% FCS. Opsonization was done for 30 minutes on ice in PBS 
supplemented with 20% or 10 % mouse serum for yeast or hyphal cells, respectively. 
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7.5.2 Ethics statement  
All mouse experiments described in this study were conducted in accordance with the guidelines of 
the Swiss Animal Protection Law and were performed under protocols approved by the Veterinary 
office of the Canton Zürich, Switzerland (license number 201/2012 and 183/2015). All efforts were 
made to minimize suffering and ensure the highest ethical and humane standards. 
7.5.3 OPC infection model  
Mice were infected sublingually with 2.5x106 C. albicans yeast cells as described (Solis, Filler 2012) 
without immunosuppression. Mice were weighed daily. For determination of fungal burden, the 
tongue of euthanized animals was removed, homogenized in sterile 0.05% NP40 in H2O for 3 minutes 
at 25 Hz using a Tissue Lyzer (Qiagen) and serial dilutions were plated on YPD agar containing 100 
µg/ml Ampicillin.  
7.5.4 Isolation of tongue cells  
Mice were anaesthetized with a sublethal dose of Ketamine (100 mg/kg), Xylazin (20 mg/kg) and 
Acepromazin (2.9 mg/kg), and perfused by injection of PBS into the right heart ventricle prior to 
removing the tongue. Tongues were cut into fine pieces and digested with DNase I (200 µg/ml, Roche) 
and Collagenase IV (4.8 mg/ml, Invitrogen) in PBS at 37°C for 45-60 min. Single cell suspensions were 
passed through a 70 µm strainer using ice-cold PBS supplemented with 1% FCS and 2 mM EDTA and 
analyzed by flow cytometry (see below).  
7.5.5 Flow cytometry  
All antibodies were from BioLegend, if not stated otherwise. Single cell suspensions of tongues were 
stained in ice-cold PBS supplemented with 1% FCS, 5 mM EDTA, and 0.02% NaN3 with LIVE/DEAD 
Fixable Near-IR Stain (Life Technologies), anti-CD45.2 (clone 104), anti-CD11b (clone M1/70), anti-Ly6C 
(clone AL-21, BD Biosciences) and anti-Ly6G (clone 1A8). Data were acquired on a FACS LSRII (BD 
Biosciences) or on a FACS Gallios (Becton Coulter) and analyzed with FlowJo software (Tristar). For all 
experiments, the data were pre-gated on live single cells. 
7.5.6 RNA isolation and quantitative RT-PCR from mouse tissues  
Isolation of total RNA from bulk tongues was carried out according to standard protocols using Trizol 
Reagent (Sigma). cDNA was generated by RevertAid reverse transcriptase (Thermo Scientific). 
Quantitative PCR was performed using SYBR Green (Roche) and a Rotor-Gene 3000 (Corbett Research) 
or a QuantStudio 7 Flex (LifeTechnologies). The primers were Actb fwd 5'-CCCTGAAGTACCCCATTGAAC-
3', Actb rev 5'-CTTTTCACGGTTGGCCTTAG-3', S100a9 fwd 5’-GTCCAGGTCCTCCATGATGT-3’ and S100a9 
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rev 5’-TCAGACAAATGGTGGAAGCA-3’; Il17f fwd 5’-GAGGATAACACTGTGAGAGTTGAC -3’ and Il17f rev 
5’-GAGTTCATGGTGCTGTCTTCC -3’. All qPCR assays were performed in duplicates and the relative gene 
expression (rel. expr.) of each gene was determined after normalization with β-actin transcript levels. 
7.5.7 Neutrophil killing assay 
Neutrophils were purified from the bone marrow of naïve C57Bl/6 mice by density gradient 
purification (Swamydas et al. 2015). To test neutrophil-killing activity, the indicated number of 
C. albicans yeast or hyphae were exposed to 5x103 neutrophils for three hours before the neutrophils 
were lysed with water supplemented with 0.02% Triton-X-100 and the number of surviving 
yeast/hyphae cells was assessed with alamar blue. A standard curve was generated with serial dilutions 
of yeast or hyphae cells. Killing activity is expressed as percent of cells surviving in the presence of 
neutrophils compared to the conditions without neutrophils. Candida yeast or hyphal cells were 
opsonized with fresh mouse serum, as described below. 
7.5.8 Antimicrobial peptide assay 
Antimicrobial peptides LL-37 (LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES), Hst 5 
(DSHAKRHHGYKRKFHEKHHSHRGY) and hBD-3 
(GIINTLQKYYCRVRGGRCAVSCLPKEEQIGKCSTRGRKCCRRKK) were obtained from Synpeptide (China). C. 
albicans cells from a 12 hours overnight culture were harvested, washed twice in PBS and incubated 
for two hours at 30°C. Afterwards, cells were adjusted to 1x106cells/ml, 100 μl were transferred to 
every well of a 96-well plate and the plate was centrifuged. The supernatant was removed and the cell 
pellet was resuspended in 25 μl working solution of the indicated concentration of the antimicrobial 
peptide or PBS as untreated control. After incubation for 3.5 hours at 37°C, the wells were washed 
with PBS and the supernatant removed. Percentage of surviving cells was assessed by alamar blue. A 
standard curve was generated with serial dilutions of Candida cells. 
7.5.9 Statistics 
Statistical significance was determined by one-way ANOVA and Dunnett´s multiple comparison test 
using GraphPad Prism (GraphPad Software) with *, p < 0.05; **, p < 0.01; ***, p < 0.001. Data displayed 
on a logarithmic scale were log-transformed before statistical analysis. 
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 Prevalence of Candida colonization 
Candida spp. are important fungal pathogens. The clinically most relevant species are C. albicans, C. 
tropicalis, C. glabrata, C. guilliermondii, C. krusei, C. lusitaniae, C. parapsilosis, and C. stellatoidea (Odds 
1988). Transmission is commonly vertically, although cases of horizontal transmission have been 
reported, predominantly in nosocomial settings (Bliss et al. 2008). The increasing use of 
immunosuppressive therapies and broad-spectrum antibiotics predispose individuals to opportunistic 
fungal infections. Under these special conditions the host is unable to control overgrowth of the 
colonizing fungus and to prevent its switch from a commensal to pathogenic state (Singh 2001). 
Colonization with Candida spp. in the oral cavity or digestive tract are a known risk factor for oral and 
disseminated candidiasis (Fanello et al. 2006; Charles et al. 2005; Gammelsrud et al. 2011; Nucci, M. 
and Anaissie, E. 2001). 
Reported prevalence of Candida spp. ranges between 26% and 71% in healthy children from Turkey 
and the United Kingdom, respectively (Martin, Wilkinson 1983; Kadir et al. 2005). We aimed to 
investigate the prevalence of C. albicans colonization in a defined population (healthy children) in a 
distinct geographical area (southern Switzerland), which is of high medical importance. 
It was the first study to investigate the colonization rates in 130 healthy children in a local population 
in southern Switzerland. We could show that with 19.2%, the colonization rate with Candida spp. was 
lower in this local population than the majority of reported numbers from other geographical regions. 
Only a few studies, for example from India and Turkey, detected a lower prevalence of Candida spp. 
(8% and 5%) in groups of healthy children between six and nine years (Smiline et al. 2012; Akdeniz et 
al. 2002). In contrast to our study, only the oral cavity was tested while we examined the perianal 
region, skin and oral cavity. 
In agreement with the literature we detected C. albicans (11.5%), as the most prevalent species among 
all Candida spp. ( Jarvis 1993; Abi-Said et al. 1997; Schuman et al. 1998; Bassetti et al. 2006). 
Nevertheless, non-albicans species are on the raise, most possibly due to the increased use of 
fluconazole and other azole drugs (Nguyen et al. 1996). C. glabrata and C. krusei are naturally multi-
drug resistant and consequently represent a severe health hazard (Pfaller et al. 2008). We had no cases 
of C. glabrata or C. tropicalis colonization in our cohort, and only one child was colonized with C. krusei 
8 General Discussion         
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in the tested population in southern Switzerland. Other identified species, with less prevalence, were 
C. guilliermondii, C. tropicalis and C. pelliculosa. 
We showed that the prevalence and distribution of Candida spp. is lower in our investigated cohort. 
Suggesting that the geographical area may impact the prevalence and distribution. Raising the 
importance in knowledge of local epidemiology. Further well defined studies are needed to elucidate 
the impact of the geographical region on prevalence and a possible influence on cases of oral 
candidiasis in the same population. C. albicans isolates are commonly associated with the host over 
long periods and transmissions usually occur during birth from the mother to the child (Bougnoux et 
al. 2006; Bliss et al. 2008). Epidemiological studies on the prevalence of vulvovaginal and oral 
colonization in healthy individuals in southern Switzerland would proof or dispel the theory of an 
overall low prevalence of Candida spp. in the investigated region.  
 
 Genetic variability among C. albicans isolates 
Microsatellites are hypervariable and frequent markers for differentiation of clinical isolates. We 
analyzed 88 isolates from healthy children and adults and diseased individuals by MLMT. Tested 
individuals were colonized by clonal populations. Across all individuals, the isolates revealed a high 
genetic diversity, independently from isolation of healthy or diseased individuals. 
From the three tested loci, CDC3, EF3 and HIS3 by microsatellite analysis, several allelic combinations 
presented homologous fragment sizes in both alleles. It remains unclear if this is the result of the same 
length of the amplified fragments or due to loss of heterozygosity (Sampaio et al. 2005). Chromosomal 
alterations, like loss of heterozygosity, are widely reported and can be associated with the loss of 
chromosomal parts or the entire chromosome (Rustchenko et al. 1994; Rustchenko-Bulgac 1991; 
Tavanti et al. 2004). 
Three sequence types (ST) showed homologous allelic combinations in all three tested loci. The isolates 
could be haploid, homozygous diploid, might have loss of heterozygosity events at the three loci or the 
same fragment size on both alleles (Sampaio et al. 2005; Hickman et al. 2013). Genomic 
rearrangements can occur as an adaptive response to environmental stress conditions (Selmecki et al. 
2010). Loss of heterozygosity can be induced by the exposure to fluconazole, other stressors, like heat 
shock or changed carbon source (Hilton et al. 1985; Perepnikhatka et al. 1999; Rustchenko et al. 1994). 
C. albicans populations within an individual are mostly clonal and adaptation to changing conditions 
through sexual reproduction is rather unlikely. An observed adaptation is the phenotype switching to 
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the grey morphology, in which mating is more efficiently compared to the white morphology (Tao et 
al. 2014). The above discussed genomic rearrangements could confer a selective advantage in a host 
environment. On transcriptional level, it has already been demonstrated that tristable phenotypic 
switching between white, gray and opaque cells with distinct genetic expression profiles play a role in 
adaptation to the host (Tao et al. 2014). To further address this in more details, long-term studies are 
needed to clarify if isolates adapt on a genetic level to host stresses or if even strain replacement 
occurs.  
We detected a high genetic diversity, based on the fragment size of the Microsatellites, in C. albicans 
isolates from healthy children in southern Switzerland. Furthermore, we analyzed isolates from 
healthy children and adults and diseased individuals. The 88 obtained isolates clustered in 59 ST´s. The 
obtained diversity in the diseased population is comparable to the variation found in healthy 
individuals. Analysis by MLST would provide further insight to affiliation to one of 18 described 
phylogenetic clades (Odds et al. 2007). 
It was proposed that distinct ST´s or clonal complexes have a higher pathogenicity or host adaptation 
(Dalle et al. 2003). In agreement with other studies, with partly different typing methods, we showed 
a similar distribution of isolates from healthy and diseased individuals across different clonal 
complexes (Bougnoux et al. 2002; Dalle et al. 2003), thus disproving the original idea. 
In project II we could correlate induced immune response in vivo and pathogenicity, defined by damage 
induction in epithelial monolayers in vitro. Two Isolates (SC5314, ATCC14053) described in project II 
belong to the same clonal complex 1, but to different ST and showed massive differences in their 
pathogenicity. The isolates 529L, 101 and Cag could not be assigned to any clonal complex and are 
singletons. Isolate UC820 was grouped in clonal complex 2 and 3605 was not tested by MLMT. With 
this approach we tested a large collection of isolates (irrespective of the collection in project I) from 
superficial and invasive origin. Isolates described as high, mid and low-pathogenic did not segregate 
according to the origin. It remains questionable if phenotypic differences can reflect the clustering in 
clonal complexes by MLMT or clades by MLST. Deep sequencing might reveal more insight into natural 
genetic differences underlying the phenotypic differences.  
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 Fungal determinants define the balance between commensalism 
and pathogenicity 
A broad diversity exists among natural isolates of C. albicans, both from a phylogenomic as well as a 
phenotypic perspective. However, little attention has been paid so far to the contribution of the 
intraspecies variation of C. albicans to the decision between health and disease. We assessed the host 
response to natural C. albicans isolates in the murine OPC model, where the impact of fungal 
differences can be studied in a Candida-naïve environment, which is complex but uniform. We 
demonstrated a broad spectrum of temporally and qualitatively distinct immune responses to 
C. albicans isolates. 
8.3.1 C. albicans strains induce distinct host immune responses in vivo 
Highly pathogenic isolates led to a strong and rapid induction of inflammation, which was correlated 
with fungal clearance. Low-pathogenic isolates persisted for at least 4 weeks in the host, which was 
linked to a low induction of inflammation. Even a delayed induction of the IL-17 pathway and an 
antimicrobial response did not result in fungal clearance. Surprisingly, these drastic differences in the 
initial acute host response to distinct C. albicans isolates did not translate into differences in the 
adaptive immune response. Irrespectively of the pathogenicity and consequent capacity to initiate an 
innate response, the subsequently induced Th17 response was comparable. The quality of the T cell 
response to highly and low-pathogenic isolates has to be further investigated.  
8.3.2 Selective persistence of low-pathogenic strain 101 in co-infection 
Induction of a rapid and acute inflammatory response appeared to be decisive for persistence or fungal 
clearance in single-strain infections. We challenged this hypothesis in a setting of co-infection with two 
fungal isolates with opposing behavior, namely the high-pathogenic strain SC5314 and the low-
pathogenic strain 101. During a co-infection, strain SC5314 elicited a strong immune response as 
during single-strain-infection, but this did not affect the persistence of strain 101 in the same host. 
Consequently, we could rule out that strain 101 actively suppressed the induction of a host response, 
which would have also influenced clearance of SC5314 during co-infection.  
The mechanism of immune evasion of strain 101, as an example for a persisting, low-pathogenic 
strains, remains to be further investigated. We could show co-localization of both strains on the tongue 
when looking vertically/in top-view, but we can not exclude a separation in different epithelial cell 
layers of the mucosal tissue. We speculate that the two distinct isolates may actually segregate with 
respect of their invasion depth, as we observed in single-strain-infections, where low-pathogenic 
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strains were restricted to the stratum corneum and the high-pathogenic strains invaded the stratum 
granulosum and spinosum. A possible approach to answer this question could be microdermabrasion 
of the stratum corneum of the tongue prior to infection with a low- or high-pathogenic strain or co-
infection of the two, to generate a situation in which both strains reach the stratum 
granulosum/spinosum. In experiments with skin, the stratum corneum largely reformed within the 
first 24 hours after microdermabrasion (Andrews et al. 2011). This would allow us to modify the initial 
contact site of the fungus with the host and target C. albicans low-pathogenic isolates to a different 
epithelial layer, which likely determines the outcome of the disease. Effector molecules might not 
reach the stratum corneum, in which persistent strains reside, infection of the stratum spinosum can 
proof or dispel this hypothesis. 
We observed drastic differences in invasion depth of distinct C. albicans isolates at an early time point 
of infection, before neutrophil infiltration can keep the invading fungus under control. Activation of c-
Fos and the subsequent proinflammatory cytokine response in epithelial cells to C. albicans is dose-
dependent (Moyes et al. 2010). During exposure of epithelial cells with a low fungal burden, the oral 
epithelial cells may remain "silent", whereas an infection with damage-inducing hyphae and/or a 
higher fungal burden can induce a strong proinflammatory response in the epithelium (Moyes et al. 
2010; Jacobsen et al. 2012). However, our findings could not be correlated with differences in the 
morphology or fungal load of the isolates. We detected only small differences in hyphae formation 
with two triggers for hyphae formation, 37°C and serum. Differences were more pronounced after 
contact with epithelial cells, whereas the proportion of cells forming pseudohyphae or hyphae, the 
hyphal length and the degree of branching highly varied. 
The fungal burden at the onset of infection was comparable among all isolates, although we assessed 
the fungal load in the whole tongue and we can not distinguish between cells which adhere at the 
surface and invaded cells. This could be further investigated in a simplified system with a 3-dimensional 
model of epithelial cells. Staining with fluorescent conjugate of Concanavalin A stains only non-invaded 
fungal elements and would give insight on the proportion of invaded and surface-attached fungal cells 
(Wachtler et al. 2011b). Not only the fungal burden at the onset of infection, but also growth in the 
host tissue might give fitness advantages and impacts the outcome of the infection. It is unclear if 
isolates actively grow or only reside in the host tissue after OPC infection. In order to determine the 
behaviour in the host, a reporter model with photoconvertible C. albicans strains could be used 
(SC5314-mKIKGR, 101-mKIKGR) (Muller et al. 2013). The photoconvertible fluorescent protein 
mKikumeGR expression was introduced in the pathogen under the promoter of the alcohol 
dehydrogenase in order to quantify its growth. The green fluorescent protein in the pathogen converts 
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to red when illuminated with violet light. As the pathogen grows and proliferates, new green proteins 
are produced and the growth can be quantified.  
8.3.3 Morphology does not correlate with virulence and induction of epithelial 
immune response 
Filamentation per se does not appear to be sufficient for pathogenicity and damage induction (Noble 
et al. 2010; Tang et al. 2016; Moyes et al. 2016). The impact of the different C. albicans morphologies 
on the induction of the host immune response is still not well understood (Jacobsen et al. 2012). It was 
proposed that the yeast-to hyphae transition is one of the key virulence factors and non-filamentous 
strains show an attenuated virulence (Lo et al. 1997b; Thompson et al. 2011; Zheng, Wang 2004). 
Infection with a yeast-locked strain in immunocompetent mice led to no severe infection, whereas the 
same strain induced a high killing rate in immunocompromised mice (Saville et al. 2008). 
Hyphae are considered to be the pathogenic phenotype, since they can penetrate tissue and cause 
damage (Jacobsen et al. 2012). However, a mutant (ece1Δ/Δ), which formed normal hyphae is 
unable to induce a damage response and thereby was attenuated in its capacity to trigger an 
inflammatory response in the host when compared to the parental strain (Moyes et al. 2016). 
Proteolytic cleavage of the Ece1 protein leads to the release of a peptide toxin called Candidalysin 
which was described to be required and sufficient for induction of epithelial damage by strain SC5314 
(Moyes et al. 2016). However, in our study we could not correlate filamentation, ECE1 expression and 
damage induction in epithelial cells in vitro. In support of our findings, a previous study by Noble et al. 
also uncoupled infectivity and morphogenesis. These authors showed that infectivity attenuated 
mutants revealed a normal morphological transition (Noble et al. 2010). More refined analysis of 
filamentation under conditions more closely linked to the situation in vivo are needed. We assessed 
filamentation on the surface of the tongue, but investigation of invaded fungal cells remains open. We 
could not correlate morphological differences with the varying degrees of damage induction. It is most 
likely that damage, at least partly, is induced by secreted factors. Supernatants from infected epithelial 
cell culture were sufficient to cause damage (data not shown). Proteomics of the supernatant and the 
secretome in the saliva of infected mice, might give more insight into extracellular factors causing 
damage and influencing the host response. Extracellular vesicles (EV) containing RNA, polysaccharides, 
pigments, proteins and lipids have been found in culture supernatants from fungal pathogens, like 
C.  albicans, Cryptococcus neoformans, Histoplasma capsulatum and Malassezia sympodialis (Joffe et 
al. 2016; Vargas et al. 2015). Proteomic analysis revealed proteins related to pathogenesis and stress 
response, as a result EVs might interfere with the host response (Vargas et al. 2015).  
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The origin of the isolates we tested (mucosal surfaces or blood cultures) did not segregate according 
to differences in pathogenicity. This is in contrast to a study, suggesting tissue-specific virulence of C. 
albicans isolates (Taylor et al. 2000). Herein, mucosal isolates were virulent in the vaginitis infection 
model, whereas most of these isolates were less virulent in the systemic model (Taylor et al. 2000). 
We tested several know virulence attributes to find a possible explanation of the observed differences 
in pathogenicity between isolates seen in vivo. An important virulence attribute of C. albicans is fungal 
adhesion and invasion to host cells (Wachtler et al. 2011b). Proteins of the Als family ( e.g. Als3) play a 
role in cell-surface, cell-cell contacts and invasion (Sheppard et al. 2004). All tested isolates included in 
our study were able to adhere to epithelial cells and to form biofilms, even though at a variable degree. 
The differences in adherence and biofilm formation did, however, not correlate with ALS3 expression 
levels, which were comparable in all isolates. In accordance with other studies, C. albicans isolates 
showed intraspecies variation in their ability to adhere to different substrates and to form biofilm (da 
Costa et al. 2012; Li et al. 2003).  
A possible explanation for differences in pathogenicity between C. albicans isolates could also be at 
the level of fungal recognition by innate immune cells. An example for this is provided by a study which 
showed different recognition by innate immune cells between two unrelated isolates in mice lacking 
the β-1,3-glucan receptor Dectin-, which was based on differences in the composition of their cell walls 
(Marakalala et al. 2013). However, we did not observe differences in the cell wall composition and 
degree of β-glucan exposure among the tested isolates. 
We revealed striking differences in the induction of damage in epithelial cells and were able to link this 
to the release of IL-1α in vitro. Furthermore, IL-1α induction could also be shown in vivo in response to 
two extreme isolates exemplified by strains SC5314 and 101. IL-1 signaling is linked to the regulation 
of neutrophil recruitment in response to C. albicans (Altmeier et al. 2016b; Tomalka et al. 2015; 
Tomalka et al. 2011b). Our data demonstrated that the differential induction of an inflammatory 
response, like infiltrating neutrophils, correlated closely with the induction of damage in keratinocytes 
in vitro. This knowledge provided us with the advantage to investigate a larger collection of isolates as 
it would be possible with mouse experiments in vivo. We performed a preliminary study with 76 
isolates from superficial or invasive origin. The clustering in high, mid and low damage induction 
capacity served as a surrogate for determining the degree of pathogenicity, which correlated with the 
induction of inflammation in the host tissue in vivo. The underlying impact of the C. albicans isolate 
genome on the host response still remains unclear, but the high degree of the possible sequence 
variation between individual isolates is a big challenge (Hirakawa et al. 2015; Ford et al. 2015). 
Variation in the genome will be difficult to translate to phenotypic differences, due to several 
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regulatory levels in between. Proteomics of the secretome in the saliva of infected mice (see above) 
and RNA-seq from the fungus in the infected tongue, might reveal more information. 
8.3.4 Fungal adaptation to host stresses 
Gene expression is dependent on environmental stimuli and provides a fast adaptation to changing 
conditions and niches. Expression of many virulence factors is regulated at the level of transcription in 
response to host encounter. We measured the expression levels of known virulence factors of 
C. albicans in contact with epithelial cell culture but did not find significant differences, apart from 
Ece1 expression (as discussed above). A central role in the pathogenicity of C. albicans is extracellular 
proteolytic activity with several functions in the infective process (Naglik, JR et al. 2003a). SAP 
transcripts in human saliva or vaginal swabs are more frequently detected in oral and vaginal infection 
compared to asymptomatic carriage (Naglik et al. 2003). Analysis of secreted proteins and transcripts 
of C. albicans in the saliva of OPC infected mice might provide better insights in host adaptation. 
C.albicans is, independent of being in a commensal or pathogenic state, exposed to different stressors 
of the host such as changes in temperature, nutrient availability, pH, osmolarity or attack by 
neutrophils and antimicrobial peptides (Wilson et al. 2009). On the other hand, the fungus seems to 
have an adaptation which is predictive, preparing for subsequent events. For example, genes which 
mediate oxidative stress response are already expressed before the actual host response occurs 
(Jacobsen et al. 2012). Adaptation to host stress might vary among isolates, which can be further 
investigated by RNA-seq in the setting of OPC infection in mice. The low-pathogenic strain 101 appear 
to be more susceptible to neutrophil killing in vitro compared to the highly pathogenic strain SC5314. 
Nevertheless, in the setting of co-infection 101 resides in the epithelium despite the infiltrating 
neutrophils, suggesting a possible higher resistance to oxidative stress by reactive oxygen species. 
Our study clearly showed that not only host immune pathways are activated differently to contribute 
to antifungal defense and immunity. Natural variations between the fungal isolates result in selective 
activation of different defense mechanisms and influence the outcome of the fungal-host interaction 
with impact on fungal clearance or possible persistence, independent of the host immune state. 
 
 The hallmark cytokine IL17 plays a non-redundant role in immune 
response to C. albicans irrespective of the pathogenicity 
Dysregulation of IL-17 is associated with psoriasis, rheumatoid and psoriatic arthritis and the 
immunopathology causing these autoinflammatory diseases (Gregersen, Olsson 2009; Di Cesare et al. 
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2009) and most research on IL-17 has been devoted to understanding the host-adversive effects of the 
cytokine. IL-17 is an important therapeutic target, either be blocking IL-17A directly or its receptor, and 
available on the market with spectacular results in remission of psoriasis, rheumatoid and psoriatic 
arthritis (Lonnberg et al. 2014).. However, from an evolutionary perspective, IL-17 has a host-beneficial 
role. More specifically, IL-17 is a key regulator of the mucosal immunity and protective host response 
to fungal infections. Superficial candidiasis is occasionally observed as a side effect of IL-17 targeting, 
underlining the protective role of IL-17 in antifungal immunity (Welch et al. 2015). The non-redundant 
role of IL-17 has been identified in individuals with genetic defects involved in the differentiation of 
Th17 cells or in IL17 signaling that display an increased susceptibility to mucocutaneous candidiasis 
(Cypowyi et al. 2012). 
In several mouse models, infections with Histoplasma capsulatum, Aspergillus fumigatus and 
C. albicans, the absence of IL-17 blunted the clearance of the fungus (Deepe, Gibbons 2009; Werner 
et al. 2009; Gladiator et al. 2013; Trautwein-Weidner et al. 2015b; Kashem et al. 2015a). 
A robust innate immune response is needed to protect the host from superficial and systemic 
candidiasis (Jacobsen et al. 2012). Likewise, it has been shown that depletion of critical components of 
the host immune response, such as neutrophils or IL-17, leads to impaired fungal control or even lethal 
dissemination (Conti et al. 2009; Gladiator et al. 2013; Trautwein-Weidner et al. 2015b; Schönherr et 
al. 2017; Kashem et al. 2015a). From the fungal side, it was shown that IL-17A directly targets 
C. albicans cells and induces a stress response similar to nutrient starvation (Zelante et al. 2012). 
It was shown that neutrophil recruitment and activation during OPC is independent of IL-17. During 
acute OPC IL-17 induces the production of host defense peptides, especially S100A8/9 and mBD3 
(Trautwein-Weidner et al. 2015b). In our study, all isolates triggered a strong IL-17 response, 
irrespective of their pathogenicity, albeit the IL-17 induction was delayed in case of the persistent 
isolates. The delayed IL-17 induction did not entail an enhanced neutrophil response at any time. The 
qualitative differences in the host response between different C. albicans isolates, and in particular the 
observation that the delayed induction of IL-17 by persistent isolates was not accompanied by 
significant neutrophil infiltration, underlines the notion that the IL-17 and neutrophil pathways are 
uncoupled during OPC (Trautwein-Weidner et al. 2015b). By testing these strains in OPC in IL-17-
deficient mice, we were able to demonstrate that the IL-17 pathway is required for preventing fungal 
overgrowth irrespectively of the pathogenicity of the strain. Supporting the fact that the IL-17-
dependent antimicrobial mechanisms are needed for fungal control. This implies that AMPs or other 
IL-17 effector molecules might reach the cornified layer of the epithelium where the persistent isolates 
reside, while neutrophil do not get recruited. Histological analysis revealed that the persistent strains 
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were restricted to the stratum corneum. Nevertheless, IL-17 and its targets are not sufficient for fungal 
clearance in case of persistent isolates. In conclusion, for complete fungal clearance of highly 
pathogenic strains, IL-17 independent neutrophil recruitment and IL-17 dependent antimicrobial 
effector mechanisms are needed (Trautwein-Weidner et al. 2015b). Whereby neutrophils, IL-17 and 
induced effector molecules might diminish the fungal outgrowth of low-pathogenic strains but are not 
sufficient to clear the fungus 
In our study we highlighted the key role of the cytokine IL-17 in protective immunity against C. albicans. 
The IL-17 pathway was required for the prevention of fungal outgrowth and to control the infection, 
irrespective of the pathogenicity of the isolates tested. With this work we raised the importance of the 
natural diversity of C. albicans. The genetic understanding to the phenotypic and functional diversity 
has to be studied. Our study is the first to show strain dependent host immune responses and 
persistence in infection in vivo and highlights the importance of natural diversity in the research of 
fungal infections. 
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Als   Agglutinin-Like Sequence 
APC    antigen presenting cell 
APECED   recessive autoimmune polyendocrinopathy syndrome 
CARD9    caspase recruitment domain-containing protein 9 
CC    clonal Complex 
CDC3    cell division cycle protein 
CMC    Chronic mucocutaneous candidiasis 
CR    complement receptor 
DC    Dendritic cell 
DNA   deoxyribonucleic acid 
Ece1   Extent of Cell Elongation, Candidalysin 
EF3    elongation factor 3 
EGFR    epidermal growth factor receptor 
EV   extracellular vesicle 
G-CSF    Granulocyte colony-stimulating factor 
GM-CSF   Granulocyte-macrophage colony-stimulating factor 
GPI   glycophosphatidylinositol 
Her2   human epidermal growth factor receptor 2 
HIS3    imidazole glycerol phosphate dehydratase 
HIV    Human Immunodeficiency Virus 
Hst-5    Histatin 5 
Hwp1   hyphal wall protein 
IL   interleukin 
ILC   innate lymphoid cells 
LL-37    Cathelicidin 
LOH    loss of heterozygosity 
MALDI-TOF   Matrix-Assisted Laser Desorption/Ionization Time-of-Flight 
MAPK    mitogen-activated protein kinase 
mBD   murine beta defensin 
MLMT   mulitlocus microsatellite typing 
MLST   multilocus sequence typing 
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NET    neutrophil extracellular traps 
NF-кB   nuclear factor 'kappa-light-chain-enhancer' of activated B-cells 
OPC   oropharyngeal candidiasis 
PAMP    pathogen-associated molecular patterns 
PCR    Polymerase chain reaction 
PRR    pathogen recognition receptors 
RNA   ribonucleid acid 
RVVC    recurrent episodes of vulvovaginal candidiasis 
S100A8/S100A9 subunits of calprotectin 
SAP   secreted asparty proteinases 
spp.    species 
ST   sequence type 
STAT1/STAT3   Signal transducer and activator of transcription 1/3 
Syk    spleen tyrosine kinase 
Th   T helper  
TLR    Toll-like receptor 
TNF    tumor necrosis factor 
Treg   regulatory T cell 
VVC    vulvovaginal candidiasis 
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Study Synopsis 
Name of company: 
Dipartimento di pediatria 
Ospedale regionale di Lugano 
 
Tabulated 
Study Protocol 
 
 
 
 
Protocol date: 
11 February 2013 
Trial Number: 
2669 
Planned Study period: 
01.03.2013-01.01.2016 
 
Title of study: Oral and anal colonisation by Candida species in children: an open, 
prospective, non-interventional, matched case study 
Investigators:  Dr. med. Valdo Pezzoli 
Study centre(s): 4 (Ospedale Regionale di Lugano, FMH medicina intensiva via Morosini 6 
6943 Vezia; via Monte Boglia 5 6900 Lugano; Medici-Pediatria  via Foletti 19 
6900 Massagno) 
Clinical phase: n.a. 
Objectives: To study the colonisation by Candida species of the mouth and the anal region 
of children with recurrent candidiasis and healthy, matched controls. 
Methodology: Open, prospective, non-interventional and non randomised, matched case 
control study 
No. of subjects 
 total: 
 each group: 
 
30  
15  
(20 / 60 will be enrolled to cater for dropout and non-carriers) 
Diagnosis and main 
criteria for inclusion: 
Children with recurrent candidiasis and corresponding matched controls with no 
overt candidiasis 
Age: 0-12 years 
 
Procedures: Swabs from skin, throat/mouth and anal region 
 First swab taken at hospital by treating physician or study nurse 
 Follow up swabs to be taken by parents during 3 weeks (1 swab/week) 
 
Duration of 
treatment: 
4 weeks 
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Name of company: 
Dipartimento di pediatria 
Ospedale regionale di Lugano 
 
Tabulated 
Study Protocol 
 
 
 
 
Protocol date: 
11 February 2013 
Trial Number: 
2669 
Planned Study period: 
01.03.2013-01.01.2016 
 
Study Schedule: Swabs will be taken using cotton swabs by the investigator or a study nurse at 
the time of diagnosis (in the case of candidiasis patients) or during a regular 
control visit (for the matched controls) 
Criteria for efficacy:  
Criteria for safety: No safety data will be collected, this being a non-interventional study 
Statistical methods: Pielou’s Evenness index for primary endpoint; Richness, Shannon and Simpson 
diversity indices for the secondary endpoints; contingency tables for frequencies 
of colonisation; demographic data will be presented using descriptive analyses 
(mean, standard deviation, 95% confidence intervals, percentages)  
 
Flow chart 
Study Periods Screening Observational Period 
Visit 1 2 3 4 
Follow-up Day 0 Day 7 +/- 2 Day 14 +/- 2 Day 21 +/- 2 
Informed Consent x    
Demographics x    
Medical History x    
In- /Exclusion Criteria x    
Physical Examination x    
Swabs x x* x* x* 
Concomitant Therapies x x x x 
Conclusion of Subject 
Participation 
    
* at home by parents after instruction 
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Introduction 
Species of Candida are common commensals of the skin and mucosae of the mouth, gastrointestinal 
and genital tract in humans. They may cause superficial mucosal and cutaneous diseases, as well as 
deep tissue and blood infections in humans (1; 2). 
It is still unclear why Candida, in particular C. albicans, can become pathogenic not only in 
immunosuppressed or debilitated patients, but also in healthy individuals. Published data indicate that 
25-35% of women are normal carriers of Candida, but not all of them develop infections (3), suggesting 
that these pathogens may act through a mechanism of immune evasion depending on different 
virulent factors possibly associated to strain specific features. 
The influence of predisposing factors on the colonisation and infection by Candida spp. and the 
outcome of the infection have been studied in clinical settings (4), yet no clear correlation has been 
established between patients’ characteristics and the phenotype/genotype of the etiological agent. 
Candida species may colonise the mucosal surface, on which they normally live without causing any 
symptoms. In some cases, however, they may cause a so-called oral thrush, particularly in infants and 
young babies. Thrush may occur when the yeast grows particularly well, forming extended colonies. 
Known predisposing host factors could be the occurrence of an unbalanced mouth flora during 
antibiotic treatment or a special diet (5; 6). 
According to the literature, 5-7% of less than one-month old babies may develop an oral candidiasis. 
Groups at increased risk are infants, AIDS and cancer patients, where 9-31% may develop an infection 
with C. albicans (7) 
Medical Background 
Oral candidiasis is caused by an extended growth of Candida species. Four main different groups of 
oral forms are distinguished: pseudomenbranous (thrush), chronic erythematous, acute 
erythematous, and chronic hyperplastic candidiasis (6). 
50% of oral candidiasis cases are caused by Candida albicans (5). Especially imunocompromised 
patients can develop a chronic pseudomembranous candidiasis, which can be treated, but often the 
infection is recurrent (8). 
Competition among bacteria and fungi is very extensive on mucosal surfaces, because the nutrients 
are limited; this provides a selective pressure. The nutritional competition, the elaboration of toxic and 
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metabolic products and the alteration of the microenvironment are part of microbial interactions. The 
native bacterial flora can decrease colonization of Candida albicans by competition (8). 
So far, nothing is known on the genotypic composition of the Candida populations colonising the 
mouth and anal region of children with a thrush, as opposed to healthy controls. It is also unknown 
whether or not Candida strains colonising children with candidiasis are genotypically substantially 
different from those present on healthy controls.  
Description and Rationale for Performing the Trial 
The project presented here is the result of collaborative efforts between the paediatrician Dr. med. 
Valdo Pezzoli (Ospedale civico di Lugano) and the Cantonal institute of microbiology (ICM Bellinzona) 
and. 
This project has mainly an epidemiological value and the data resulting from this work will be evaluated 
with the aim of collecting information that may later be used to plan a larger work on the epidemiology 
and distribution of Candida species in small children, as well as of understanding the genotypic 
composition of Candida populations in diseased and healthy children, but the strains isolated will also 
be used within the scope of a larger project that aims at elucidating the pathogenicity of Candida.  
We shall, in fact, use the C. albicans isolated from symptomatic children and healthy matched controls 
to identify biomarkers that could distinguish pathogenic C. albicans from commensal C. albicans, 
because in a pilot study we observed that some pathogenic strains were significantly more resistant to 
at least two oxidant agents as compared with isolates from healthy volunteers. Within the scope of 
the same project, we should also like to study changes on protein expression in C. albicans as a 
response to several physiological conditions. Identification of valid biomarkers will help to clarify the 
complex nature of the fungus-host interaction. We should then like to characterise immunological 
parameters of the patients for which clinical pathology and physiology data are available, as well as 
clinical risk factors that could be responsible for the outcome of the fungal infection, and to correlate 
them with the results of the molecular, biochemical and proteomic characterisation. 
Benefit / Risk Assessment 
The number of patients who develop fungal infections has increased dramatically in the last decades. 
Candidiasis rates are still extremely high, particularly in immunosuppressed patients. A more detailed 
knowledge of the epidemiology of Candida species in children will be helpful to predict infection 
patterns and eventually to develop effective prevention or/and treatment schedules of oral thrush. 
The genotypic and phenotypic characterization of the fungal strains isolated will additionally allow us 
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to prove or dispel the generally accepted dogma that infections by Candida are driven only by the 
patient’s predisposition. The medical information we can obtain from this study may also allow us to 
better characterize the immune response to Candida infections by relating the genotype of the isolated 
strains with the type of patient/volunteer colonised. The results collected will have obvious advantages 
for the planning of therapeutic interventions against candidiasis. The possibility of studying molecular 
pathways possibly altered after fungal infections in cells of the immune system will be of great interest 
to clarify the complicated scenario occurring during fungal infection. 
This being a non-interventional, non-invasive trial, no risks are foreseen for the participating children, 
so that the benefits of the trials will clearly outweigh any risk. 
Study Objectives 
General Aim / Primary Objective 
To investigate the epidemiology of Candida strains in oral candidiasis patients and to compare the 
taxonomic and genetic composition of the fungal (Candida) biota of children with recurrent candidiasis 
with that of matched case controls.  
Primary Endpoint 
The diversity of the Candida populations isolated from the mouth of the patients suffering from thrush 
and from the healthy controls as expressed by the Pielou’s Evenness Index. 
Secondary Endpoints 
The diversity of the Candida populations isolated from the mouth of the patients suffering from thrush 
and from the healthy controls as expressed by the Pielou’s Evenness Index and the Shannon and 
Simpson Diversity Indices. 
The diversity of the Candida populations isolated from the anal regions of the patients suffering from 
thrush and from the healthy controls as expressed by the Pielou’s Evenness Index and the Shannon 
and Simpson Diversity Indices. 
The colonisation rates by different Candida species in the oral and anal regions between children 
suffering from recurrent candidiasis as compared to children with no overt candidiasis but with 
Candida colonisation. 
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The diversity of the Candida populations isolated from the skin of the patients suffering from thrush 
or from the healthy controls as expressed by the Pielou’s Evenness Index and the Shannon and Simpson 
Diversity Indices. 
Determination of the gene expression and proteome profiles of the isolates obtained during the study 
and the correlation of their pathogenicity with the health status of the children as described by their 
general medical history. 
The diversity of the Candida populations isolated from the mouth of the patients suffering from thrush 
after antimycotic treatment as expressed by the Pielou’s Evenness Index and the Shannon and Simpson 
Diversity Indices. 
Description of design and trial population 
Overall Study Design and Plan 
Open, prospective, non-interventional and non randomised, matched case study. 
Discussion of study design, including the choice of control groups  
The design of this study is appropriate to identify the differences in colonisation by different Candida 
species in a population of children with recurrent oral candidiasis (oral thrush). The use of a matched 
case control design will allow us to get first information on the conditions that may be responsible for 
the development of a thrush and to get a reliable estimate of the sample size to be used in a follow-
up, main study.  
Selection of Study Population 
The study population will consist of children between 0-12 years with oral recurrent candidiasis. 
The case controls will be determined by age, race, and gender. The match case control should also 
have a colonization by Candida but no symptoms. 
Inclusion Criteria 
 Age between 0-12 years 
 Informed consent signed 
 No immunosuppression or immune diseases 
 Presence of a candidiasis (in the candidiasis group) or symptomless Candida colonisation in 
the control group. 
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 History of candidiasis (at least one oral thrush before the screening visit) in the candidiasis 
group. 
Exclusion Criteria 
 No colonization by Candida in the matched controls.  
 Current intake of antibiotics 
 Current participation in another clinical study or having already been enrolled in this study. 
Primary Efficacy Variables. 
The diversity of the Candida populations isolated from the mouth of the patients suffering from thrush 
and from the healthy controls as expressed by the Pielou’s Evenness Index. 
Secondary Efficacy Variables 
 The diversity of the Candida populations isolated from the mouth of the patients suffering from thrush 
and from the healthy controls as expressed by the Pielou’s Evenness Index and the Shannon and 
Simpson Diversity Indices. 
The diversity of the Candida populations isolated from the anal regions of the patients suffering from 
thrush and from the healthy controls as expressed by the Pielou’s Evenness Index and the Shannon 
and Simpson Diversity Indices. 
The diversity of the Candida populations isolated from the skin of the patients suffering from thrush 
or from the healthy controls as expressed by the Pielou’s Evenness Index and the Shannon and Simpson 
Diversity Indices. 
The colonisation rates by different Candida species in the oral and anal regions between children 
suffering from recurrent candidiasis as compared to children with no overt candidiasis but with 
Candida colonisation. 
Determination of the gene expression and proteome profiles of the isolates obtained during the study 
and the correlation of their pathogenicity with the health status of the children as described by their 
general medical history. 
The diversity of the Candida populations isolated from the mouth of the patients suffering from thrush 
after antimycotic treatment as expressed by the Pielou’s Evenness Index and the Shannon and Simpson 
Diversity Indices. 
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Appropriateness of Measurements and Variables 
The data collected are appropriate for an epidemiological study of Candida colonisation and infection 
in children. All variables are well suited for the evaluation by the diversity indices foreseen and 
contingency tables as usual in epidemiological studies. 
Routine Monitoring 
Case report forms, progress notes and copies of laboratory and medical test results must be available 
at all times for inspection by the sponsor's clinical study monitor, the health authorities (e.g. FDA) and 
the IRB/IEC. The field monitor may review (all or in part) case report forms, and written informed 
consents. The accuracy of the data will be verified by reviewing the above referenced documents. 
Audits and Inspections 
A quality assurance audit/inspection of this study may be conducted by the sponsor/regulatory 
authorities/IRB/IEC, respectively. The quality assurance auditor/inspector will have access to all 
medical records, the investigator's study related files and correspondence, and the informed consent 
documentation that is relevant to this clinical study.  
Investigational Plan 
For children with recurrent candidiasis: 
The first visit at the hospital for a recurrent candidiasis will be the first time point of the observational 
period. The parents, if agreeable to have their child participate in the investigation, will have to sign 
the informed consent; demographics and medical history will be recorded in the case report form 
(CRF). The paediatrician will also record any concomitant therapy. After checking of the In/Exclusion 
Criteria a physical examination will be carried out and swabs from the mouth region/throat, anal 
regions and if appropriate of skin will be taken by the treating physician or a study nurse. Samples 2-4 
will be taken at home by the parents at weekly intervals, after careful instruction of the parents by the 
physician on how to take the swabs and send them to the laboratory.  
For healthy volunteers (matched case controls): 
During a control visit of their child, the parents will be asked to participate in the study. This control 
visit coincides with the Screening visit and, if agreeable to have their child take part in the investigation, 
the parents will be asked to fill in the informed consent. Demographics, medical history and 
concomitant therapies will be recorded. After checking of the In/Exclusion Criteria a physical 
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examination will be carried out and swabs from mouth region/throat, anal regions and if appropriate 
of the skin will be taken by the treating physician or a study nurse. The swab(s) will be immediately 
plated out in the lab and the culture results communicated to the physician, who will then inform the 
parents about the continuation of the trial. If the swab is positive for Candida species and the 
In/Exclusion Criteria are fulfilled, the child will be included in the study. Samples 2-4 will be taken at 
home by the parents at weekly intervals, after careful instruction of the parents by the physician on 
how to take the swabs and send them to the laboratory.  
Trial procedures at each visit 
Screening Phase 
For all participants the screening phase is also the first time point of the observational period. 
Observational period 
The observational period is 4 weeks and samples will be taken at weekly intervals. Sample #1 will be 
taken in the hospital. Samples #2 to #4 will be taken by the parents and sent directly to the laboratory 
in Bellinzona. 
Follow-up and end of trial 
No follow-up period is foreseen. 
Molecular analyses 
All samples will be studied using standard molecular and biochemical techniques, which include 
microsatellite sequencing, biofilm formation, growth on menadione and other techniques that the 
biologists may deem appropriate to differentiate genotypically and biochemically the strains collected. 
Removal of Patients from Therapy or Assessment (Adherence to Protocol) 
Dropouts and Withdrawals 
Any dropouts will be replaced until the final number of 15 participants per group will be reached. 
Statistical Methods and Determination of sample size 
Statistical Design/Model 
This study has been conceived as a pilot investigation, because no data are available in the literature 
to determine the sample size needed to provide reliable epidemiological data on candida colonisation 
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in patients with recurrent candidiasis and healthy controls. Thus, no statistical design has been set up 
for the study. All analyses will be carried out on an exploratory basis only. 
Null and Alternative Hypotheses 
Primary endpoint 
H0:  No difference exists in the diversity of the Candida populations isolated from the mouth of the 
patients suffering from thrush and from the healthy controls as expressed by the Pielou’s Evenness 
Index. 
H1:  There is a difference in the diversity of the Candida populations isolated from the mouth of 
the patients suffering from thrush and from the healthy controls as expressed by the Pielou’s Evenness 
Index. 
Secondary endpoint 
The null hypotheses for the secondary endpoints will be constructed as for the primary endpoint. 
Planned Analyses 
This being a pilot trial, no specific statistical analyses have been planned. Data will be presented and 
analysed by chi-square for the contingency tables in the case of frequency rates and by appropriate 
tests for diversity indices, using the available software (e.g. http://www.ecosym.univ-montp2.fr/). 
Demographic data will be presented using standard parametric and non-parametric measures. 
Interim Analyses 
No interim analyses are foreseen. 
Handling of Missing Data 
No plans for handling dropouts and imputing missing data are foreseen. Enrolment will be continued 
until the planned number of 15 subjects per group will be reached. 
Evaluable subjects are thus all subjects that provide data for evaluation at all five sampling time points. 
Randomisation 
No randomisation of the subjects is foreseen. 
Determination of Sample Size 
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The sample size of 30 subjects is not based on any statistical considerations, but rather on the 
maximum number of samples that can be reasonably worked up in the lab by the existing manpower. 
On the other hand, 15 subjects for each group should yield a sample size large enough to achieve the 
objectives of the study. Considering an estimated dropout rate of 20%, the inclusion of 20 subjects in 
the candidiasis group should be enough to reach the planned sample size of 15. 
For the matched case controls one can expects approximately 30% of the subject to have a 
symptomless colonisation by Candida species. Thus we plan to screen 50 children to have at least 15 
healthy volunteers colonised by Candida. Considering again an estimated dropout rate of 20%, the 
inclusion of 60 subjects in this group should be enough to reach the planned sample size of 15. 
Administrative matters 
Ethics 
The trial will be carried out in compliance with the protocol, the principles laid down in the Declaration 
of Helsinki, latest version, in accordance with the ICH Harmonised Tripartite Guideline for Good Clinical 
Practice (GCP) and in accordance with applicable regulatory requirements.  
Institutional Review Board (IRB) or Independent Ethics Committee  (IEC) 
According to the regulatory requirements of the participating country, the study will not start before 
the protocol has either been reviewed or approved by the local institutional review board (IRB) i.e. an 
Independent Ethics Committee  (IEC). The constitution of the IRB or IEC must meet the requirements 
of the participating country. The IRB or IEC must also perform all duties outlined by the requirements 
of the participating country. 
Patient Information and Informed Consent 
Prior to subject participation in the study, informed consent will be obtained from each subject (or the 
subject's legally authorised representative) according to the Swiss regulatory and legal requirements. 
This consent must be personally dated and signed by the subject (or its legally authorised 
representative) and the investigator (or his designee) and retained by the investigator as part of the 
study records. The subject must be informed that his / her medical records may be examined by 
authorised representatives from ICM, of health authorities and IRB/IECs. Should a protocol addendum 
(a)/amendment be made, the subject consent form may be revised to reflect the changes of the 
protocol. It is the responsibility of the investigator to ensure that an amended consent is approved or 
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reviewed by the IRB or the IEC, and that it is signed by all subjects subsequently entered in the study 
and those currently in the study, if affected by the amendment. 
Records 
Case Report Forms 
Case report forms for individual subjects will be provided by the sponsor. A copy will be given to the 
laboratory, the original will remain with the investigator. Case report forms are used to record clinical 
study data and are an integral part of the study and subsequent reports. The case report forms, 
therefore, must be legible and complete. All forms should be filled using a black ball point pen. Errors 
should be lined out but not obliterated and the correction inserted, initialled and dated. A declaration 
ensuring accuracy of data recorded in the case report forms must be signed by the investigator. Case 
report forms must be kept current to reflect subject status at each phase during the course of study. 
Subjects are not to be identified on the case report form by name. Appropriate coded identification 
(e.g. Subject Number) and subject initials must be used. Documented medical histories and narrative 
statements relative to the subject's progress during the study will be maintained. These records should 
also include originals or copies of laboratory and other medical test results (e.g. ECGs, etc.), which must 
be kept on file with the individual subject's case report forms. The investigator will be responsible for 
retaining all records pertaining to the study in accordance with local regulatory and legal guidelines. 
Source documents 
Source documents provide evidence for the existence of the subject and substantiate the integrity of 
the data collected. Source documents are filed at the investigator’s site. Data reported on the Case 
Report Forms that are derived from source documents must be consistent with the source documents 
or the discrepancies must be explained. 
The investigator may need to request previous medical records or transfer records, depending on the 
trial; also current medical records – not just shadow charts – must be available.  
The following data to be reported on the CRF should be included and derived from the source 
documents: 
Subject identification (gender, data of birth) 
Subject participation in the trial (substance, trial number, subject number, date informed consent 
given) 
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 Dates of subject’s visits 
 Medical history 
 Medication history 
 Conclusion of subject’s participation in the trial. 
 No AE data will be collected, this being no interventional trial. 
Direct access to source data/documents 
The investigator / institution will permit trial related monitoring, audits, IRB / IEC review and regulatory 
inspection, providing direct access to all related source data / documents. Case report forms and all 
source documents, including progress notes and copies of laboratory and medical test results must be 
available at all times for review by the sponsor’s clinical trial monitor and inspection by health 
authorities (e.g., Swissmedic). The on-site monitor may review all case report forms, and written 
informed consents. The accuracy of the data will be verified by reviewing the documents described in 
Section 7.2.2. 
Quality Assurance Audit 
A quality assurance audit of this trial may be conducted by the sponsor or sponsor’s designees. The 
quality assurance auditor will have access to all medical records, the investigator’s trial related files 
and correspondence, and the informed consent documentation that is relevant to this clinical trial. 
Rules for amending protocol 
All amendments must be documented, dated and signed by the investigator and sponsor. 
Discontinuation of the study 
ICM and the investigator reserve the right to discontinue this study at any time for failure to meet 
expected enrolment goals and any other administrative reasons.  
Statement of confidentiality 
Individual subject medical information obtained as a result of this study is considered confidential and 
disclosure to third parties is prohibited. Subject confidentiality will be further ensured by utilising 
subject identification code numbers to correspond to treatment data in the computer files. Such 
medical information may be given to the subject's personal physician or to other appropriate medical 
personnel responsible for the subject's welfare. Data generated as a result of this study are to be 
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available for inspection on request by the participating physicians, the sponsor's monitors, by the IRB 
or IEC and the regulatory health authorities. 
Insurance 
The study is performed within the scope of clinical activities covered by the insurance of civil liability 
of EOC. 
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